P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.060e-07 | -16.06 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 13 | 18204 | 48 |
VAV3,PLXND1,PREX1,ACER2,SH2B3,SLC9A1,PTPRC,SYK,TMEM131L,DISC1,DOCK8,PTPN6,DAB2 |
2.369e-07 | -15.26 | LCP2 (lymphocyte cytosolic protein 2) | protein interactions | 3937 | 54 | 5 | 19454 | 49 |
PTPRC,VAV3,SYK,HCK,PTPN6 |
5.092e-07 | -14.49 | SH2DOMAIN | prints domains | PR00401 | 72 | 5 | 5227 | 13 |
HCK,VAV3,SH2B3,PTPN6,SYK |
7.955e-07 | -14.04 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 11 | 19454 | 49 |
PREX1,RAPGEF6,MPP1,CADM4,SLC9A1,PPFIBP2,GRK6,RHBDF2,OSBPL8,DOCK8,GAB1 |
1.453e-06 | -13.44 | membrane | cellular component | GO:0016020 | 9220 | 40 | 19108 | 49 |
STAB1,TMCC3,PREX2,CADM4,VMP1,KREMEN1,TMEM131L,TFEB,GRK6,DOCK2,MPP1,ENTPD1,RAPGEF6,SYK,CEMIP,GALNT1,PREX1,SMOX,SH2B3,OSBPL8,PLXND1,SEMA4B,PTGIR,PTPN6,ATP10D,TMTC1,RHBDF2,ACACB,PTPRC,DAB2,SLC9A1,ASCC3,ACER2,HCK,SLC16A10,DOCK8,VAV3,ATG14,FCHO2,PHKB |
2.183e-06 | -13.03 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 7 | 18094 | 48 |
PREX1,PTGIR,DOCK2,VAV3,PREX2,DOCK8,RAPGEF6 |
3.370e-06 | -12.60 | cell migration | biological process | GO:0016477 | 921 | 12 | 18204 | 48 |
PTPRC,DISC1,SYK,DOCK8,SLC9A1,DOCK2,SEMA4B,HCK,GAB1,VAV3,PLXND1,PREX1 |
3.511e-06 | -12.56 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 22 | 18204 | 48 |
CADM4,SH2B3,PTGIR,PREX1,BMP2K,VAV3,KREMEN1,DOCK2,RBM47,RHBDF2,GRK6,DAB2,SYK,DISC1,PTPRC,TMEM131L,DOCK8,OSBPL8,PTPN6,SLC9A1,NACC2,PREX2 |
3.552e-06 | -12.55 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 7 | 19454 | 49 |
SYK,HCK,GAB1,SH2B3,PTPN6,DISC1,VAV3 |
4.077e-06 | -12.41 | BLNK (B cell linker) | protein interactions | 29760 | 43 | 4 | 19454 | 49 |
PTPN6,GAB1,SYK,VAV3 |
4.286e-06 | -12.36 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 15 | 18204 | 48 |
HCK,DOCK2,PREX2,SLC9A1,PTPN6,DOCK8,SYK,DISC1,PTPRC,ACER2,PREX1,SH2B3,VAV3,ATG14,RAPGEF6 |
5.345e-06 | -12.14 | B cell receptor signaling pathway | biological process | GO:0050853 | 44 | 4 | 18204 | 48 |
VAV3,PTPN6,PTPRC,SYK |
7.163e-06 | -11.85 | SH2 | pfam domains | PF00017 | 100 | 5 | 17795 | 48 |
SH2B3,HCK,PTPN6,SYK,VAV3 |
7.537e-06 | -11.80 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 25 | 18204 | 48 |
OSBPL8,TMEM131L,RHBDF2,HCK,DAB2,GRK6,BMP2K,SH2B3,MPP1,PREX1,PTPN6,DOCK8,DISC1,PTPRC,SYK,PREX2,NACC2,SLC9A1,RBM47,DOCK2,KREMEN1,VAV3,CADM4,ACACB,PTGIR |
8.135e-06 | -11.72 | CD247 (CD247 molecule) | protein interactions | 919 | 51 | 4 | 19454 | 49 |
DOCK2,PTPN6,SH2B3,PTPRC |
8.250e-06 | -11.71 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 5 | 19454 | 49 |
VAV3,HCK,SH2B3,PTPN6,SYK |
9.988e-06 | -11.51 | SH2 | interpro domains | IPR000980 | 109 | 5 | 18521 | 49 |
VAV3,PTPN6,SH2B3,HCK,SYK |
1.006e-05 | -11.51 | plasma membrane | cellular component | GO:0005886 | 5538 | 29 | 19108 | 49 |
ATP10D,PTGIR,SEMA4B,PTPN6,DAB2,PTPRC,RHBDF2,HCK,SLC9A1,PHKB,FCHO2,VAV3,DOCK8,SLC16A10,PREX2,STAB1,DOCK2,GRK6,TMEM131L,KREMEN1,VMP1,CEMIP,RAPGEF6,SYK,MPP1,ENTPD1,PLXND1,SH2B3,PREX1 |
1.191e-05 | -11.34 | SH2_dom_sf | interpro domains | IPR036860 | 113 | 5 | 18521 | 49 |
SH2B3,SYK,HCK,PTPN6,VAV3 |
1.646e-05 | -11.01 | SH2 domain | gene3d domains | 3.30.505.10 | 111 | 5 | 14470 | 42 |
SYK,HCK,VAV3,SH2B3,PTPN6 |
1.707e-05 | -10.98 | cell periphery | cellular component | GO:0071944 | 6020 | 30 | 19108 | 49 |
DAB2,RHBDF2,PTPRC,ATP10D,SEMA4B,PTPN6,PTGIR,FCHO2,PHKB,VAV3,SLC16A10,DOCK8,HCK,SLC9A1,DOCK2,TMEM131L,GRK6,KREMEN1,VMP1,PREX2,STAB1,PLXND1,OSBPL8,PREX1,SH2B3,CEMIP,ENTPD1,MPP1,RAPGEF6,SYK |
1.894e-05 | -10.87 | SH2 | prosite domains | PS50001 | 107 | 5 | 12186 | 38 |
VAV3,SYK,HCK,SH2B3,PTPN6 |
1.901e-05 | -10.87 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | biological process | GO:0002433 | 20 | 3 | 18204 | 48 |
SYK,VAV3,HCK |
1.901e-05 | -10.87 | Fc-gamma receptor signaling pathway involved in phagocytosis | biological process | GO:0038096 | 20 | 3 | 18204 | 48 |
VAV3,HCK,SYK |
2.063e-05 | -10.79 | cell motility | biological process | GO:0048870 | 1101 | 12 | 18204 | 48 |
SEMA4B,DOCK2,PREX1,PLXND1,HCK,GAB1,SYK,DISC1,PTPRC,DOCK8,VAV3,SLC9A1 |
2.194e-05 | -10.73 | Fc gamma R-mediated phagocytosis | KEGG pathways | hsa04666 | 90 | 5 | 7161 | 28 |
SYK,PTPRC,VAV3,HCK,DOCK2 |
2.194e-05 | -10.73 | Fc gamma R-mediated phagocytosis | KEGG pathways | ko04666 | 90 | 5 | 7161 | 28 |
HCK,VAV3,DOCK2,PTPRC,SYK |
2.238e-05 | -10.71 | GDS_CDC24_CS | interpro domains | IPR001331 | 21 | 3 | 18521 | 49 |
PREX2,VAV3,PREX1 |
2.276e-05 | -10.69 | SH2 | smart domains | SM00252 | 103 | 5 | 9717 | 33 |
PTPN6,VAV3,HCK,SH2B3,SYK |
2.282e-05 | -10.69 | CCDC107 (coiled-coil domain containing 107) | protein interactions | 203260 | 66 | 4 | 19454 | 49 |
ACACB,SLC9A1,RHBDF2,TMEM131L |
2.558e-05 | -10.57 | Fc receptor mediated stimulatory signaling pathway | biological process | GO:0002431 | 22 | 3 | 18204 | 48 |
SYK,HCK,VAV3 |
2.882e-05 | -10.45 | INPP5D (inositol polyphosphate-5-phosphatase D) | protein interactions | 3635 | 70 | 4 | 19454 | 49 |
GAB1,HCK,SYK,DAB2 |
2.887e-05 | -10.45 | regulation of signaling | biological process | GO:0023051 | 3534 | 22 | 18204 | 48 |
BMP2K,KREMEN1,VAV3,CADM4,SH2B3,PTGIR,PREX1,DOCK8,DISC1,PTPRC,TMEM131L,SYK,PTPN6,OSBPL8,NACC2,SLC9A1,PREX2,RBM47,DOCK2,RHBDF2,GRK6,DAB2 |
2.981e-05 | -10.42 | regulation of cell communication | biological process | GO:0010646 | 3541 | 22 | 18204 | 48 |
PREX2,SLC9A1,NACC2,OSBPL8,PTPN6,TMEM131L,SYK,DISC1,PTPRC,DOCK8,DAB2,GRK6,RHBDF2,DOCK2,RBM47,VAV3,KREMEN1,BMP2K,PREX1,PTGIR,SH2B3,CADM4 |
3.157e-05 | -10.36 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 11 | 19454 | 49 |
OSBPL8,GAB1,DOCK8,DAB2,DIAPH2,DOCK2,SLC9A1,PREX2,PREX1,FCHO2,VAV3 |
3.579e-05 | -10.24 | DH_1 | prosite domains | PS00741 | 21 | 3 | 12186 | 38 |
PREX1,VAV3,PREX2 |
3.595e-05 | -10.23 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 8 | 18204 | 48 |
DAB2,PREX1,PTPN6,DOCK8,PTPRC,SYK,DISC1,VAV3 |
4.199e-05 | -10.08 | PTGIR (prostaglandin I2 receptor) | protein interactions | 5739 | 77 | 4 | 19454 | 49 |
VMP1,SLC9A1,OSBPL8,PTGIR |
4.748e-05 | -9.96 | T cell proliferation | biological process | GO:0042098 | 76 | 4 | 18204 | 48 |
PTPRC,DOCK2,DOCK8,PTPN6 |
5.331e-05 | -9.84 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 10 | 18204 | 48 |
DOCK2,SLC9A1,VAV3,PREX2,PTPRC,SYK,DOCK8,ATG14,PTPN6,RAPGEF6 |
6.423e-05 | -9.65 | CSF2RB (colony stimulating factor 2 receptor subunit beta) | protein interactions | 1439 | 31 | 3 | 19454 | 49 |
PTPN6,HCK,SYK |
6.780e-05 | -9.60 | PLCG2 (phospholipase C gamma 2) | protein interactions | 5336 | 87 | 4 | 19454 | 49 |
SYK,PTPN6,GAB1,HCK |
6.910e-05 | -9.58 | PH_domain | interpro domains | IPR001849 | 266 | 6 | 18521 | 49 |
GAB1,SH2B3,OSBPL8,PREX2,VAV3,PREX1 |
7.442e-05 | -9.51 | signaling | biological process | GO:0023052 | 4968 | 26 | 18204 | 48 |
TMEM131L,GRK6,DAB2,HCK,GAB1,STAB1,ATG14,PREX1,ACER2,MPP1,SH2B3,SLC9A1,PREX2,SYK,DISC1,PTPRC,DOCK8,PTPN6,DOCK2,SLC16A10,SEMA4B,VAV3,KREMEN1,RAPGEF6,PTGIR,PLXND1 |
8.087e-05 | -9.42 | Fc-gamma receptor signaling pathway | biological process | GO:0038094 | 32 | 3 | 18204 | 48 |
HCK,VAV3,SYK |
8.344e-05 | -9.39 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 5 | 19454 | 49 |
VAV3,SYK,HCK,PTPN6,SH2B3 |
8.607e-05 | -9.36 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 6 | 18204 | 48 |
DOCK8,RAPGEF6,PREX2,VAV3,PREX1,PLXND1 |
8.683e-05 | -9.35 | cell communication | biological process | GO:0007154 | 5010 | 26 | 18204 | 48 |
TMEM131L,DAB2,HCK,GRK6,STAB1,ATG14,GAB1,ACER2,PREX1,SH2B3,MPP1,PREX2,SLC9A1,PTPN6,DOCK8,DISC1,PTPRC,SYK,SEMA4B,SLC16A10,DOCK2,KREMEN1,VAV3,RAPGEF6,PLXND1,PTGIR |
8.880e-05 | -9.33 | negative regulation of inflammatory response to antigenic stimulus | biological process | GO:0002862 | 33 | 3 | 18204 | 48 |
HCK,RHBDF2,SYK |
9.572e-05 | -9.25 | Regulation of RAC1 activity | Pathway Interaction DB | rac1_reg_pathway | 39 | 4 | 2226 | 15 |
DOCK2,VAV3,PREX2,PREX1 |
1.008e-04 | -9.20 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 9 | 18204 | 48 |
ACER2,PREX1,PLXND1,PREX2,VAV3,DOCK8,PTPRC,SYK,RAPGEF6 |
1.014e-04 | -9.20 | membrane raft distribution | biological process | GO:0031580 | 6 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
1.094e-04 | -9.12 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 44 | 16828 | 46 |
PREX2,DAB2,TFEB,KREMEN1,CADM4,ACER2,MPP1,SLC16A10,VAV3,VMP1,DOCK2,RHBDF2,BMP2K,PTGIR,PREX1,SH2B3,SEMA4B,GALNT1,ATG14,GRK6,SLC9A1,TMCC3,ACACB,BLVRA,DIAPH2,DISC1,PTPN6,GAB1,NACC2,ATP10D,TMTC1,SMOX,PPFIBP2,FCHO2,DOCK8,PTPRC,ASCC3,STAB1,SYK,RAPGEF6,OSBPL8,PPP1R7,RBM47,PLXND1 |
1.099e-04 | -9.12 | CD22 (CD22 molecule) | protein interactions | 933 | 37 | 3 | 19454 | 49 |
PTPRC,SYK,PTPN6 |
1.143e-04 | -9.08 | regulation of cytokine-mediated signaling pathway | biological process | GO:0001959 | 182 | 5 | 18204 | 48 |
PTPRC,SYK,RBM47,SH2B3,PTPN6 |
1.183e-04 | -9.04 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 4 | 18204 | 48 |
SYK,VAV3,DAB2,HCK |
1.192e-04 | -9.03 | regulation of endocytosis | biological process | GO:0030100 | 295 | 6 | 18204 | 48 |
PTPRC,SYK,BMP2K,DOCK2,DAB2,HCK |
1.201e-04 | -9.03 | cytoplasm | cellular component | GO:0005737 | 12081 | 43 | 19108 | 49 |
RBM47,TMCC3,GRK6,TFEB,DIAPH2,BMP2K,CEMIP,GALNT1,DISC1,OSBPL8,PREX1,SMOX,SH2B3,GAB1,PTGIR,ATP10D,TMTC1,PTPRC,BLVRA,HCK,SLC9A1,ASCC3,VAV3,NACC2,FCHO2,PHKB,DOCK8,PREX2,STAB1,TMEM131L,DOCK2,VMP1,MPP1,RAPGEF6,SYK,PPFIBP2,PPP1R7,PTPN6,RHBDF2,ACACB,DAB2,ACER2,ATG14 |
1.211e-04 | -9.02 | negative regulation of response to external stimulus | biological process | GO:0032102 | 428 | 7 | 18204 | 48 |
KREMEN1,SYK,PTPRC,PTPN6,HCK,RHBDF2,SH2B3 |
1.269e-04 | -8.97 | regulation of cell motility | biological process | GO:2000145 | 1122 | 11 | 18204 | 48 |
DAB2,SEMA4B,DOCK8,PTPRC,OSBPL8,PLXND1,PREX1,CADM4,MPP1,GAB1,CEMIP |
1.284e-04 | -8.96 | regulation of molecular function | biological process | GO:0065009 | 2005 | 15 | 18204 | 48 |
HCK,DAB2,SLC9A1,PREX2,VMP1,DOCK8,PTPRC,SYK,DISC1,ACER2,PREX1,PLXND1,VAV3,RAPGEF6,CEMIP |
1.300e-04 | -8.95 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 7 | 18521 | 49 |
DAB2,OSBPL8,PREX2,PREX1,GAB1,VAV3,SH2B3 |
1.386e-04 | -8.88 | hematopoietic progenitor cell differentiation | biological process | GO:0002244 | 100 | 4 | 18204 | 48 |
PTPRC,RBM47,SH2B3,PTPN6 |
1.416e-04 | -8.86 | prostate | COSMIC cancer mutations | prostate | 13883 | 46 | 16828 | 46 |
RAPGEF6,PLXND1,RBM47,PPP1R7,OSBPL8,STAB1,SYK,ENTPD1,ATP10D,NACC2,GAB1,PTPN6,TMTC1,DIAPH2,BLVRA,DISC1,HCK,ASCC3,PTPRC,SMOX,DOCK8,FCHO2,PPFIBP2,SLC9A1,GRK6,ATG14,SEMA4B,SH2B3,GALNT1,ACACB,TMCC3,ACER2,MPP1,CADM4,SLC16A10,PREX2,KREMEN1,TFEB,DAB2,BMP2K,PTGIR,RHBDF2,PREX1,DOCK2,VMP1,VAV3 |
1.418e-04 | -8.86 | positive regulation of gamma-delta T cell differentiation | biological process | GO:0045588 | 7 | 2 | 18204 | 48 |
SYK,PTPRC |
1.418e-04 | -8.86 | autophagosome membrane docking | biological process | GO:0016240 | 7 | 2 | 18204 | 48 |
VMP1,ATG14 |
1.418e-04 | -8.86 | membrane raft localization | biological process | GO:0051665 | 7 | 2 | 18204 | 48 |
DOCK2,PTPRC |
1.440e-04 | -8.85 | platelet activation | biological process | GO:0030168 | 101 | 4 | 18204 | 48 |
ENTPD1,PTPN6,SYK,VAV3 |
1.442e-04 | -8.84 | PH | pfam domains | PF00169 | 187 | 5 | 17795 | 48 |
VAV3,GAB1,OSBPL8,PREX2,SH2B3 |
1.455e-04 | -8.84 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 6 | 18204 | 48 |
DOCK8,VAV3,PREX2,DOCK2,CADM4,PREX1 |
1.466e-04 | -8.83 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 39 | 16828 | 46 |
PREX2,DIAPH2,TFEB,KREMEN1,DISC1,DAB2,MPP1,ACER2,ATP10D,GAB1,PTPN6,NACC2,SLC16A10,TMTC1,VMP1,DOCK8,DOCK2,PPFIBP2,VAV3,PTGIR,BMP2K,HCK,RHBDF2,PTPRC,PREX1,ASCC3,SEMA4B,STAB1,SH2B3,GALNT1,SYK,RAPGEF6,RBM47,PLXND1,GRK6,PPP1R7,SLC9A1,TMCC3,ACACB |
1.488e-04 | -8.81 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 39 | 16828 | 46 |
ACACB,TMCC3,RAPGEF6,PPP1R7,SLC9A1,PLXND1,RBM47,GRK6,STAB1,SH2B3,SEMA4B,GALNT1,SYK,HCK,RHBDF2,PTGIR,BMP2K,PTPRC,ASCC3,PREX1,PPFIBP2,VAV3,VMP1,DOCK8,DOCK2,GAB1,PTPN6,NACC2,ACER2,MPP1,ATP10D,TMTC1,SLC16A10,PREX2,DIAPH2,DISC1,DAB2,TFEB,KREMEN1 |
1.496e-04 | -8.81 | regulation of phagocytosis | biological process | GO:0050764 | 102 | 4 | 18204 | 48 |
HCK,DOCK2,PTPRC,SYK |
1.541e-04 | -8.78 | regulation of response to cytokine stimulus | biological process | GO:0060759 | 194 | 5 | 18204 | 48 |
SH2B3,PTPN6,RBM47,PTPRC,SYK |
1.562e-04 | -8.76 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 6 | 18204 | 48 |
PLXND1,ACER2,PTPN6,SH2B3,TMEM131L,PTPRC |
1.582e-04 | -8.75 | VAV1 (vav guanine nucleotide exchange factor 1) | protein interactions | 7409 | 204 | 5 | 19454 | 49 |
HCK,GAB1,DOCK2,PTPN6,SYK |
1.656e-04 | -8.71 | negative regulation of immune response | biological process | GO:0050777 | 197 | 5 | 18204 | 48 |
PTPRC,SYK,RHBDF2,PTPN6,HCK |
1.704e-04 | -8.68 | T cell activation | biological process | GO:0042110 | 315 | 6 | 18204 | 48 |
PTPN6,DOCK8,PTPRC,SYK,DOCK2,PREX1 |
1.755e-04 | -8.65 | regulation of locomotion | biological process | GO:0040012 | 1164 | 11 | 18204 | 48 |
CEMIP,GAB1,PLXND1,PREX1,MPP1,CADM4,OSBPL8,PTPRC,DOCK8,DAB2,SEMA4B |
1.818e-04 | -8.61 | negative regulation of inflammatory response | biological process | GO:0050728 | 201 | 5 | 18204 | 48 |
PTPN6,RHBDF2,PTPRC,SYK,HCK |
1.852e-04 | -8.59 | CRKL (CRK like proto-oncogene, adaptor protein) | protein interactions | 1399 | 211 | 5 | 19454 | 49 |
SYK,HCK,GAB1,DOCK2,PPFIBP2 |
1.855e-04 | -8.59 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 14 | 18204 | 48 |
VAV3,PREX1,CADM4,SH2B3,NACC2,SLC9A1,PREX2,DOCK8,PTPRC,SYK,PTPN6,OSBPL8,DAB2,DOCK2 |
1.978e-04 | -8.53 | EPOR (erythropoietin receptor) | protein interactions | 2057 | 45 | 3 | 19454 | 49 |
GAB1,PTPN6,SYK |
2.045e-04 | -8.49 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 7 | 18204 | 48 |
PREX2,DOCK8,SYK,PTPRC,RAPGEF6,ACER2,PREX1 |
2.046e-04 | -8.49 | PH | smart domains | SM00233 | 259 | 6 | 9717 | 33 |
VAV3,PREX2,PREX1,OSBPL8,SH2B3,GAB1 |
2.168e-04 | -8.44 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 7 | 14470 | 42 |
OSBPL8,SH2B3,VAV3,DAB2,PREX1,GAB1,PREX2 |
2.212e-04 | -8.42 | KLRA1P (killer cell lectin like receptor A1, pseudogene) | protein interactions | 10748 | 9 | 2 | 19454 | 49 |
SYK,PTPN6 |
2.223e-04 | -8.41 | signal transduction | biological process | GO:0007165 | 4637 | 24 | 18204 | 48 |
VAV3,KREMEN1,RAPGEF6,PTGIR,PLXND1,SLC9A1,PREX2,SYK,DISC1,PTPRC,DOCK8,PTPN6,DOCK2,SEMA4B,GAB1,ATG14,PREX1,ACER2,MPP1,SH2B3,TMEM131L,GRK6,HCK,DAB2 |
2.259e-04 | -8.40 | negative regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050732 | 45 | 3 | 18204 | 48 |
PTPN6,CADM4,PTPRC |
2.422e-04 | -8.33 | gamma-delta T cell differentiation | biological process | GO:0042492 | 9 | 2 | 18204 | 48 |
SYK,PTPRC |
2.422e-04 | -8.33 | positive regulation of gamma-delta T cell activation | biological process | GO:0046645 | 9 | 2 | 18204 | 48 |
SYK,PTPRC |
2.422e-04 | -8.33 | regulation of gamma-delta T cell differentiation | biological process | GO:0045586 | 9 | 2 | 18204 | 48 |
SYK,PTPRC |
2.464e-04 | -8.31 | response to external stimulus | biological process | GO:0009605 | 1882 | 14 | 18204 | 48 |
SEMA4B,DOCK2,HCK,PTPN6,SYK,DISC1,PTPRC,SLC9A1,PREX1,PTGIR,STAB1,GAB1,TFEB,VAV3 |
2.480e-04 | -8.30 | RHOF (ras homolog family member F, filopodia associated) | protein interactions | 54509 | 671 | 8 | 19454 | 49 |
FCHO2,SLC9A1,BLVRA,OSBPL8,DOCK8,GAB1,DAB2,DIAPH2 |
2.571e-04 | -8.27 | T cell selection | biological process | GO:0045058 | 47 | 3 | 18204 | 48 |
PTPRC,SYK,DOCK2 |
2.596e-04 | -8.26 | Nef and signal transduction | REACTOME pathways | R-HSA-164944 | 8 | 2 | 10285 | 32 |
DOCK2,HCK |
2.608e-04 | -8.25 | RHOU (ras homolog family member U) | protein interactions | 58480 | 507 | 7 | 19454 | 49 |
DAB2,SYK,OSBPL8,GAB1,FCHO2,BLVRA,GRK6 |
2.617e-04 | -8.25 | phosphotyrosine residue binding | molecular function | GO:0001784 | 47 | 3 | 18094 | 48 |
SYK,HCK,PTPN6 |
2.738e-04 | -8.20 | regulation of inflammatory response to antigenic stimulus | biological process | GO:0002861 | 48 | 3 | 18204 | 48 |
HCK,SYK,RHBDF2 |
2.783e-04 | -8.19 | chemotaxis | biological process | GO:0006935 | 345 | 6 | 18204 | 48 |
DOCK2,SEMA4B,PREX1,GAB1,SYK,VAV3 |
2.822e-04 | -8.17 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 5 | 18204 | 48 |
SLC9A1,PREX1,ACER2,DAB2,DISC1 |
2.870e-04 | -8.16 | taxis | biological process | GO:0042330 | 347 | 6 | 18204 | 48 |
GAB1,SYK,VAV3,SEMA4B,DOCK2,PREX1 |
2.911e-04 | -8.14 | regulation of cell adhesion mediated by integrin | biological process | GO:0033628 | 49 | 3 | 18204 | 48 |
SYK,PTPN6,ACER2 |
2.917e-04 | -8.14 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 7 | 18094 | 48 |
PREX2,VAV3,DOCK2,PTGIR,PREX1,RAPGEF6,DOCK8 |
2.917e-04 | -8.14 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 7 | 18094 | 48 |
DOCK2,VAV3,PREX1,PTGIR,PREX2,RAPGEF6,DOCK8 |
2.989e-04 | -8.12 | JAK1 (Janus kinase 1) | protein interactions | 3716 | 234 | 5 | 19454 | 49 |
DISC1,PTPRC,SYK,PTPN6,GAB1 |
3.101e-04 | -8.08 | endocytosis | biological process | GO:0006897 | 499 | 7 | 18204 | 48 |
VAV3,SYK,FCHO2,STAB1,DAB2,HCK,DOCK2 |
3.257e-04 | -8.03 | immune response-activating cell surface receptor signaling pathway | biological process | GO:0002429 | 228 | 5 | 18204 | 48 |
PTPN6,PTPRC,SYK,HCK,VAV3 |
3.423e-04 | -7.98 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 17 | 16828 | 46 |
ASCC3,PTGIR,VMP1,DOCK2,DOCK8,ENTPD1,TMCC3,PLXND1,SLC9A1,ATG14,OSBPL8,TMTC1,ATP10D,RAPGEF6,PTPN6,GALNT1,STAB1 |
3.571e-04 | -7.94 | regulation of B cell activation | biological process | GO:0050864 | 128 | 4 | 18204 | 48 |
VAV3,PTPN6,PTPRC,SYK |
3.688e-04 | -7.91 | regulation of gamma-delta T cell activation | biological process | GO:0046643 | 11 | 2 | 18204 | 48 |
PTPRC,SYK |
3.706e-04 | -7.90 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 33 | 16828 | 46 |
SEMA4B,SH2B3,STAB1,SYK,GRK6,PPP1R7,PLXND1,OSBPL8,ATG14,TMCC3,ACACB,DIAPH2,BLVRA,PREX2,ATP10D,MPP1,NACC2,GAB1,CADM4,SLC16A10,TMTC1,DOCK2,DOCK8,VMP1,FCHO2,VAV3,PPFIBP2,PTGIR,BMP2K,HCK,PREX1,ASCC3,PTPRC |
3.714e-04 | -7.90 | DOCKER_Lobe_C | interpro domains | IPR046773 | 11 | 2 | 18521 | 49 |
DOCK8,DOCK2 |
3.714e-04 | -7.90 | DOCKER_Lobe_B | interpro domains | IPR046770 | 11 | 2 | 18521 | 49 |
DOCK8,DOCK2 |
3.714e-04 | -7.90 | DOCKER_Lobe_A | interpro domains | IPR046769 | 11 | 2 | 18521 | 49 |
DOCK2,DOCK8 |
3.714e-04 | -7.90 | C2_DOCK-type_domain | interpro domains | IPR027007 | 11 | 2 | 18521 | 49 |
DOCK2,DOCK8 |
3.714e-04 | -7.90 | DOCKER_dom | interpro domains | IPR027357 | 11 | 2 | 18521 | 49 |
DOCK8,DOCK2 |
3.714e-04 | -7.90 | DOCK_C_lobe_A | interpro domains | IPR043161 | 11 | 2 | 18521 | 49 |
DOCK2,DOCK8 |
3.714e-04 | -7.90 | DOCK_C_lobe_C | interpro domains | IPR043162 | 11 | 2 | 18521 | 49 |
DOCK8,DOCK2 |
3.714e-04 | -7.90 | DOCK | interpro domains | IPR026791 | 11 | 2 | 18521 | 49 |
DOCK8,DOCK2 |
3.726e-04 | -7.90 | regulation of cell migration | biological process | GO:0030334 | 1061 | 10 | 18204 | 48 |
PTPRC,GAB1,DOCK8,CEMIP,OSBPL8,PREX1,PLXND1,DAB2,MPP1,SEMA4B |
3.788e-04 | -7.88 | lymphocyte proliferation | biological process | GO:0046651 | 130 | 4 | 18204 | 48 |
DOCK8,PTPRC,DOCK2,PTPN6 |
3.790e-04 | -7.88 | PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) | protein interactions | 5294 | 56 | 3 | 19454 | 49 |
GAB1,SYK,CEMIP |
3.831e-04 | -7.87 | PICALM (phosphatidylinositol binding clathrin assembly protein) | protein interactions | 8301 | 247 | 5 | 19454 | 49 |
DAB2,RBM47,FCHO2,BMP2K,VMP1 |
3.858e-04 | -7.86 | DOCK-C2 | pfam domains | PF14429 | 11 | 2 | 17795 | 48 |
DOCK2,DOCK8 |
3.858e-04 | -7.86 | DHR-2_Lobe_A | pfam domains | PF06920 | 11 | 2 | 17795 | 48 |
DOCK2,DOCK8 |
3.858e-04 | -7.86 | DHR-2_Lobe_C | pfam domains | PF20421 | 11 | 2 | 17795 | 48 |
DOCK8,DOCK2 |
3.858e-04 | -7.86 | DHR-2_Lobe_B | pfam domains | PF20422 | 11 | 2 | 17795 | 48 |
DOCK8,DOCK2 |
3.870e-04 | -7.86 | locomotion | biological process | GO:0040011 | 367 | 6 | 18204 | 48 |
PREX1,SEMA4B,DOCK2,VAV3,GAB1,SYK |
3.902e-04 | -7.85 | MET (MET proto-oncogene, receptor tyrosine kinase) | protein interactions | 4233 | 248 | 5 | 19454 | 49 |
SYK,SH2B3,GAB1,HCK,VAV3 |
3.915e-04 | -7.85 | import into cell | biological process | GO:0098657 | 687 | 8 | 18204 | 48 |
STAB1,FCHO2,SYK,VAV3,SLC9A1,DOCK2,HCK,DAB2 |
3.993e-04 | -7.83 | PTPRC (protein tyrosine phosphatase receptor type C) | protein interactions | 5788 | 57 | 3 | 19454 | 49 |
PPFIBP2,PTPRC,PTPN6 |
4.036e-04 | -7.81 | SOWAHB (sosondowah ankyrin repeat domain family member B) | protein interactions | 345079 | 12 | 2 | 19454 | 49 |
DIAPH2,RAPGEF6 |
4.068e-04 | -7.81 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 43 | 16828 | 46 |
SMOX,PPFIBP2,DOCK8,HCK,ASCC3,PTPRC,DIAPH2,BLVRA,GAB1,NACC2,PTPN6,ATP10D,TMTC1,ENTPD1,STAB1,SYK,RAPGEF6,OSBPL8,RBM47,PLXND1,PPP1R7,VAV3,DOCK2,VMP1,RHBDF2,PTGIR,BMP2K,PREX1,PREX2,DAB2,KREMEN1,TFEB,ACER2,MPP1,SLC16A10,TMCC3,ACACB,SH2B3,SEMA4B,GALNT1,ATG14,GRK6,SLC9A1 |
4.099e-04 | -7.80 | Fc receptor signaling pathway | biological process | GO:0038093 | 55 | 3 | 18204 | 48 |
SYK,HCK,VAV3 |
4.099e-04 | -7.80 | neutrophil chemotaxis | biological process | GO:0030593 | 55 | 3 | 18204 | 48 |
SYK,PREX1,VAV3 |
4.213e-04 | -7.77 | B Cell Receptor Signaling Pathway | WikiPathways | WP23 | 98 | 4 | 5310 | 20 |
PTPRC,GAB1,PTPN6,SYK |
4.249e-04 | -7.76 | mononuclear cell proliferation | biological process | GO:0032943 | 134 | 4 | 18204 | 48 |
DOCK8,DOCK2,PTPRC,PTPN6 |
4.418e-04 | -7.72 | positive thymic T cell selection | biological process | GO:0045059 | 12 | 2 | 18204 | 48 |
DOCK2,PTPRC |
4.418e-04 | -7.72 | negative thymic T cell selection | biological process | GO:0045060 | 12 | 2 | 18204 | 48 |
DOCK2,PTPRC |
4.443e-04 | -7.72 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 14 | 18204 | 48 |
GAB1,VAV3,KREMEN1,SH2B3,PLXND1,SYK,DISC1,TMEM131L,PTPRC,PTPN6,SEMA4B,GRK6,HCK,DAB2 |
4.449e-04 | -7.72 | - | gene3d domains | 1.20.58.740 | 11 | 2 | 14470 | 42 |
DOCK2,DOCK8 |
4.449e-04 | -7.72 | - | gene3d domains | 1.25.40.410 | 11 | 2 | 14470 | 42 |
DOCK2,DOCK8 |
4.527e-04 | -7.70 | leukocyte migration | biological process | GO:0050900 | 245 | 5 | 18204 | 48 |
PREX1,VAV3,HCK,SYK,DOCK8 |
4.763e-04 | -7.65 | SEMA4A (semaphorin 4A) | protein interactions | 64218 | 13 | 2 | 19454 | 49 |
SEMA4B,PLXND1 |
4.763e-04 | -7.65 | FCRL3 (Fc receptor like 3) | protein interactions | 115352 | 13 | 2 | 19454 | 49 |
SYK,PTPN6 |
4.881e-04 | -7.62 | antigen receptor-mediated signaling pathway | biological process | GO:0050851 | 139 | 4 | 18204 | 48 |
VAV3,PTPN6,SYK,PTPRC |
4.895e-04 | -7.62 | VIRMA (vir like m6A methyltransferase associated) | protein interactions | 25962 | 2914 | 17 | 19454 | 49 |
PHKB,PLXND1,TMCC3,ACACB,DISC1,RBM47,TMTC1,BMP2K,OSBPL8,GAB1,DIAPH2,VMP1,ASCC3,ATP10D,PREX1,RAPGEF6,TMEM131L |
4.926e-04 | -7.62 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 5 | 19454 | 49 |
GAB1,ATG14,MPP1,FCHO2,SLC9A1 |
5.015e-04 | -7.60 | FBXO2 (F-box protein 2) | protein interactions | 26232 | 403 | 6 | 19454 | 49 |
TMEM131L,CADM4,OSBPL8,PLXND1,CEMIP,SEMA4B |
5.116e-04 | -7.58 | DOCKER | prosite domains | PS51651 | 11 | 2 | 12186 | 38 |
DOCK8,DOCK2 |
5.116e-04 | -7.58 | C2_DOCK | prosite domains | PS51650 | 11 | 2 | 12186 | 38 |
DOCK2,DOCK8 |
5.213e-04 | -7.56 | negative T cell selection | biological process | GO:0043383 | 13 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
5.392e-04 | -7.53 | protein phosphorylated amino acid binding | molecular function | GO:0045309 | 60 | 3 | 18094 | 48 |
SYK,HCK,PTPN6 |
5.547e-04 | -7.50 | MS4A2 (membrane spanning 4-domains A2) | protein interactions | 2206 | 14 | 2 | 19454 | 49 |
SYK,PTPN6 |
5.598e-04 | -7.49 | cell activation | biological process | GO:0001775 | 725 | 8 | 18204 | 48 |
PREX1,DOCK2,ENTPD1,VAV3,PTPRC,SYK,DOCK8,PTPN6 |
5.696e-04 | -7.47 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 7 | 16828 | 46 |
VMP1,DOCK2,OSBPL8,VAV3,PREX1,DIAPH2,TMCC3 |
5.961e-04 | -7.43 | PDZ | interpro domains | IPR001478 | 146 | 4 | 18521 | 49 |
RAPGEF6,MPP1,PREX1,PREX2 |
6.071e-04 | -7.41 | immunological synapse formation | biological process | GO:0001771 | 14 | 2 | 18204 | 48 |
DOCK2,DOCK8 |
6.071e-04 | -7.41 | alpha-beta T cell proliferation | biological process | GO:0046633 | 14 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
6.093e-04 | -7.40 | GPVI-mediated activation cascade | REACTOME pathways | R-HSA-114604 | 54 | 3 | 10285 | 32 |
VAV3,SYK,PTPN6 |
6.132e-04 | -7.40 | Chemokine signaling pathway | KEGG pathways | ko04062 | 182 | 5 | 7161 | 28 |
DOCK2,VAV3,HCK,PREX1,GRK6 |
6.132e-04 | -7.40 | Chemokine signaling pathway | KEGG pathways | hsa04062 | 182 | 5 | 7161 | 28 |
HCK,VAV3,DOCK2,PREX1,GRK6 |
6.140e-04 | -7.40 | immune response-regulating cell surface receptor signaling pathway | biological process | GO:0002768 | 262 | 5 | 18204 | 48 |
HCK,VAV3,PTPN6,SYK,PTPRC |
6.329e-04 | -7.37 | RHOA (ras homolog family member A) | protein interactions | 387 | 1186 | 10 | 19454 | 49 |
OSBPL8,GAB1,PREX2,VMP1,DIAPH2,DAB2,PREX1,VAV3,SLC9A1,BLVRA |
6.391e-04 | -7.36 | PTPRCAP (protein tyrosine phosphatase receptor type C associated protein) | protein interactions | 5790 | 15 | 2 | 19454 | 49 |
OSBPL8,PTPRC |
6.434e-04 | -7.35 | PDZ_sf | interpro domains | IPR036034 | 149 | 4 | 18521 | 49 |
RAPGEF6,MPP1,PREX1,PREX2 |
7.002e-04 | -7.26 | leukocyte proliferation | biological process | GO:0070661 | 153 | 4 | 18204 | 48 |
PTPN6,DOCK2,PTPRC,DOCK8 |
7.006e-04 | -7.26 | peptidyl-tyrosine phosphorylation | biological process | GO:0018108 | 66 | 3 | 18204 | 48 |
HCK,PTPN6,SYK |
7.006e-04 | -7.26 | neutrophil migration | biological process | GO:1990266 | 66 | 3 | 18204 | 48 |
VAV3,PREX1,SYK |
7.161e-04 | -7.24 | FCGR activation | REACTOME pathways | R-HSA-2029481 | 13 | 2 | 10285 | 32 |
SYK,HCK |
7.540e-04 | -7.19 | IL-3 Signaling Pathway | WikiPathways | WP286 | 49 | 3 | 5310 | 20 |
PTPN6,HCK,SYK |
7.545e-04 | -7.19 | enzyme binding | molecular function | GO:0019899 | 2086 | 14 | 18094 | 48 |
PTPRC,PREX1,ATG14,CADM4,NACC2,SLC9A1,SYK,RBM47,TFEB,DOCK2,PTPN6,DIAPH2,RAPGEF6,SH2B3 |
7.555e-04 | -7.19 | T cell receptor complex | cellular component | GO:0042101 | 16 | 2 | 19108 | 49 |
SYK,PTPN6 |
7.645e-04 | -7.18 | peptidyl-tyrosine modification | biological process | GO:0018212 | 68 | 3 | 18204 | 48 |
SYK,PTPN6,HCK |
7.693e-04 | -7.17 | membrane organization | biological process | GO:0061024 | 761 | 8 | 18204 | 48 |
DOCK2,SLC9A1,VAV3,VMP1,ATP10D,PTPRC,OSBPL8,FCHO2 |
7.712e-04 | -7.17 | positive regulation of endocytosis | biological process | GO:0045807 | 157 | 4 | 18204 | 48 |
DAB2,PTPRC,SYK,DOCK2 |
7.853e-04 | -7.15 | RASA1 (RAS p21 protein activator 1) | protein interactions | 5921 | 165 | 4 | 19454 | 49 |
SYK,HCK,GAB1,PTPRC |
7.865e-04 | -7.15 | cytosol | cellular component | GO:0005829 | 5475 | 25 | 19108 | 49 |
OSBPL8,PPFIBP2,DISC1,SH2B3,SMOX,PREX1,RAPGEF6,SYK,DOCK2,TFEB,DIAPH2,PREX2,PHKB,ATG14,FCHO2,VAV3,DOCK8,HCK,ASCC3,DAB2,ACACB,BLVRA,GAB1,PTPN6,PTGIR |
8.020e-04 | -7.13 | regulation of transport | biological process | GO:0051049 | 1621 | 12 | 18204 | 48 |
CEMIP,BMP2K,PTPRC,SYK,OSBPL8,PTPN6,SLC9A1,VMP1,DOCK2,RHBDF2,DAB2,HCK |
8.038e-04 | -7.13 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 6 | 19454 | 49 |
DOCK8,GAB1,OSBPL8,SLC9A1,DIAPH2,FCHO2 |
8.054e-04 | -7.12 | MIB1 (MIB E3 ubiquitin protein ligase 1) | protein interactions | 57534 | 291 | 5 | 19454 | 49 |
ASCC3,DAB2,TMCC3,FCHO2,CEMIP |
8.399e-04 | -7.08 | GAB1 (GRB2 associated binding protein 1) | protein interactions | 2549 | 168 | 4 | 19454 | 49 |
VAV3,HCK,GAB1,SYK |
8.410e-04 | -7.08 | DH-domain | interpro domains | IPR000219 | 70 | 3 | 18521 | 49 |
VAV3,PREX1,PREX2 |
8.584e-04 | -7.06 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 7 | 18204 | 48 |
GAB1,PTPRC,DOCK8,CEMIP,SEMA4B,PREX1,DAB2 |
8.688e-04 | -7.05 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 5 | 18204 | 48 |
TMEM131L,DISC1,DAB2,KREMEN1,GRK6 |
8.765e-04 | -7.04 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 3 | 18521 | 49 |
PREX2,PREX1,VAV3 |
8.791e-04 | -7.04 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 31 | 16828 | 46 |
ACACB,TMCC3,PPP1R7,SLC9A1,PLXND1,ATG14,OSBPL8,SEMA4B,SH2B3,STAB1,ASCC3,PREX1,PTPRC,RHBDF2,DOCK8,DOCK2,VMP1,VAV3,PPFIBP2,SLC16A10,TMTC1,ATP10D,ACER2,NACC2,GAB1,KREMEN1,TFEB,DAB2,BLVRA,DIAPH2,PREX2 |
8.870e-04 | -7.03 | receptor-mediated endocytosis | biological process | GO:0006898 | 163 | 4 | 18204 | 48 |
DAB2,SYK,FCHO2,STAB1 |
8.881e-04 | -7.03 | RhoGEF | pfam domains | PF00621 | 70 | 3 | 17795 | 48 |
VAV3,PREX1,PREX2 |
8.887e-04 | -7.03 | regulation of biological quality | biological process | GO:0065008 | 2936 | 17 | 18204 | 48 |
ATG14,VAV3,SH2B3,ENTPD1,PREX1,PLXND1,PTGIR,PTPN6,DISC1,ATP10D,SYK,VMP1,SLC9A1,RBM47,SLC16A10,DAB2,HCK |
8.917e-04 | -7.02 | - | gene3d domains | 2.30.42.10 | 149 | 4 | 14470 | 42 |
PREX2,PREX1,MPP1,RAPGEF6 |
9.137e-04 | -7.00 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 2 | 18094 | 48 |
PTPN6,PTPRC |
9.137e-04 | -7.00 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 2 | 18094 | 48 |
PTPRC,PTPN6 |
9.267e-04 | -6.98 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 10 | 18204 | 48 |
VMP1,PREX2,SLC9A1,CEMIP,RAPGEF6,SYK,PTPRC,DOCK8,PREX1,ACER2 |
9.341e-04 | -6.98 | RHOJ (ras homolog family member J) | protein interactions | 57381 | 628 | 7 | 19454 | 49 |
FCHO2,SLC9A1,OSBPL8,DOCK8,GAB1,VMP1,DIAPH2 |
9.376e-04 | -6.97 | PH_DOMAIN | prosite domains | PS50003 | 246 | 5 | 12186 | 38 |
OSBPL8,GAB1,PREX1,PREX2,VAV3 |
9.452e-04 | -6.96 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 6 | 19454 | 49 |
SH2B3,GAB1,HCK,SYK,PTPN6,PTPRC |
9.845e-04 | -6.92 | PDZ | prosite domains | PS50106 | 143 | 4 | 12186 | 38 |
RAPGEF6,PREX2,PREX1,MPP1 |
1.014e-03 | -6.89 | regulation of clathrin-dependent endocytosis | biological process | GO:2000369 | 18 | 2 | 18204 | 48 |
BMP2K,DAB2 |
1.014e-03 | -6.89 | clathrin coat assembly | biological process | GO:0048268 | 18 | 2 | 18204 | 48 |
FCHO2,DAB2 |
1.014e-03 | -6.89 | gamma-delta T cell activation | biological process | GO:0046629 | 18 | 2 | 18204 | 48 |
SYK,PTPRC |
1.014e-03 | -6.89 | regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002923 | 18 | 2 | 18204 | 48 |
PTPRC,PTPN6 |
1.015e-03 | -6.89 | clathrin-coated pit | cellular component | GO:0005905 | 77 | 3 | 19108 | 49 |
DAB2,FCHO2,CEMIP |
1.015e-03 | -6.89 | negative regulation of defense response | biological process | GO:0031348 | 293 | 5 | 18204 | 48 |
PTPN6,RHBDF2,SYK,PTPRC,HCK |
1.019e-03 | -6.89 | regulation of response to stress | biological process | GO:0080134 | 1431 | 11 | 18204 | 48 |
SYK,PTPRC,PTPN6,NACC2,KREMEN1,RBM47,CADM4,SH2B3,RHBDF2,HCK,ACACB |
1.037e-03 | -6.87 | negative regulation of MAPK cascade | biological process | GO:0043409 | 170 | 4 | 18204 | 48 |
DAB2,PTPRC,SH2B3,PTPN6 |
1.037e-03 | -6.87 | regulation of calcium ion transmembrane transport | biological process | GO:1903169 | 170 | 4 | 18204 | 48 |
SLC9A1,VMP1,PTPN6,CEMIP |
1.040e-03 | -6.87 | cell junction | cellular component | GO:0030054 | 2224 | 14 | 19108 | 49 |
PTPRC,DAB2,PTPN6,SEMA4B,GAB1,CADM4,SLC16A10,DISC1,PPFIBP2,FCHO2,PLXND1,SLC9A1,MPP1,HCK |
1.061e-03 | -6.85 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 10 | 16828 | 46 |
DOCK2,SYK,PREX2,DIAPH2,SH2B3,SLC16A10,GRK6,BMP2K,HCK,GAB1 |
1.061e-03 | -6.85 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 10 | 16828 | 46 |
GAB1,HCK,BMP2K,SLC16A10,GRK6,SH2B3,DIAPH2,PREX2,SYK,DOCK2 |
1.095e-03 | -6.82 | Regulation of KIT signaling | REACTOME pathways | R-HSA-1433559 | 16 | 2 | 10285 | 32 |
PTPN6,SH2B3 |
1.113e-03 | -6.80 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 7 | 18204 | 48 |
SEMA4B,CEMIP,DOCK8,PTPRC,GAB1,DAB2,PREX1 |
1.133e-03 | -6.78 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 3 | 14470 | 42 |
PREX2,VAV3,PREX1 |
1.161e-03 | -6.76 | immune response-activating signaling pathway | biological process | GO:0002757 | 302 | 5 | 18204 | 48 |
VAV3,HCK,PTPN6,SYK,PTPRC |
1.164e-03 | -6.76 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 12 | 18204 | 48 |
GAB1,VAV3,PLXND1,ACACB,SYK,PTPRC,DISC1,DOCK8,PTPN6,SLC9A1,RBM47,DAB2 |
1.179e-03 | -6.74 | blood coagulation | biological process | GO:0007596 | 176 | 4 | 18204 | 48 |
PTPN6,ENTPD1,SYK,VAV3 |
1.183e-03 | -6.74 | STX7 (syntaxin 7) | protein interactions | 8417 | 654 | 7 | 19454 | 49 |
OSBPL8,GAB1,VMP1,BMP2K,FCHO2,DAB2,SLC9A1 |
1.197e-03 | -6.73 | EPO signaling pathway | Pathway Interaction DB | epopathway | 33 | 3 | 2226 | 15 |
PTPN6,GAB1,SH2B3 |
1.229e-03 | -6.70 | coagulation | biological process | GO:0050817 | 178 | 4 | 18204 | 48 |
VAV3,ENTPD1,PTPN6,SYK |
1.233e-03 | -6.70 | regulation of cell activation | biological process | GO:0050865 | 630 | 7 | 18204 | 48 |
VAV3,SH2B3,PTPN6,DOCK8,TMEM131L,PTPRC,SYK |
1.239e-03 | -6.69 | Hyaluronan metabolism | REACTOME pathways | R-HSA-2142845 | 17 | 2 | 10285 | 32 |
CEMIP,SLC9A1 |
1.255e-03 | -6.68 | regulation of response to wounding | biological process | GO:1903034 | 179 | 4 | 18204 | 48 |
CADM4,PTPN6,SH2B3,KREMEN1 |
1.267e-03 | -6.67 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 7 | 18204 | 48 |
PTPRC,GAB1,DOCK8,CEMIP,SEMA4B,PREX1,DAB2 |
1.283e-03 | -6.66 | ZAP70 (zeta chain of T cell receptor associated protein kinase 70) | protein interactions | 7535 | 85 | 3 | 19454 | 49 |
PTPRC,SH2B3,PTPN6 |
1.287e-03 | -6.66 | CXCR4-mediated signaling events | Pathway Interaction DB | cxcr4_pathway | 76 | 4 | 2226 | 15 |
PTPN6,GRK6,PTPRC,HCK |
1.313e-03 | -6.64 | RAC2 (Rac family small GTPase 2) | protein interactions | 5880 | 666 | 7 | 19454 | 49 |
DOCK2,SLC9A1,FCHO2,OSBPL8,VMP1,DIAPH2,DAB2 |
1.317e-03 | -6.63 | granulocyte chemotaxis | biological process | GO:0071621 | 82 | 3 | 18204 | 48 |
SYK,PREX1,VAV3 |
1.321e-03 | -6.63 | PDZ | smart domains | SM00228 | 143 | 4 | 9717 | 33 |
PREX2,RAPGEF6,MPP1,PREX1 |
1.326e-03 | -6.63 | DH_2 | prosite domains | PS50010 | 70 | 3 | 12186 | 38 |
PREX1,PREX2,VAV3 |
1.334e-03 | -6.62 | T cell differentiation | biological process | GO:0030217 | 182 | 4 | 18204 | 48 |
SYK,DOCK2,PTPRC,PREX1 |
1.334e-03 | -6.62 | stem cell differentiation | biological process | GO:0048863 | 182 | 4 | 18204 | 48 |
SH2B3,SEMA4B,PTPRC,SLC9A1 |
1.334e-03 | -6.62 | hemostasis | biological process | GO:0007599 | 182 | 4 | 18204 | 48 |
VAV3,SYK,PTPN6,ENTPD1 |
1.338e-03 | -6.62 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 35 | 16828 | 46 |
DOCK8,DOCK2,VMP1,VAV3,PPFIBP2,PTGIR,RHBDF2,HCK,PREX1,ASCC3,PTPRC,DIAPH2,PREX2,KREMEN1,TFEB,DAB2,ATP10D,MPP1,ACER2,CADM4,PTPN6,GAB1,SLC16A10,TMTC1,ENTPD1,ACACB,STAB1,SYK,GALNT1,RAPGEF6,PLXND1,GRK6,RBM47,PPP1R7,ATG14 |
1.362e-03 | -6.60 | regulation of lipid localization | biological process | GO:1905952 | 183 | 4 | 18204 | 48 |
ACACB,DAB2,SYK,OSBPL8 |
1.363e-03 | -6.60 | positive regulation of calcium ion transmembrane transport | biological process | GO:1904427 | 83 | 3 | 18204 | 48 |
VMP1,SLC9A1,CEMIP |
1.363e-03 | -6.60 | positive regulation of B cell activation | biological process | GO:0050871 | 83 | 3 | 18204 | 48 |
PTPRC,SYK,VAV3 |
1.372e-03 | -6.59 | FGR (FGR proto-oncogene, Src family tyrosine kinase) | protein interactions | 2268 | 87 | 3 | 19454 | 49 |
DAB2,SYK,HCK |
1.385e-03 | -6.58 | thymic T cell selection | biological process | GO:0045061 | 21 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
1.390e-03 | -6.58 | FCGR2B (Fc gamma receptor IIb) | protein interactions | 2213 | 22 | 2 | 19454 | 49 |
PTPN6,GAB1 |
1.391e-03 | -6.58 | Regulation of signaling by CBL | REACTOME pathways | R-HSA-912631 | 18 | 2 | 10285 | 32 |
SYK,HCK |
1.440e-03 | -6.54 | lamellipodium membrane | cellular component | GO:0031258 | 22 | 2 | 19108 | 49 |
PLXND1,DOCK8 |
1.448e-03 | -6.54 | DEP | pfam domains | PF00610 | 21 | 2 | 17795 | 48 |
PREX2,PREX1 |
1.465e-03 | -6.53 | SLC25A41 (solute carrier family 25 member 41) | protein interactions | 284427 | 89 | 3 | 19454 | 49 |
FCHO2,DAB2,BMP2K |
1.499e-03 | -6.50 | lymphocyte activation | biological process | GO:0046649 | 476 | 6 | 18204 | 48 |
PTPN6,PTPRC,SYK,DOCK8,PREX1,DOCK2 |
1.499e-03 | -6.50 | positive regulation of transport | biological process | GO:0051050 | 844 | 8 | 18204 | 48 |
DAB2,DOCK2,SLC9A1,VMP1,SYK,PTPRC,OSBPL8,CEMIP |
1.508e-03 | -6.50 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
TFEB,SYK,KREMEN1,OSBPL8,PLXND1,PPP1R7,RBM47,RAPGEF6,GAB1,PTPN6,PPFIBP2,VAV3,VMP1,TMCC3,PTPRC,ACACB,PTGIR |
1.508e-03 | -6.50 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
SYK,KREMEN1,TFEB,OSBPL8,RBM47,PLXND1,PPP1R7,GAB1,PTPN6,RAPGEF6,VAV3,PPFIBP2,VMP1,TMCC3,PTPRC,ACACB,PTGIR |
1.514e-03 | -6.49 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 11 | 18094 | 48 |
SEMA4B,VAV3,DOCK2,DIAPH2,MPP1,DAB2,SH2B3,PTPRC,CADM4,HCK,SYK |
1.521e-03 | -6.49 | positive regulation of cell adhesion mediated by integrin | biological process | GO:0033630 | 22 | 2 | 18204 | 48 |
PTPN6,SYK |
1.531e-03 | -6.48 | DEP_dom | interpro domains | IPR000591 | 22 | 2 | 18521 | 49 |
PREX2,PREX1 |
1.539e-03 | -6.48 | RhoGEF | smart domains | SM00325 | 68 | 3 | 9717 | 33 |
VAV3,PREX2,PREX1 |
1.552e-03 | -6.47 | Other semaphorin interactions | REACTOME pathways | R-HSA-416700 | 19 | 2 | 10285 | 32 |
PTPRC,PLXND1 |
1.561e-03 | -6.46 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 3 | 19454 | 49 |
PTPN6,GAB1,HCK |
1.566e-03 | -6.46 | ERBB3 (erb-b2 receptor tyrosine kinase 3) | protein interactions | 2065 | 338 | 5 | 19454 | 49 |
VAV3,PTPN6,SH2B3,HCK,SYK |
1.662e-03 | -6.40 | UTP25 (UTP25 small subunit processome component) | protein interactions | 27042 | 93 | 3 | 19454 | 49 |
PREX1,BMP2K,GRK6 |
1.663e-03 | -6.40 | megakaryocyte development | biological process | GO:0035855 | 23 | 2 | 18204 | 48 |
PTPN6,SH2B3 |
1.672e-03 | -6.39 | positive regulation of lymphocyte activation | biological process | GO:0051251 | 328 | 5 | 18204 | 48 |
VAV3,PTPN6,DOCK8,SYK,PTPRC |
1.692e-03 | -6.38 | INSR (insulin receptor) | protein interactions | 3643 | 344 | 5 | 19454 | 49 |
PTPRC,VAV3,OSBPL8,PTPN6,GAB1 |
1.714e-03 | -6.37 | ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) | protein interactions | 6098 | 94 | 3 | 19454 | 49 |
PTPN6,OSBPL8,VAV3 |
1.723e-03 | -6.36 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 46 |
TMTC1,ATP10D,PTPN6,NACC2,GAB1,DISC1,DIAPH2,BLVRA,PTPRC,ASCC3,HCK,FCHO2,DOCK8,PPFIBP2,SMOX,PLXND1,RBM47,PPP1R7,OSBPL8,RAPGEF6,SYK,STAB1,ENTPD1,SLC16A10,ACER2,MPP1,CADM4,TFEB,KREMEN1,DAB2,PREX2,PREX1,BMP2K,PTGIR,RHBDF2,VMP1,DOCK2,VAV3,GRK6,SLC9A1,ATG14,GALNT1,SEMA4B,ACACB,TMCC3 |
1.723e-03 | -6.36 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 46 |
ENTPD1,SYK,STAB1,RBM47,PLXND1,PPP1R7,OSBPL8,RAPGEF6,DOCK8,FCHO2,PPFIBP2,SMOX,ASCC3,PTPRC,HCK,DISC1,DIAPH2,BLVRA,TMTC1,ATP10D,NACC2,PTPN6,GAB1,TMCC3,ACACB,GALNT1,SEMA4B,SLC9A1,GRK6,ATG14,DOCK2,VMP1,VAV3,PREX1,BMP2K,PTGIR,RHBDF2,KREMEN1,TFEB,DAB2,PREX2,SLC16A10,MPP1,ACER2,CADM4 |
1.735e-03 | -6.36 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 17 | 18204 | 48 |
SLC9A1,SYK,PTPRC,DISC1,TMEM131L,DOCK8,PTPN6,DAB2,RBM47,BMP2K,VAV3,KREMEN1,GAB1,STAB1,ACACB,PLXND1,SH2B3 |
1.745e-03 | -6.35 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 27 | 18204 | 48 |
TMEM131L,SMOX,GRK6,DAB2,HCK,GAB1,TFEB,ATG14,MPP1,SH2B3,PREX1,ACER2,DISC1,PTPRC,SYK,DOCK8,PTPN6,SLC9A1,PREX2,DOCK2,SEMA4B,RAPGEF6,VAV3,KREMEN1,PTGIR,ASCC3,PLXND1 |
1.759e-03 | -6.34 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 7 | 16828 | 46 |
PREX2,STAB1,SYK,BMP2K,RHBDF2,HCK,GRK6 |
1.775e-03 | -6.33 | regulation of localization | biological process | GO:0032879 | 2028 | 13 | 18204 | 48 |
CEMIP,BMP2K,ACACB,PTPN6,OSBPL8,SYK,PTPRC,VMP1,SLC9A1,RHBDF2,DOCK2,DAB2,HCK |
1.790e-03 | -6.33 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 8 | 18204 | 48 |
SYK,PTPRC,DOCK8,CEMIP,RAPGEF6,PREX2,PREX1,ACER2 |
1.796e-03 | -6.32 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 30 | 16828 | 46 |
GAB1,ATP10D,MPP1,ACER2,TMTC1,SLC16A10,DIAPH2,BLVRA,PREX2,DAB2,KREMEN1,ASCC3,PREX1,PTPRC,SMOX,VAV3,PPFIBP2,DOCK8,DOCK2,VMP1,OSBPL8,ATG14,SLC9A1,SH2B3,STAB1,SEMA4B,GALNT1,ACACB,TMCC3,ENTPD1 |
1.797e-03 | -6.32 | ZHX1-C8orf76 (ZHX1-C8orf76 readthrough) | protein interactions | 100533106 | 25 | 2 | 19454 | 49 |
PHKB,DISC1 |
1.875e-03 | -6.28 | human chr1q31.3-q32.1 | chromosome location | human chr1q31.3-q32.1 | 1 | 1 | 26134 | 49 |
PTPRC |
1.904e-03 | -6.26 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 12 | 18204 | 48 |
PTPN6,TMEM131L,DISC1,PTPRC,NACC2,HCK,DAB2,VAV3,SH2B3,CADM4,ACER2,PTGIR |
1.915e-03 | -6.26 | DEP | prosite domains | PS50186 | 21 | 2 | 12186 | 38 |
PREX2,PREX1 |
1.922e-03 | -6.25 | regulation of cell-cell adhesion | biological process | GO:0022407 | 500 | 6 | 18204 | 48 |
SH2B3,PTPN6,DOCK8,PTPRC,SYK,TMEM131L |
1.923e-03 | -6.25 | phosphoprotein binding | molecular function | GO:0051219 | 93 | 3 | 18094 | 48 |
PTPN6,HCK,SYK |
1.924e-03 | -6.25 | HRAS (HRas proto-oncogene, GTPase) | protein interactions | 3265 | 712 | 7 | 19454 | 49 |
DOCK8,GAB1,FCHO2,SLC9A1,PPFIBP2,RAPGEF6,MPP1 |
1.925e-03 | -6.25 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 10 | 18094 | 48 |
PREX2,PREX1,PTGIR,PPP1R7,DOCK2,VAV3,ATG14,DOCK8,BMP2K,RAPGEF6 |
1.928e-03 | -6.25 | anchoring junction | cellular component | GO:0070161 | 902 | 8 | 19108 | 49 |
DAB2,PTPRC,MPP1,SLC9A1,PTPN6,CADM4,HCK,GAB1 |
1.940e-03 | -6.25 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 7 | 19454 | 49 |
HCK,GAB1,PTPN6,SYK,PTPRC,MPP1,FCHO2 |
1.949e-03 | -6.24 | endocytic vesicle | cellular component | GO:0030139 | 349 | 5 | 19108 | 49 |
STAB1,RAPGEF6,SYK,CEMIP,ATG14 |
1.965e-03 | -6.23 | Fc-epsilon receptor signaling pathway | biological process | GO:0038095 | 25 | 2 | 18204 | 48 |
SYK,VAV3 |
1.988e-03 | -6.22 | Flnb (filamin, beta) | protein interactions | 286940 | 99 | 3 | 19454 | 49 |
DAB2,FCHO2,BMP2K |
2.021e-03 | -6.20 | regulation of lymphocyte activation | biological process | GO:0051249 | 505 | 6 | 18204 | 48 |
VAV3,TMEM131L,SYK,PTPRC,DOCK8,PTPN6 |
2.041e-03 | -6.19 | hemopoiesis | biological process | GO:0030097 | 688 | 7 | 18204 | 48 |
PTPN6,SYK,PTPRC,SH2B3,DOCK2,RBM47,PREX1 |
2.070e-03 | -6.18 | negative regulation of response to wounding | biological process | GO:1903035 | 96 | 3 | 18204 | 48 |
SH2B3,PTPN6,KREMEN1 |
2.070e-03 | -6.18 | granulocyte migration | biological process | GO:0097530 | 96 | 3 | 18204 | 48 |
VAV3,PREX1,SYK |
2.095e-03 | -6.17 | CD72 (CD72 molecule) | protein interactions | 971 | 27 | 2 | 19454 | 49 |
SYK,PTPN6 |
2.095e-03 | -6.17 | SLA (Src like adaptor) | protein interactions | 6503 | 27 | 2 | 19454 | 49 |
SYK,GAB1 |
2.095e-03 | -6.17 | OLIG1 (oligodendrocyte transcription factor 1) | protein interactions | 116448 | 27 | 2 | 19454 | 49 |
HCK,PTPN6 |
2.096e-03 | -6.17 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 14 | 16828 | 46 |
VMP1,DOCK8,DOCK2,ENTPD1,TMCC3,PTGIR,STAB1,SLC9A1,PLXND1,ATG14,TMTC1,ATP10D,RAPGEF6,PTPN6 |
2.104e-03 | -6.16 | CLEC4A (C-type lectin domain family 4 member A) | protein interactions | 50856 | 101 | 3 | 19454 | 49 |
RHBDF2,CADM4,PTPN6 |
2.125e-03 | -6.15 | membrane raft organization | biological process | GO:0031579 | 26 | 2 | 18204 | 48 |
DOCK2,PTPRC |
2.150e-03 | -6.14 | hyaluronic acid binding | molecular function | GO:0005540 | 26 | 2 | 18094 | 48 |
STAB1,CEMIP |
2.170e-03 | -6.13 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 10 | 16828 | 46 |
STAB1,PREX2,DISC1,TFEB,DOCK8,SYK,DOCK2,CADM4,PTPRC,RBM47 |
2.252e-03 | -6.10 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 6 | 18204 | 48 |
HCK,DAB2,DOCK2,BMP2K,SYK,PTPRC |
2.253e-03 | -6.10 | WDR53 (WD repeat domain 53) | protein interactions | 348793 | 28 | 2 | 19454 | 49 |
ACACB,BLVRA |
2.256e-03 | -6.09 | DEP | smart domains | SM00049 | 21 | 2 | 9717 | 33 |
PREX2,PREX1 |
2.260e-03 | -6.09 | phospholipid transport | biological process | GO:0015914 | 99 | 3 | 18204 | 48 |
ATP10D,OSBPL8,VMP1 |
2.272e-03 | -6.09 | regulation of response to external stimulus | biological process | GO:0032101 | 1116 | 9 | 18204 | 48 |
PTPN6,PTPRC,SYK,KREMEN1,MPP1,RHBDF2,SH2B3,RBM47,HCK |
2.291e-03 | -6.08 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 4 | 18204 | 48 |
PREX2,PREX1,RAPGEF6,DOCK8 |
2.339e-03 | -6.06 | SFTPC (surfactant protein C) | protein interactions | 6440 | 222 | 4 | 19454 | 49 |
PLXND1,TMEM131L,CADM4,SEMA4B |
2.350e-03 | -6.05 | Fcgamma receptor (FCGR) dependent phagocytosis | REACTOME pathways | R-HSA-2029480 | 86 | 3 | 10285 | 32 |
SYK,HCK,VAV3 |
2.363e-03 | -6.05 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 4 | 18521 | 49 |
HCK,DOCK2,VAV3,MPP1 |
2.389e-03 | -6.04 | regulation of body fluid levels | biological process | GO:0050878 | 356 | 5 | 18204 | 48 |
ENTPD1,PTPN6,SH2B3,SYK,VAV3 |
2.411e-03 | -6.03 | positive regulation of transmembrane transport | biological process | GO:0034764 | 214 | 4 | 18204 | 48 |
SLC9A1,VMP1,CEMIP,OSBPL8 |
2.411e-03 | -6.03 | negative regulation of cell activation | biological process | GO:0050866 | 214 | 4 | 18204 | 48 |
TMEM131L,PTPRC,SH2B3,PTPN6 |
2.416e-03 | -6.03 | NMUR2 (neuromedin U receptor 2) | protein interactions | 56923 | 29 | 2 | 19454 | 49 |
OSBPL8,VMP1 |
2.416e-03 | -6.03 | CD5 (CD5 molecule) | protein interactions | 921 | 29 | 2 | 19454 | 49 |
PPP1R7,PTPN6 |
2.422e-03 | -6.02 | positive regulation of signal transduction | biological process | GO:0009967 | 1593 | 11 | 18204 | 48 |
VAV3,NACC2,SLC9A1,BMP2K,PTPN6,OSBPL8,DISC1,PTPRC,SYK,DAB2,RBM47 |
2.460e-03 | -6.01 | B cell receptor signaling pathway | KEGG pathways | hsa04662 | 70 | 3 | 7161 | 28 |
VAV3,SYK,PTPN6 |
2.460e-03 | -6.01 | B cell receptor signaling pathway | KEGG pathways | ko04662 | 70 | 3 | 7161 | 28 |
VAV3,SYK,PTPN6 |
2.460e-03 | -6.01 | alpha-beta T cell activation | biological process | GO:0046631 | 102 | 3 | 18204 | 48 |
PTPRC,SYK,DOCK2 |
2.480e-03 | -6.00 | RPL39 (ribosomal protein L39) | protein interactions | 6170 | 107 | 3 | 19454 | 49 |
VMP1,PTPN6,SYK |
2.481e-03 | -6.00 | Plexin_repeat | interpro domains | IPR002165 | 28 | 2 | 18521 | 49 |
PLXND1,SEMA4B |
2.487e-03 | -6.00 | NAHEXCHNGR1 | prints domains | PR01085 | 1 | 1 | 5227 | 13 |
SLC9A1 |
2.487e-03 | -6.00 | PRSTNOIDIPR | prints domains | PR00856 | 1 | 1 | 5227 | 13 |
PTGIR |
2.493e-03 | -5.99 | regulation of lymphocyte differentiation | biological process | GO:0045619 | 216 | 4 | 18204 | 48 |
PTPN6,PTPRC,TMEM131L,SYK |
2.493e-03 | -5.99 | cell chemotaxis | biological process | GO:0060326 | 216 | 4 | 18204 | 48 |
VAV3,PREX1,SYK,GAB1 |
2.495e-03 | -5.99 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 4 | 19454 | 49 |
SYK,STAB1,HCK,GAB1 |
2.519e-03 | -5.98 | Tfap2a (transcription factor AP-2 alpha) | protein interactions | 306862 | 1 | 1 | 19454 | 49 |
DAB2 |
2.519e-03 | -5.98 | ACER2 (alkaline ceramidase 2) | protein interactions | 340485 | 1 | 1 | 19454 | 49 |
MPP1 |
2.519e-03 | -5.98 | PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3) | protein interactions | 103222505 | 1 | 1 | 19454 | 49 |
ATG14 |
2.519e-03 | -5.98 | BECN1 (beclin 1) | protein interactions | 103243387 | 1 | 1 | 19454 | 49 |
ATG14 |
2.519e-03 | -5.98 | NTA1 (amidase) | protein interactions | 853525 | 1 | 1 | 19454 | 49 |
DOCK8 |
2.519e-03 | -5.98 | ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2) | protein interactions | 103239106 | 1 | 1 | 19454 | 49 |
VMP1 |
2.519e-03 | -5.98 | EUC1 (Euc1p) | protein interactions | 855138 | 1 | 1 | 19454 | 49 |
DOCK8 |
2.550e-03 | -5.97 | negative regulation of immune system process | biological process | GO:0002683 | 529 | 6 | 18204 | 48 |
RHBDF2,HCK,PTPN6,SYK,PTPRC,TMEM131L |
2.564e-03 | -5.97 | extrinsic component of phagophore assembly site membrane | cellular component | GO:0097632 | 1 | 1 | 19108 | 49 |
ATG14 |
2.568e-03 | -5.96 | positive regulation of leukocyte activation | biological process | GO:0002696 | 362 | 5 | 18204 | 48 |
DOCK8,SYK,PTPRC,PTPN6,VAV3 |
2.575e-03 | -5.96 | PSI | pfam domains | PF01437 | 28 | 2 | 17795 | 48 |
SEMA4B,PLXND1 |
2.584e-03 | -5.96 | PECAM1 (platelet and endothelial cell adhesion molecule 1) | protein interactions | 5175 | 30 | 2 | 19454 | 49 |
PTPN6,HCK |
2.584e-03 | -5.96 | CSF3R (colony stimulating factor 3 receptor) | protein interactions | 1441 | 30 | 2 | 19454 | 49 |
SYK,HCK |
2.584e-03 | -5.96 | AP4S1 (adaptor related protein complex 4 subunit sigma 1) | protein interactions | 11154 | 30 | 2 | 19454 | 49 |
SLC9A1,DISC1 |
2.617e-03 | -5.95 | SPPL2B (signal peptide peptidase like 2B) | protein interactions | 56928 | 229 | 4 | 19454 | 49 |
GALNT1,VMP1,CADM4,OSBPL8 |
2.637e-03 | -5.94 | lactic acid secretion | biological process | GO:0046722 | 1 | 1 | 18204 | 48 |
ACACB |
2.637e-03 | -5.94 | leading edge cell differentiation | biological process | GO:0035026 | 1 | 1 | 18204 | 48 |
DAB2 |
2.637e-03 | -5.94 | plasma membrane raft distribution | biological process | GO:0044855 | 1 | 1 | 18204 | 48 |
PTPRC |
2.637e-03 | -5.94 | plasma membrane raft localization | biological process | GO:0044856 | 1 | 1 | 18204 | 48 |
PTPRC |
2.637e-03 | -5.94 | intracellular aspartate homeostasis | biological process | GO:0090459 | 1 | 1 | 18204 | 48 |
ACACB |
2.637e-03 | -5.94 | positive regulation of interleukin-3 production | biological process | GO:0032752 | 1 | 1 | 18204 | 48 |
SYK |
2.637e-03 | -5.94 | memory T cell proliferation | biological process | GO:0061485 | 1 | 1 | 18204 | 48 |
DOCK8 |
2.641e-03 | -5.94 | regulation of platelet aggregation | biological process | GO:0090330 | 29 | 2 | 18204 | 48 |
SYK,SH2B3 |
2.646e-03 | -5.93 | VAV3_SH2 | interpro domains | IPR035881 | 1 | 1 | 18521 | 49 |
VAV3 |
2.646e-03 | -5.93 | Ptprc | interpro domains | IPR016335 | 1 | 1 | 18521 | 49 |
PTPRC |
2.646e-03 | -5.93 | Biliverdin_Rdtase_A | interpro domains | IPR017094 | 1 | 1 | 18521 | 49 |
BLVRA |
2.646e-03 | -5.93 | SH2B3_SH2 | interpro domains | IPR035059 | 1 | 1 | 18521 | 49 |
SH2B3 |
2.646e-03 | -5.93 | DHR2_DOCK2 | interpro domains | IPR026799 | 1 | 1 | 18521 | 49 |
DOCK2 |
2.646e-03 | -5.93 | RBM47_RRM1 | interpro domains | IPR047044 | 1 | 1 | 18521 | 49 |
RBM47 |
2.646e-03 | -5.93 | MPP1_SH3 | interpro domains | IPR035475 | 1 | 1 | 18521 | 49 |
MPP1 |
2.646e-03 | -5.93 | VAV3_SH3_2 | interpro domains | IPR035734 | 1 | 1 | 18521 | 49 |
VAV3 |
2.646e-03 | -5.93 | Plexin-D1_Sema | interpro domains | IPR042719 | 1 | 1 | 18521 | 49 |
PLXND1 |
2.646e-03 | -5.93 | PTP_recept_N | interpro domains | IPR024739 | 1 | 1 | 18521 | 49 |
PTPRC |
2.646e-03 | -5.93 | HCK_SH2 | interpro domains | IPR035851 | 1 | 1 | 18521 | 49 |
HCK |
2.646e-03 | -5.93 | BMP2K_C | interpro domains | IPR028182 | 1 | 1 | 18521 | 49 |
BMP2K |
2.646e-03 | -5.93 | FCHo2_F-BAR | interpro domains | IPR030122 | 1 | 1 | 18521 | 49 |
FCHO2 |
2.646e-03 | -5.93 | RBM47_RRM3 | interpro domains | IPR034445 | 1 | 1 | 18521 | 49 |
RBM47 |
2.646e-03 | -5.93 | DISC1 | interpro domains | IPR026081 | 1 | 1 | 18521 | 49 |
DISC1 |
2.646e-03 | -5.93 | Biliverdin_Rdtase_cat | interpro domains | IPR015249 | 1 | 1 | 18521 | 49 |
BLVRA |
2.646e-03 | -5.93 | NHE-1-like | interpro domains | IPR001970 | 1 | 1 | 18521 | 49 |
SLC9A1 |
2.646e-03 | -5.93 | RBM47_RRM2 | interpro domains | IPR034440 | 1 | 1 | 18521 | 49 |
RBM47 |
2.646e-03 | -5.93 | Rex2_DEP_1 | interpro domains | IPR037367 | 1 | 1 | 18521 | 49 |
PREX2 |
2.646e-03 | -5.93 | Prostglndn_IP_rcpt | interpro domains | IPR000370 | 1 | 1 | 18521 | 49 |
PTGIR |
2.646e-03 | -5.93 | bHLHzip_TFEB | interpro domains | IPR024098 | 1 | 1 | 18521 | 49 |
TFEB |
2.646e-03 | -5.93 | VAV3_SH3_1 | interpro domains | IPR047015 | 1 | 1 | 18521 | 49 |
VAV3 |
2.653e-03 | -5.93 | ITPase activity | molecular function | GO:0103023 | 1 | 1 | 18094 | 48 |
ENTPD1 |
2.653e-03 | -5.93 | norspermine:oxygen oxidoreductase activity | molecular function | GO:0052894 | 1 | 1 | 18094 | 48 |
SMOX |
2.653e-03 | -5.93 | prostacyclin receptor activity | molecular function | GO:0016501 | 1 | 1 | 18094 | 48 |
PTGIR |
2.653e-03 | -5.93 | L-tyrosine transmembrane transporter activity | molecular function | GO:0005302 | 1 | 1 | 18094 | 48 |
SLC16A10 |
2.653e-03 | -5.93 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential | molecular function | GO:0086040 | 1 | 1 | 18094 | 48 |
SLC9A1 |
2.653e-03 | -5.93 | interleukin-15 receptor binding | molecular function | GO:0016170 | 1 | 1 | 18094 | 48 |
SYK |
2.653e-03 | -5.93 | N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity | molecular function | GO:0052895 | 1 | 1 | 18094 | 48 |
SMOX |
2.664e-03 | -5.93 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 4 | 18204 | 48 |
PTPN6,SYK,CADM4,PTPRC |
2.697e-03 | -5.92 | BMP2K_C | pfam domains | PF15282 | 1 | 1 | 17795 | 48 |
BMP2K |
2.697e-03 | -5.92 | CD45 | pfam domains | PF12567 | 1 | 1 | 17795 | 48 |
PTPRC |
2.697e-03 | -5.92 | PTP_N | pfam domains | PF12453 | 1 | 1 | 17795 | 48 |
PTPRC |
2.697e-03 | -5.92 | Biliv-reduc_cat | pfam domains | PF09166 | 1 | 1 | 17795 | 48 |
BLVRA |
2.721e-03 | -5.91 | seminoma | COSMIC cancer mutations | seminoma | 700 | 7 | 16828 | 46 |
PREX2,STAB1,SYK,BMP2K,RHBDF2,HCK,GRK6 |
2.757e-03 | -5.89 | activation of immune response | biological process | GO:0002253 | 368 | 5 | 18204 | 48 |
HCK,VAV3,PTPN6,PTPRC,SYK |
2.757e-03 | -5.89 | immune response-regulating signaling pathway | biological process | GO:0002764 | 368 | 5 | 18204 | 48 |
VAV3,HCK,SYK,PTPRC,PTPN6 |
2.758e-03 | -5.89 | SEMA4D (semaphorin 4D) | protein interactions | 10507 | 31 | 2 | 19454 | 49 |
SEMA4B,PTPRC |
2.758e-03 | -5.89 | ADISSP (adipose secreted signaling protein) | protein interactions | 54976 | 31 | 2 | 19454 | 49 |
PHKB,PPP1R7 |
2.791e-03 | -5.88 | SH3_domain | interpro domains | IPR001452 | 222 | 4 | 18521 | 49 |
HCK,DOCK2,VAV3,MPP1 |
2.792e-03 | -5.88 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 7 | 10285 | 32 |
SYK,SH2B3,PTPN6,DOCK2,DOCK8,PTGIR,VAV3 |
2.825e-03 | -5.87 | megakaryocyte differentiation | biological process | GO:0030219 | 30 | 2 | 18204 | 48 |
SH2B3,PTPN6 |
2.949e-03 | -5.83 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 3 | 16828 | 46 |
NACC2,ATP10D,DOCK2 |
2.953e-03 | -5.82 | Sema | pfam domains | PF01403 | 30 | 2 | 17795 | 48 |
PLXND1,SEMA4B |
2.957e-03 | -5.82 | RHOD (ras homolog family member D) | protein interactions | 29984 | 570 | 6 | 19454 | 49 |
FCHO2,SLC9A1,DAB2,DIAPH2,OSBPL8,GAB1 |
2.965e-03 | -5.82 | Thromboxane A2 receptor signaling | Pathway Interaction DB | txa2pathway | 45 | 3 | 2226 | 15 |
PTGIR,HCK,SYK |
2.966e-03 | -5.82 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 7 | 19454 | 49 |
PTPRC,VAV3,PTPN6,DAB2,SYK,GAB1,SH2B3 |
2.980e-03 | -5.82 | cell adhesion | biological process | GO:0007155 | 942 | 8 | 18204 | 48 |
VMP1,PTPN6,STAB1,PTPRC,SYK,HCK,ENTPD1,CADM4 |
2.983e-03 | -5.81 | CKAP4 (cytoskeleton associated protein 4) | protein interactions | 10970 | 571 | 6 | 19454 | 49 |
VAV3,VMP1,DISC1,OSBPL8,TMEM131L,RHBDF2 |
2.983e-03 | -5.81 | cell-cell adhesion | biological process | GO:0098609 | 546 | 6 | 18204 | 48 |
VMP1,SYK,PTPRC,PTPN6,CADM4,ENTPD1 |
3.007e-03 | -5.81 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 10 | 18204 | 48 |
PREX2,VAV3,DOCK8,PTPRC,SYK,RAPGEF6,CEMIP,ACER2,PREX1,PLXND1 |
3.015e-03 | -5.80 | positive regulation of calcium ion transmembrane transporter activity | biological process | GO:1901021 | 31 | 2 | 18204 | 48 |
SLC9A1,VMP1 |
3.015e-03 | -5.80 | neutrophil activation | biological process | GO:0042119 | 31 | 2 | 18204 | 48 |
PREX1,SYK |
3.036e-03 | -5.80 | Semap_dom | interpro domains | IPR001627 | 31 | 2 | 18521 | 49 |
PLXND1,SEMA4B |
3.036e-03 | -5.80 | Semap_dom_sf | interpro domains | IPR036352 | 31 | 2 | 18521 | 49 |
SEMA4B,PLXND1 |
3.048e-03 | -5.79 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 5 | 19454 | 49 |
SYK,PTPN6,GAB1,HCK,VAV3 |
3.102e-03 | -5.78 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 46 | 16828 | 46 |
PREX1,BMP2K,PTGIR,RHBDF2,DOCK2,VMP1,VAV3,SLC16A10,ACER2,MPP1,CADM4,KREMEN1,TFEB,DAB2,PREX2,ACACB,TMCC3,SLC9A1,GRK6,ATG14,GALNT1,SEMA4B,SH2B3,ASCC3,PTPRC,HCK,DOCK8,FCHO2,PPFIBP2,SMOX,TMTC1,ATP10D,PTPN6,GAB1,NACC2,DISC1,BLVRA,DIAPH2,ENTPD1,PPP1R7,RBM47,PLXND1,OSBPL8,RAPGEF6,SYK,STAB1 |
3.109e-03 | -5.77 | TOP3B (DNA topoisomerase III beta) | protein interactions | 8940 | 1465 | 10 | 19454 | 49 |
SEMA4B,RBM47,RAPGEF6,GRK6,PLXND1,PREX1,DIAPH2,RHBDF2,TFEB,SH2B3 |
3.194e-03 | -5.75 | PTGER3 (prostaglandin E receptor 3) | protein interactions | 5733 | 117 | 3 | 19454 | 49 |
OSBPL8,RHBDF2,SLC9A1 |
3.200e-03 | -5.74 | positive regulation of cell activation | biological process | GO:0050867 | 381 | 5 | 18204 | 48 |
VAV3,DOCK8,SYK,PTPRC,PTPN6 |
3.240e-03 | -5.73 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 26 | 16828 | 46 |
HCK,RHBDF2,PTPRC,PREX1,ASCC3,SMOX,DOCK8,DOCK2,PPFIBP2,VAV3,MPP1,ATP10D,NACC2,GAB1,TMTC1,PREX2,KREMEN1,DAB2,ACACB,ENTPD1,TMCC3,RAPGEF6,PLXND1,GRK6,SEMA4B,STAB1 |
3.271e-03 | -5.72 | HLA-G (major histocompatibility complex, class I, G) | protein interactions | 3135 | 118 | 3 | 19454 | 49 |
OSBPL8,CADM4,TMEM131L |
3.305e-03 | -5.71 | ERBB2 (erb-b2 receptor tyrosine kinase 2) | protein interactions | 2064 | 583 | 6 | 19454 | 49 |
VAV3,SYK,SH2B3,PTPN6,GAB1,HCK |
3.309e-03 | -5.71 | regulation of T cell activation | biological process | GO:0050863 | 384 | 5 | 18204 | 48 |
PTPN6,DOCK8,TMEM131L,PTPRC,SYK |
3.309e-03 | -5.71 | regulation of leukocyte cell-cell adhesion | biological process | GO:1903037 | 384 | 5 | 18204 | 48 |
DOCK8,TMEM131L,SYK,PTPRC,PTPN6 |
3.312e-03 | -5.71 | ELMO1 (engulfment and cell motility 1) | protein interactions | 9844 | 34 | 2 | 19454 | 49 |
DOCK2,HCK |
3.321e-03 | -5.71 | OTULINL (OTU deubiquitinase with linear linkage specificity like) | protein interactions | 54491 | 402 | 5 | 19454 | 49 |
VMP1,PPP1R7,SLC9A1,TMEM131L,OSBPL8 |
3.335e-03 | -5.70 | ITSN1 (intersectin 1) | protein interactions | 6453 | 245 | 4 | 19454 | 49 |
PREX1,FCHO2,DISC1,DAB2 |
3.430e-03 | -5.68 | CD79B (CD79b molecule) | protein interactions | 974 | 120 | 3 | 19454 | 49 |
PTPRC,PTPN6,SYK |
3.479e-03 | -5.66 | regulation of lymphocyte proliferation | biological process | GO:0050670 | 237 | 4 | 18204 | 48 |
TMEM131L,PTPRC,PTPN6,VAV3 |
3.484e-03 | -5.66 | SYK (spleen associated tyrosine kinase) | protein interactions | 6850 | 248 | 4 | 19454 | 49 |
OSBPL8,GAB1,PTPN6,SYK |
3.497e-03 | -5.66 | immune effector process | biological process | GO:0002252 | 389 | 5 | 18204 | 48 |
VAV3,HCK,DOCK2,SYK,PTPN6 |
3.507e-03 | -5.65 | IL2RB (interleukin 2 receptor subunit beta) | protein interactions | 3560 | 35 | 2 | 19454 | 49 |
SYK,PTPN6 |
3.516e-03 | -5.65 | testis | COSMIC cancer mutations | testis | 733 | 7 | 16828 | 46 |
BMP2K,HCK,RHBDF2,GRK6,PREX2,STAB1,SYK |
3.540e-03 | -5.64 | Nanoparticle triggered autophagic cell death | WikiPathways | WP2509 | 24 | 2 | 5310 | 20 |
VMP1,ATG14 |
3.593e-03 | -5.63 | FLNA (filamin A) | protein interactions | 2316 | 593 | 6 | 19454 | 49 |
SYK,SH2B3,DAB2,VMP1,DISC1,BMP2K |
3.613e-03 | -5.62 | The role of Nef in HIV-1 replication and disease pathogenesis | REACTOME pathways | R-HSA-164952 | 29 | 2 | 10285 | 32 |
HCK,DOCK2 |
3.615e-03 | -5.62 | LRRC59 (leucine rich repeat containing 59) | protein interactions | 55379 | 797 | 7 | 19454 | 49 |
ASCC3,TMCC3,RHBDF2,TMEM131L,OSBPL8,DOCK8,VMP1 |
3.619e-03 | -5.62 | positive T cell selection | biological process | GO:0043368 | 34 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
3.619e-03 | -5.62 | regulation of B cell differentiation | biological process | GO:0045577 | 34 | 2 | 18204 | 48 |
SYK,PTPN6 |
3.621e-03 | -5.62 | PRTYPHPHTASE | prints domains | PR00700 | 37 | 2 | 5227 | 13 |
PTPRC,PTPN6 |
3.681e-03 | -5.60 | KRAS (KRAS proto-oncogene, GTPase) | protein interactions | 3845 | 2876 | 15 | 19454 | 49 |
RAPGEF6,MPP1,FCHO2,PPP1R7,ATP10D,PREX1,VMP1,OSBPL8,HCK,DOCK8,GAB1,RHBDF2,GRK6,PPFIBP2,SLC9A1 |
3.686e-03 | -5.60 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 11 | 18204 | 48 |
SYK,PTPRC,PTPN6,OSBPL8,GRK6,HCK,BMP2K,ATG14,ACACB,MPP1,ENTPD1 |
3.714e-03 | -5.60 | positive regulation of calcium ion transport | biological process | GO:0051928 | 118 | 3 | 18204 | 48 |
CEMIP,SLC9A1,VMP1 |
3.714e-03 | -5.60 | regulation of receptor-mediated endocytosis | biological process | GO:0048259 | 118 | 3 | 18204 | 48 |
DAB2,BMP2K,SYK |
3.742e-03 | -5.59 | nef (Nef) | protein interactions | 156110 | 802 | 7 | 19454 | 49 |
SLC9A1,PTPRC,DOCK2,DAB2,SYK,TFEB,HCK |
3.748e-03 | -5.59 | regulation of mononuclear cell proliferation | biological process | GO:0032944 | 242 | 4 | 18204 | 48 |
TMEM131L,PTPRC,PTPN6,VAV3 |
3.751e-03 | -5.59 | regulation of leukocyte activation | biological process | GO:0002694 | 572 | 6 | 18204 | 48 |
VAV3,PTPN6,SYK,TMEM131L,PTPRC,DOCK8 |
3.832e-03 | -5.56 | granulocyte activation | biological process | GO:0036230 | 35 | 2 | 18204 | 48 |
SYK,PREX1 |
3.847e-03 | -5.56 | CD79A (CD79a molecule) | protein interactions | 973 | 255 | 4 | 19454 | 49 |
TMEM131L,PTPN6,SYK,PTPRC |
3.864e-03 | -5.56 | FCERI mediated Ca+2 mobilization | REACTOME pathways | R-HSA-2871809 | 30 | 2 | 10285 | 32 |
VAV3,SYK |
3.880e-03 | -5.55 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 46 |
PREX1,HCK,DOCK2,FCHO2,SH2B3,STAB1,SMOX,PREX2 |
3.880e-03 | -5.55 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 46 |
PREX1,HCK,FCHO2,DOCK2,SMOX,PREX2,SH2B3,STAB1 |
3.885e-03 | -5.55 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 42 |
MPP1,DOCK2,HCK,VAV3 |
3.913e-03 | -5.54 | GPR183 (G protein-coupled receptor 183) | protein interactions | 1880 | 37 | 2 | 19454 | 49 |
GRK6,OSBPL8 |
3.913e-03 | -5.54 | SNCG (synuclein gamma) | protein interactions | 6623 | 37 | 2 | 19454 | 49 |
GRK6,SEMA4B |
3.922e-03 | -5.54 | OPTN (optineurin) | protein interactions | 10133 | 418 | 5 | 19454 | 49 |
MPP1,PPP1R7,OSBPL8,DOCK8,ATG14 |
4.051e-03 | -5.51 | regulation of homotypic cell-cell adhesion | biological process | GO:0034110 | 36 | 2 | 18204 | 48 |
SYK,SH2B3 |
4.111e-03 | -5.49 | BTK (Bruton tyrosine kinase) | protein interactions | 695 | 128 | 3 | 19454 | 49 |
GAB1,HCK,SYK |
4.111e-03 | -5.49 | GAB2 (GRB2 associated binding protein 2) | protein interactions | 9846 | 128 | 3 | 19454 | 49 |
SYK,GAB1,PTPN6 |
4.121e-03 | -5.49 | PTPN6 (protein tyrosine phosphatase non-receptor type 6) | protein interactions | 5777 | 260 | 4 | 19454 | 49 |
PTPRC,ASCC3,SYK,PTPN6 |
4.123e-03 | -5.49 | MPPED1 (metallophosphoesterase domain containing 1) | protein interactions | 758 | 38 | 2 | 19454 | 49 |
PHKB,DISC1 |
4.123e-03 | -5.49 | FCGR3A (Fc gamma receptor IIIa) | protein interactions | 2214 | 38 | 2 | 19454 | 49 |
SYK,PTPRC |
4.123e-03 | -5.49 | STK33 (serine/threonine kinase 33) | protein interactions | 65975 | 38 | 2 | 19454 | 49 |
HCK,PHKB |
4.139e-03 | -5.49 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 38 | 16828 | 46 |
ENTPD1,TMCC3,ACACB,SEMA4B,SH2B3,STAB1,SYK,GALNT1,RAPGEF6,GRK6,PPP1R7,RBM47,SLC9A1,OSBPL8,DOCK8,DOCK2,FCHO2,VAV3,PPFIBP2,PTGIR,BMP2K,RHBDF2,HCK,PREX1,ASCC3,PTPRC,DIAPH2,BLVRA,PREX2,KREMEN1,TFEB,DAB2,ATP10D,MPP1,CADM4,NACC2,GAB1,SLC16A10 |
4.148e-03 | -5.49 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 11 | 18204 | 48 |
OSBPL8,ATG14,PTPN6,SYK,PTPRC,BMP2K,ENTPD1,MPP1,ACACB,HCK,GRK6 |
4.148e-03 | -5.49 | regulation of calcium ion transport | biological process | GO:0051924 | 249 | 4 | 18204 | 48 |
SLC9A1,VMP1,CEMIP,PTPN6 |
4.157e-03 | -5.48 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 21 | 16828 | 46 |
PTPN6,GAB1,RAPGEF6,MPP1,PPP1R7,GRK6,SH2B3,SEMA4B,DIAPH2,PREX2,DAB2,SYK,KREMEN1,TFEB,HCK,BMP2K,PREX1,PTPRC,VAV3,PPFIBP2,VMP1 |
4.159e-03 | -5.48 | SEMA | prosite domains | PS51004 | 31 | 2 | 12186 | 38 |
PLXND1,SEMA4B |
4.160e-03 | -5.48 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 36 | 16828 | 46 |
ACACB,TMCC3,ATG14,PPP1R7,GRK6,RBM47,PLXND1,RAPGEF6,SYK,GALNT1,STAB1,SH2B3,SEMA4B,ASCC3,PREX1,RHBDF2,BMP2K,PTGIR,VAV3,PPFIBP2,DOCK2,DOCK8,VMP1,FCHO2,SMOX,TMTC1,GAB1,NACC2,ATP10D,ACER2,DAB2,KREMEN1,TFEB,BLVRA,DIAPH2,PREX2 |
4.231e-03 | -5.47 | cell development | biological process | GO:0048468 | 2236 | 13 | 18204 | 48 |
DIAPH2,PREX2,PTPN6,SYK,DISC1,PTPRC,SEMA4B,RBM47,DOCK2,RAPGEF6,PREX1,PLXND1,SH2B3 |
4.267e-03 | -5.46 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 3 | 18204 | 48 |
DISC1,PREX1,DAB2 |
4.270e-03 | -5.46 | phagophore assembly site | cellular component | GO:0000407 | 38 | 2 | 19108 | 49 |
ATG14,VMP1 |
4.343e-03 | -5.44 | PDZ | pfam domains | PF00595 | 122 | 3 | 17795 | 48 |
MPP1,PREX2,RAPGEF6 |
4.364e-03 | -5.43 | regulation of cell-matrix adhesion | biological process | GO:0001952 | 125 | 3 | 18204 | 48 |
ACER2,SLC9A1,DISC1 |
4.386e-03 | -5.43 | ASIC4 (acid sensing ion channel subunit family member 4) | protein interactions | 55515 | 131 | 3 | 19454 | 49 |
CADM4,TMEM131L,OSBPL8 |
4.452e-03 | -5.41 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 20 | 16828 | 46 |
DAB2,TFEB,KREMEN1,SYK,PREX2,DIAPH2,SEMA4B,GRK6,PPP1R7,RAPGEF6,PTPN6,GAB1,MPP1,PPFIBP2,VAV3,VMP1,PTPRC,PREX1,HCK,BMP2K |
4.488e-03 | -5.41 | Signaling events mediated by Stem cell factor receptor (c-Kit) | Pathway Interaction DB | kitpathway | 52 | 3 | 2226 | 15 |
PTPN6,GAB1,SH2B3 |
4.505e-03 | -5.40 | actin filament polymerization | biological process | GO:0030041 | 38 | 2 | 18204 | 48 |
PREX1,DIAPH2 |
4.513e-03 | -5.40 | positive regulation of T cell activation | biological process | GO:0050870 | 255 | 4 | 18204 | 48 |
PTPN6,PTPRC,SYK,DOCK8 |
4.544e-03 | -5.39 | GSK3B (glycogen synthase kinase 3 beta) | protein interactions | 2932 | 831 | 7 | 19454 | 49 |
DAB2,ACACB,DISC1,MPP1,RAPGEF6,ASCC3,GAB1 |
4.545e-03 | -5.39 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 43 | 16828 | 46 |
TMTC1,NACC2,PTPN6,GAB1,ATP10D,DISC1,DIAPH2,BLVRA,ASCC3,PTPRC,HCK,PPFIBP2,DOCK8,FCHO2,SMOX,OSBPL8,RBM47,PLXND1,PPP1R7,RAPGEF6,SYK,STAB1,ENTPD1,SLC16A10,CADM4,ACER2,MPP1,DAB2,KREMEN1,PREX2,PREX1,PTGIR,VAV3,DOCK2,VMP1,ATG14,SLC9A1,GRK6,GALNT1,SH2B3,SEMA4B,ACACB,TMCC3 |
4.561e-03 | -5.39 | PPFIA3 (PTPRF interacting protein alpha 3) | protein interactions | 8541 | 40 | 2 | 19454 | 49 |
DISC1,PPFIBP2 |
4.574e-03 | -5.39 | RHOB (ras homolog family member B) | protein interactions | 388 | 832 | 7 | 19454 | 49 |
FCHO2,SLC9A1,RAPGEF6,OSBPL8,GAB1,DIAPH2,DAB2 |
4.605e-03 | -5.38 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 6 | 19454 | 49 |
PTPRC,DAB2,HCK,GAB1,PTPN6,SYK |
4.627e-03 | -5.38 | SH3 | smart domains | SM00326 | 202 | 4 | 9717 | 33 |
DOCK2,MPP1,HCK,VAV3 |
4.646e-03 | -5.37 | regulation of protein modification process | biological process | GO:0031399 | 1242 | 9 | 18204 | 48 |
CEMIP,ATG14,PPP1R7,PTPN6,PTPRC,SYK,CADM4,DAB2,ACER2 |
4.687e-03 | -5.36 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 10 | 18204 | 48 |
ACACB,PLXND1,STAB1,PTPN6,TMEM131L,SYK,GAB1,DISC1,PTPRC,BMP2K |
4.695e-03 | -5.36 | leukocyte activation | biological process | GO:0045321 | 599 | 6 | 18204 | 48 |
PREX1,DOCK2,PTPN6,DOCK8,PTPRC,SYK |
4.703e-03 | -5.36 | small GTPase-mediated signal transduction | biological process | GO:0007264 | 258 | 4 | 18204 | 48 |
DOCK8,DOCK2,RAPGEF6,VAV3 |
4.705e-03 | -5.36 | plasma membrane region | cellular component | GO:0098590 | 1278 | 9 | 19108 | 49 |
HCK,ENTPD1,RAPGEF6,SEMA4B,SLC9A1,FCHO2,PLXND1,SLC16A10,DOCK8 |
4.707e-03 | -5.36 | regulation of developmental process | biological process | GO:0050793 | 2540 | 14 | 18204 | 48 |
PTPN6,SYK,TMEM131L,PTPRC,DISC1,HCK,DAB2,KREMEN1,BMP2K,STAB1,GAB1,ACACB,PREX1,PLXND1 |
4.710e-03 | -5.36 | PTCH1 (patched 1) | protein interactions | 5727 | 270 | 4 | 19454 | 49 |
SEMA4B,PLXND1,TMEM131L,CADM4 |
4.717e-03 | -5.36 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 13 | 16828 | 46 |
PPFIBP2,VAV3,DOCK2,ASCC3,PREX2,DIAPH2,KREMEN1,GAB1,ATP10D,TMTC1,SLC16A10,PLXND1,GRK6 |
4.717e-03 | -5.36 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 13 | 16828 | 46 |
KREMEN1,PREX2,DIAPH2,TMTC1,PLXND1,GRK6,SLC16A10,GAB1,ATP10D,PPFIBP2,VAV3,DOCK2,ASCC3 |
4.745e-03 | -5.35 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 15 | 16828 | 46 |
DOCK2,SMOX,PREX1,ACACB,KREMEN1,TFEB,GALNT1,DIAPH2,PREX2,STAB1,SLC16A10,ATG14,ATP10D,GAB1,NACC2 |
4.758e-03 | -5.35 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 4 | 16828 | 46 |
PLXND1,VMP1,PREX1,ASCC3 |
4.760e-03 | -5.35 | response to stimulus | biological process | GO:0050896 | 7803 | 30 | 18204 | 48 |
DOCK2,SEMA4B,SLC9A1,PREX2,PTPRC,SYK,DISC1,DOCK8,PTPN6,PTGIR,ASCC3,PLXND1,ACACB,ENTPD1,VAV3,KREMEN1,RAPGEF6,GRK6,HCK,DAB2,SMOX,TMEM131L,PREX1,ACER2,MPP1,SH2B3,GAB1,TFEB,STAB1,ATG14 |
4.770e-03 | -5.35 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 3 | 19454 | 49 |
FCHO2,DAB2,BMP2K |
4.777e-03 | -5.34 | ZFPL1 (zinc finger protein like 1) | protein interactions | 7542 | 438 | 5 | 19454 | 49 |
FCHO2,DISC1,SLC9A1,OSBPL8,GAB1 |
4.823e-03 | -5.33 | ATG9A (autophagy related 9A) | protein interactions | 79065 | 439 | 5 | 19454 | 49 |
BMP2K,FCHO2,DISC1,DAB2,PTGIR |
4.871e-03 | -5.32 | SH3 | prosite domains | PS50002 | 222 | 4 | 12186 | 38 |
VAV3,DOCK2,HCK,MPP1 |
4.873e-03 | -5.32 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 46 |
HCK,ATP10D,BMP2K,GRK6,PPFIBP2,DISC1,SYK |
4.873e-03 | -5.32 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 7 | 16828 | 46 |
ATP10D,BMP2K,HCK,GRK6,SYK,PPFIBP2,DISC1 |
4.890e-03 | -5.32 | Sema | smart domains | SM00630 | 31 | 2 | 9717 | 33 |
PLXND1,SEMA4B |
4.897e-03 | -5.32 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 21 | 16828 | 46 |
GRK6,PPP1R7,MPP1,RAPGEF6,PTPN6,GAB1,TFEB,KREMEN1,SYK,DAB2,PREX2,DIAPH2,SEMA4B,PTPRC,PREX1,BMP2K,HCK,VMP1,DOCK2,PPFIBP2,VAV3 |
4.897e-03 | -5.32 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 21 | 16828 | 46 |
BMP2K,HCK,PREX1,PTPRC,DOCK2,VMP1,VAV3,PPFIBP2,MPP1,PTPN6,GAB1,RAPGEF6,GRK6,PPP1R7,SEMA4B,DIAPH2,PREX2,SYK,KREMEN1,TFEB,DAB2 |
5.031e-03 | -5.29 | Rrp1 (ribosomal RNA processing 1) | protein interactions | 18114 | 2 | 1 | 19454 | 49 |
ASCC3 |
5.031e-03 | -5.29 | FABP6 (fatty acid binding protein 6) | protein interactions | 2172 | 2 | 1 | 19454 | 49 |
OSBPL8 |
5.031e-03 | -5.29 | KIR2DL5A (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A) | protein interactions | 57292 | 2 | 1 | 19454 | 49 |
PTPN6 |
5.031e-03 | -5.29 | Siglece (sialic acid binding Ig-like lectin E) | protein interactions | 83382 | 2 | 1 | 19454 | 49 |
PTPN6 |
5.031e-03 | -5.29 | MPIG6B (megakaryocyte and platelet inhibitory receptor G6b) | protein interactions | 80739 | 2 | 1 | 19454 | 49 |
PTPN6 |
5.031e-03 | -5.29 | GCNA (germ cell nuclear acidic peptidase) | protein interactions | 93953 | 2 | 1 | 19454 | 49 |
CEMIP |
5.031e-03 | -5.29 | CUZD1 (CUB and zona pellucida like domains 1) | protein interactions | 50624 | 2 | 1 | 19454 | 49 |
PTPN6 |
5.081e-03 | -5.28 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 13 | 16828 | 46 |
GAB1,ATP10D,TMTC1,GRK6,PLXND1,SLC16A10,PREX2,DIAPH2,KREMEN1,ASCC3,PPFIBP2,VAV3,DOCK2 |
5.122e-03 | -5.27 | extrinsic component of omegasome membrane | cellular component | GO:0097629 | 2 | 1 | 19108 | 49 |
ATG14 |
5.188e-03 | -5.26 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 3 | 18204 | 48 |
PTPN6,CEMIP,PTPRC |
5.234e-03 | -5.25 | negative regulation of response to stimulus | biological process | GO:0048585 | 1760 | 11 | 18204 | 48 |
KREMEN1,SH2B3,CADM4,PTGIR,PTPN6,SYK,PTPRC,TMEM131L,RHBDF2,HCK,DAB2 |
5.236e-03 | -5.25 | regulation of inflammatory response | biological process | GO:0050727 | 428 | 5 | 18204 | 48 |
SYK,PTPRC,PTPN6,RHBDF2,HCK |
5.254e-03 | -5.25 | ITGA1 (integrin subunit alpha 1) | protein interactions | 3672 | 43 | 2 | 19454 | 49 |
DISC1,PTPN6 |
5.265e-03 | -5.25 | thyroid-other-neoplasm | COSMIC cancer mutations | thyroid-other-neoplasm | 7637 | 30 | 16828 | 46 |
SMOX,FCHO2,DOCK2,DOCK8,PPFIBP2,PTGIR,BMP2K,RHBDF2,PREX1,PREX2,DIAPH2,BLVRA,TFEB,KREMEN1,DAB2,ACER2,ATP10D,NACC2,GAB1,TMTC1,TMCC3,ACACB,SEMA4B,STAB1,SH2B3,SYK,RAPGEF6,GRK6,PPP1R7,PLXND1 |
5.267e-03 | -5.25 | negative regulation of Kit signaling pathway | biological process | GO:1900235 | 2 | 1 | 18204 | 48 |
SH2B3 |
5.267e-03 | -5.25 | spermine catabolic process | biological process | GO:0046208 | 2 | 1 | 18204 | 48 |
SMOX |
5.267e-03 | -5.25 | regulation of hematopoietic stem cell migration | biological process | GO:2000471 | 2 | 1 | 18204 | 48 |
PTPRC |
5.267e-03 | -5.25 | serotonin secretion by platelet | biological process | GO:0002554 | 2 | 1 | 18204 | 48 |
SYK |
5.267e-03 | -5.25 | positive regulation of protein tyrosine phosphatase activity | biological process | GO:1903615 | 2 | 1 | 18204 | 48 |
PTPRC |
5.267e-03 | -5.25 | positive regulation of hematopoietic stem cell migration | biological process | GO:2000473 | 2 | 1 | 18204 | 48 |
PTPRC |
5.267e-03 | -5.25 | malonyl-CoA biosynthetic process | biological process | GO:2001295 | 2 | 1 | 18204 | 48 |
ACACB |
5.267e-03 | -5.25 | positive regulation of calcium:sodium antiporter activity | biological process | GO:1903281 | 2 | 1 | 18204 | 48 |
SLC9A1 |
5.267e-03 | -5.25 | regulation of interleukin-3 production | biological process | GO:0032672 | 2 | 1 | 18204 | 48 |
SYK |
5.267e-03 | -5.25 | regulation of Kit signaling pathway | biological process | GO:1900234 | 2 | 1 | 18204 | 48 |
SH2B3 |
5.267e-03 | -5.25 | synaptic target recognition | biological process | GO:0008039 | 2 | 1 | 18204 | 48 |
PLXND1 |
5.267e-03 | -5.25 | thyroid-stimulating hormone secretion | biological process | GO:0070460 | 2 | 1 | 18204 | 48 |
SLC16A10 |
5.267e-03 | -5.25 | regulation of the force of heart contraction by cardiac conduction | biological process | GO:0086092 | 2 | 1 | 18204 | 48 |
SLC9A1 |
5.284e-03 | -5.24 | TMEM2_PANDER-like | interpro domains | IPR039473 | 2 | 1 | 18521 | 49 |
CEMIP |
5.284e-03 | -5.24 | Liprin-beta_SAM_rpt_3 | interpro domains | IPR037619 | 2 | 1 | 18521 | 49 |
PPFIBP2 |
5.284e-03 | -5.24 | TMEM131-like | interpro domains | IPR039877 | 2 | 1 | 18521 | 49 |
TMEM131L |
5.284e-03 | -5.24 | Tyr_Pase_non-rcpt_typ-6/11 | interpro domains | IPR012152 | 2 | 1 | 18521 | 49 |
PTPN6 |
5.284e-03 | -5.24 | iRhom1_2_N | interpro domains | IPR022241 | 2 | 1 | 18521 | 49 |
RHBDF2 |
5.284e-03 | -5.24 | ACCA_BT | interpro domains | IPR049074 | 2 | 1 | 18521 | 49 |
ACACB |
5.284e-03 | -5.24 | ACCA | interpro domains | IPR049076 | 2 | 1 | 18521 | 49 |
ACACB |
5.284e-03 | -5.24 | SYK/ZAP-70_N_SH2 | interpro domains | IPR035838 | 2 | 1 | 18521 | 49 |
SYK |
5.284e-03 | -5.24 | Dab_PTB | interpro domains | IPR048561 | 2 | 1 | 18521 | 49 |
DAB2 |
5.284e-03 | -5.24 | Kinase_SYK/ZAP-70_inter-SH2_sf | interpro domains | IPR023420 | 2 | 1 | 18521 | 49 |
SYK |
5.284e-03 | -5.24 | DAB1/2_SBM | interpro domains | IPR048559 | 2 | 1 | 18521 | 49 |
DAB2 |
5.284e-03 | -5.24 | Liprin-beta_SAM_rpt_1 | interpro domains | IPR037617 | 2 | 1 | 18521 | 49 |
PPFIBP2 |
5.284e-03 | -5.24 | UV_resistance/autophagy_Atg14 | interpro domains | IPR018791 | 2 | 1 | 18521 | 49 |
ATG14 |
5.284e-03 | -5.24 | Tyr_kinase_non-rcpt_SYK/ZAP70 | interpro domains | IPR012234 | 2 | 1 | 18521 | 49 |
SYK |
5.284e-03 | -5.24 | Liprin-beta_SAM_rpt_2 | interpro domains | IPR037618 | 2 | 1 | 18521 | 49 |
PPFIBP2 |
5.284e-03 | -5.24 | TMEM131-like_N | interpro domains | IPR022113 | 2 | 1 | 18521 | 49 |
TMEM131L |
5.284e-03 | -5.24 | Kremen | interpro domains | IPR017076 | 2 | 1 | 18521 | 49 |
KREMEN1 |
5.284e-03 | -5.24 | AcCoA_COase_cen | interpro domains | IPR013537 | 2 | 1 | 18521 | 49 |
ACACB |
5.284e-03 | -5.24 | TMEM131-like_conserved | interpro domains | IPR045695 | 2 | 1 | 18521 | 49 |
TMEM131L |
5.299e-03 | -5.24 | vascular endothelial growth factor receptor 1 binding | molecular function | GO:0043183 | 2 | 1 | 18094 | 48 |
CADM4 |
5.299e-03 | -5.24 | biliverdin reductase (NADPH) activity | molecular function | GO:0106277 | 2 | 1 | 18094 | 48 |
BLVRA |
5.299e-03 | -5.24 | acetyl-CoA carboxylase activity | molecular function | GO:0003989 | 2 | 1 | 18094 | 48 |
ACACB |
5.299e-03 | -5.24 | L-phenylalanine transmembrane transporter activity | molecular function | GO:0015192 | 2 | 1 | 18094 | 48 |
SLC16A10 |
5.299e-03 | -5.24 | spermine:oxygen oxidoreductase (spermidine-forming) activity | molecular function | GO:0052901 | 2 | 1 | 18094 | 48 |
SMOX |
5.299e-03 | -5.24 | biliverdin reductase (NAD(P)H) activity | molecular function | GO:0004074 | 2 | 1 | 18094 | 48 |
BLVRA |
5.299e-03 | -5.24 | biliberdin reductase NAD+ activity | molecular function | GO:0106276 | 2 | 1 | 18094 | 48 |
BLVRA |
5.299e-03 | -5.24 | phosphatidylserine transfer activity | molecular function | GO:0140343 | 2 | 1 | 18094 | 48 |
OSBPL8 |
5.377e-03 | -5.23 | regulation of leukocyte proliferation | biological process | GO:0070663 | 268 | 4 | 18204 | 48 |
PTPRC,TMEM131L,PTPN6,VAV3 |
5.382e-03 | -5.22 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 20 | 16828 | 46 |
PREX1,PTPRC,BMP2K,HCK,VMP1,VAV3,PPFIBP2,GRK6,PPP1R7,MPP1,PTPN6,GAB1,RAPGEF6,SYK,KREMEN1,TFEB,DAB2,SEMA4B,DIAPH2,PREX2 |
5.388e-03 | -5.22 | iRhom1-2_N | pfam domains | PF12595 | 2 | 1 | 17795 | 48 |
RHBDF2 |
5.388e-03 | -5.22 | ATG14 | pfam domains | PF10186 | 2 | 1 | 17795 | 48 |
ATG14 |
5.388e-03 | -5.22 | TMEM131_like_N | pfam domains | PF12371 | 2 | 1 | 17795 | 48 |
TMEM131L |
5.388e-03 | -5.22 | TMEM131_like | pfam domains | PF19532 | 2 | 1 | 17795 | 48 |
TMEM131L |
5.388e-03 | -5.22 | ACC_central | pfam domains | PF08326 | 2 | 1 | 17795 | 48 |
ACACB |
5.388e-03 | -5.22 | DAB2_SBM | pfam domains | PF21792 | 2 | 1 | 17795 | 48 |
DAB2 |
5.388e-03 | -5.22 | ACCA_BT | pfam domains | PF21385 | 2 | 1 | 17795 | 48 |
ACACB |
5.481e-03 | -5.21 | positive regulation of interleukin-10 production | biological process | GO:0032733 | 42 | 2 | 18204 | 48 |
SYK,RBM47 |
5.495e-03 | -5.20 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 24 | 18204 | 48 |
HCK,DAB2,VMP1,PPP1R7,OSBPL8,ACER2,PREX1,BMP2K,ATG14,TFEB,GAB1,SEMA4B,RBM47,DOCK2,NACC2,SLC9A1,PTPN6,DOCK8,SYK,PTPRC,DISC1,PLXND1,VAV3,CEMIP |
5.518e-03 | -5.20 | PSI | interpro domains | IPR016201 | 42 | 2 | 18521 | 49 |
SEMA4B,PLXND1 |
5.518e-03 | -5.20 | PTP_cat | interpro domains | IPR000242 | 42 | 2 | 18521 | 49 |
PTPN6,PTPRC |
5.519e-03 | -5.20 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051896 | 270 | 4 | 18204 | 48 |
SH2B3,PTPN6,OSBPL8,VAV3 |
5.545e-03 | -5.19 | SH2 domain binding | molecular function | GO:0042169 | 42 | 2 | 18094 | 48 |
SYK,PTPN6 |
5.545e-03 | -5.19 | intramembrane lipid transporter activity | molecular function | GO:0140303 | 42 | 2 | 18094 | 48 |
VMP1,ATP10D |
5.603e-03 | -5.18 | FGFR4 (fibroblast growth factor receptor 4) | protein interactions | 2264 | 455 | 5 | 19454 | 49 |
FCHO2,DAB2,MPP1,GAB1,PTPN6 |
5.632e-03 | -5.18 | myeloid leukocyte migration | biological process | GO:0097529 | 137 | 3 | 18204 | 48 |
SYK,PREX1,VAV3 |
5.632e-03 | -5.18 | cell recognition | biological process | GO:0008037 | 137 | 3 | 18204 | 48 |
DOCK2,DOCK8,PLXND1 |
5.654e-03 | -5.18 | GSK3A (glycogen synthase kinase 3 alpha) | protein interactions | 2931 | 456 | 5 | 19454 | 49 |
GAB1,ASCC3,RAPGEF6,DAB2,ACACB |
5.675e-03 | -5.17 | cellular process | biological process | GO:0009987 | 14996 | 46 | 18204 | 48 |
ACACB,ENTPD1,CADM4,KREMEN1,VAV3,RAPGEF6,SLC16A10,DOCK2,PREX2,PTPN6,DOCK8,DISC1,PTPRC,PREX1,SH2B3,MPP1,PHKB,BMP2K,GAB1,DAB2,GALNT1,RHBDF2,VMP1,OSBPL8,TMEM131L,PLXND1,ASCC3,PTGIR,CEMIP,SEMA4B,RBM47,NACC2,SLC9A1,PPFIBP2,SYK,ATP10D,ACER2,FCHO2,ATG14,TMTC1,STAB1,TFEB,HCK,GRK6,DIAPH2,SMOX |
5.679e-03 | -5.17 | positive regulation of intracellular signal transduction | biological process | GO:1902533 | 1048 | 8 | 18204 | 48 |
NACC2,SLC9A1,VAV3,PTPRC,SYK,PTPN6,OSBPL8,DAB2 |
5.715e-03 | -5.16 | Fc Epsilon Receptor I Signaling in Mast Cells | SMPDB pathways | SMP0000358 | 34 | 2 | 1369 | 5 |
VAV3,SYK |
5.727e-03 | -5.16 | Y_phosphatase | pfam domains | PF00102 | 42 | 2 | 17795 | 48 |
PTPN6,PTPRC |
5.738e-03 | -5.16 | positive regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900026 | 43 | 2 | 18204 | 48 |
DAB2,PREX1 |
5.738e-03 | -5.16 | semaphorin-plexin signaling pathway | biological process | GO:0071526 | 43 | 2 | 18204 | 48 |
PLXND1,SEMA4B |
5.742e-03 | -5.16 | PILRB (paired immunoglobin like type 2 receptor beta) | protein interactions | 29990 | 45 | 2 | 19454 | 49 |
GALNT1,PTPN6 |
5.742e-03 | -5.16 | SH3BP2 (SH3 domain binding protein 2) | protein interactions | 6452 | 45 | 2 | 19454 | 49 |
VAV3,SYK |
5.758e-03 | -5.16 | pleura | COSMIC cancer mutations | pleura | 4914 | 22 | 16828 | 46 |
PTPRC,PREX1,HCK,BMP2K,PPFIBP2,VAV3,VMP1,SMOX,PPP1R7,GRK6,RAPGEF6,PTPN6,GAB1,MPP1,DAB2,TFEB,KREMEN1,SYK,SH2B3,PREX2,SEMA4B,DIAPH2 |
5.761e-03 | -5.16 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 19 | 16828 | 46 |
DAB2,GALNT1,STAB1,PREX2,DIAPH2,OSBPL8,PLXND1,SLC9A1,RBM47,RAPGEF6,PTPN6,PPFIBP2,VAV3,DOCK2,DOCK8,SMOX,PREX1,ACACB,RHBDF2 |
5.777e-03 | -5.15 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 19 | 16828 | 46 |
RAPGEF6,PTPN6,OSBPL8,SLC9A1,RBM47,PLXND1,STAB1,PREX2,DIAPH2,DAB2,GALNT1,RHBDF2,ACACB,PREX1,SMOX,PPFIBP2,VAV3,DOCK2,DOCK8 |
5.797e-03 | -5.15 | - | gene3d domains | 6.10.250.1040 | 2 | 1 | 14470 | 42 |
SLC9A1 |
5.797e-03 | -5.15 | PreATP-grasp domain | gene3d domains | 3.90.1770.10 | 2 | 1 | 14470 | 42 |
ACACB |
5.797e-03 | -5.15 | Biotin dependent carboxylase carboxyltransferase | gene3d domains | 2.40.460.10 | 2 | 1 | 14470 | 42 |
ACACB |
5.797e-03 | -5.15 | - | gene3d domains | 6.10.250.2260 | 2 | 1 | 14470 | 42 |
GRK6 |
5.859e-03 | -5.14 | GTPase activator activity | molecular function | GO:0005096 | 273 | 4 | 18094 | 48 |
PREX2,PREX1,DOCK2,VAV3 |
5.863e-03 | -5.14 | positive regulation of cation transmembrane transport | biological process | GO:1904064 | 139 | 3 | 18204 | 48 |
CEMIP,VMP1,SLC9A1 |
5.864e-03 | -5.14 | IGF1R (insulin like growth factor 1 receptor) | protein interactions | 3480 | 460 | 5 | 19454 | 49 |
VAV3,FCHO2,GAB1,PTPN6,OSBPL8 |
5.887e-03 | -5.14 | TYR_PHOSPHATASE_PTP | prosite domains | PS50055 | 37 | 2 | 12186 | 38 |
PTPRC,PTPN6 |
5.993e-03 | -5.12 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 11 | 18204 | 48 |
DAB2,RBM47,SLC9A1,BMP2K,NACC2,VAV3,PTPRC,SYK,DISC1,OSBPL8,PTPN6 |
6.002e-03 | -5.12 | leukocyte degranulation | biological process | GO:0043299 | 44 | 2 | 18204 | 48 |
HCK,SYK |
6.002e-03 | -5.12 | positive regulation of protein dephosphorylation | biological process | GO:0035307 | 44 | 2 | 18204 | 48 |
PPP1R7,PTPRC |
6.002e-03 | -5.12 | response to electrical stimulus | biological process | GO:0051602 | 44 | 2 | 18204 | 48 |
SLC9A1,DISC1 |
6.002e-03 | -5.12 | regulation of peptidyl-threonine phosphorylation | biological process | GO:0010799 | 44 | 2 | 18204 | 48 |
CEMIP,CADM4 |
6.043e-03 | -5.11 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 11 | 18204 | 48 |
OSBPL8,PTPN6,DISC1,PTPRC,SYK,VAV3,BMP2K,SLC9A1,NACC2,RBM47,DAB2 |
6.045e-03 | -5.11 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 5 | 18204 | 48 |
KREMEN1,DAB2,PLXND1,PREX1,DISC1 |
6.083e-03 | -5.10 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 42 | 16828 | 46 |
GAB1,PTPN6,CADM4,NACC2,MPP1,ACER2,ATP10D,TMTC1,SLC16A10,PREX2,BLVRA,DIAPH2,DAB2,TFEB,KREMEN1,HCK,RHBDF2,PTGIR,PTPRC,ASCC3,PREX1,SMOX,PPFIBP2,VAV3,FCHO2,VMP1,DOCK2,DOCK8,RAPGEF6,ATG14,OSBPL8,PPP1R7,SLC9A1,PLXND1,RBM47,STAB1,SH2B3,SEMA4B,GALNT1,SYK,ACACB,TMCC3 |
6.125e-03 | -5.10 | GOPC (golgi associated PDZ and coiled-coil motif containing) | protein interactions | 57120 | 291 | 4 | 19454 | 49 |
RHBDF2,NACC2,HCK,GRK6 |
6.132e-03 | -5.09 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 45 | 16828 | 46 |
ENTPD1,TMCC3,ACACB,GALNT1,SYK,SEMA4B,STAB1,SH2B3,SLC9A1,PPP1R7,RBM47,PLXND1,GRK6,ATG14,OSBPL8,RAPGEF6,VMP1,FCHO2,DOCK8,DOCK2,PPFIBP2,VAV3,SMOX,PTPRC,ASCC3,PREX1,PTGIR,BMP2K,HCK,RHBDF2,TFEB,KREMEN1,DAB2,PREX2,DIAPH2,BLVRA,SLC16A10,TMTC1,ACER2,MPP1,ATP10D,GAB1,NACC2,CADM4,PTPN6 |
6.189e-03 | -5.08 | positive regulation of leukocyte cell-cell adhesion | biological process | GO:1903039 | 279 | 4 | 18204 | 48 |
PTPN6,SYK,PTPRC,DOCK8 |
6.213e-03 | -5.08 | PAOs oxidise polyamines to amines | REACTOME pathways | R-HSA-141334 | 2 | 1 | 10285 | 32 |
SMOX |
6.270e-03 | -5.07 | regulation of type I interferon-mediated signaling pathway | biological process | GO:0060338 | 45 | 2 | 18204 | 48 |
PTPN6,RBM47 |
6.270e-03 | -5.07 | positive regulation of B cell proliferation | biological process | GO:0030890 | 45 | 2 | 18204 | 48 |
PTPRC,VAV3 |
6.344e-03 | -5.06 | non-membrane spanning protein tyrosine kinase activity | molecular function | GO:0004715 | 45 | 2 | 18094 | 48 |
HCK,SYK |
6.348e-03 | -5.06 | KCNE3 (potassium voltage-gated channel subfamily E regulatory subunit 3) | protein interactions | 10008 | 294 | 4 | 19454 | 49 |
RHBDF2,TMEM131L,SLC9A1,GRK6 |
6.370e-03 | -5.06 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 19 | 16828 | 46 |
SMOX,VAV3,PPFIBP2,DOCK8,DOCK2,ACACB,RHBDF2,PREX1,STAB1,DIAPH2,PREX2,DAB2,GALNT1,PTPN6,RAPGEF6,OSBPL8,SLC9A1,RBM47,PLXND1 |
6.441e-03 | -5.05 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 49 |
HCK,PTPRC,ENTPD1,SLC9A1 |
6.450e-03 | -5.04 | positive regulation of immune response | biological process | GO:0050778 | 640 | 6 | 18204 | 48 |
PTPRC,SYK,RBM47,PTPN6,VAV3,HCK |
6.459e-03 | -5.04 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 3 | 16828 | 46 |
DOCK2,ATP10D,NACC2 |
6.464e-03 | -5.04 | negative regulation of canonical Wnt signaling pathway | biological process | GO:0090090 | 144 | 3 | 18204 | 48 |
DAB2,KREMEN1,TMEM131L |
6.468e-03 | -5.04 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | REACTOME pathways | R-HSA-983695 | 39 | 2 | 10285 | 32 |
SYK,PTPN6 |
6.505e-03 | -5.04 | SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1 like) | protein interactions | 23384 | 151 | 3 | 19454 | 49 |
VMP1,DISC1,PPFIBP2 |
6.511e-03 | -5.03 | CNKSR1 (connector enhancer of kinase suppressor of Ras 1) | protein interactions | 10256 | 48 | 2 | 19454 | 49 |
CADM4,PTPN6 |
6.532e-03 | -5.03 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 26 | 16828 | 46 |
ATG14,OSBPL8,PLXND1,RAPGEF6,SYK,SH2B3,STAB1,SEMA4B,ACACB,TMTC1,MPP1,ATP10D,DISC1,DAB2,TFEB,KREMEN1,PREX2,DIAPH2,PTPRC,ASCC3,PREX1,VAV3,FCHO2,VMP1,DOCK2,SMOX |
6.597e-03 | -5.02 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 49 |
PTPRC,HCK,SLC9A1,ENTPD1 |
6.652e-03 | -5.01 | mucin core 3 and core 4 O-glycosylation | BIOCYC pathways | META_PWY-7435 | 1 | 1 | 902 | 6 |
GALNT1 |
6.746e-03 | -5.00 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 18 | 16828 | 46 |
GRK6,PPP1R7,RAPGEF6,PTPN6,GAB1,DAB2,TFEB,KREMEN1,SYK,PREX2,SEMA4B,PTPRC,PREX1,HCK,BMP2K,PPFIBP2,VAV3,VMP1 |
6.777e-03 | -4.99 | PTGFRN (prostaglandin F2 receptor inhibitor) | protein interactions | 5738 | 49 | 2 | 19454 | 49 |
CEMIP,SLC9A1 |
6.782e-03 | -4.99 | localization | biological process | GO:0051179 | 4474 | 20 | 18204 | 48 |
DAB2,HCK,SLC16A10,DOCK2,RHBDF2,NACC2,SLC9A1,VMP1,ATP10D,SYK,DISC1,PTPRC,OSBPL8,ACACB,VAV3,TFEB,RAPGEF6,FCHO2,ATG14,STAB1 |
6.840e-03 | -4.98 | nodular | COSMIC cancer mutations | nodular | 1515 | 10 | 16828 | 46 |
PREX2,STAB1,SYK,DOCK8,DOCK2,TFEB,DISC1,CADM4,RBM47,PTPRC |
6.842e-03 | -4.98 | leukocyte chemotaxis | biological process | GO:0030595 | 147 | 3 | 18204 | 48 |
SYK,PREX1,VAV3 |
6.867e-03 | -4.98 | JAK2 (Janus kinase 2) | protein interactions | 3717 | 154 | 3 | 19454 | 49 |
PTPN6,SH2B3,PTPRC |
6.890e-03 | -4.98 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 12 | 16828 | 46 |
ASCC3,PTGIR,DOCK8,VAV3,TMCC3,PPP1R7,GAB1,PTPN6,RAPGEF6,SYK,KREMEN1,TFEB |
6.890e-03 | -4.98 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 12 | 16828 | 46 |
GAB1,PTPN6,RAPGEF6,PTGIR,ASCC3,PPP1R7,TMCC3,VAV3,DOCK8,SYK,KREMEN1,TFEB |
6.916e-03 | -4.97 | PTPc | smart domains | SM00194 | 37 | 2 | 9717 | 33 |
PTPRC,PTPN6 |
6.921e-03 | -4.97 | regulation of programmed cell death | biological process | GO:0043067 | 1569 | 10 | 18204 | 48 |
HCK,DAB2,ACER2,PLXND1,NACC2,SLC9A1,DOCK8,PTPRC,SYK,PTPN6 |
6.950e-03 | -4.97 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 15 | 16828 | 46 |
ACACB,PREX1,SMOX,DOCK2,GAB1,NACC2,ATP10D,ATG14,SLC16A10,STAB1,DIAPH2,PREX2,KREMEN1,TFEB,GALNT1 |
6.969e-03 | -4.97 | TCTN2 (tectonic family member 2) | protein interactions | 79867 | 302 | 4 | 19454 | 49 |
OSBPL8,TMEM131L,SLC9A1,VMP1 |
7.049e-03 | -4.95 | TRIM15 (tripartite motif containing 15) | protein interactions | 89870 | 50 | 2 | 19454 | 49 |
GAB1,SYK |
7.049e-03 | -4.95 | DOK1 (docking protein 1) | protein interactions | 1796 | 50 | 2 | 19454 | 49 |
PTPN6,HCK |
7.060e-03 | -4.95 | RHOG (ras homolog family member G) | protein interactions | 391 | 902 | 7 | 19454 | 49 |
SLC9A1,FCHO2,VAV3,PREX2,GAB1,OSBPL8,DIAPH2 |
7.080e-03 | -4.95 | lymphocyte differentiation | biological process | GO:0030098 | 290 | 4 | 18204 | 48 |
SYK,PTPRC,DOCK2,PREX1 |
7.092e-03 | -4.95 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 8 | 19454 | 49 |
TFEB,OSBPL8,GAB1,SH2B3,RAPGEF6,DISC1,TMCC3,PPFIBP2 |
7.098e-03 | -4.95 | T cell receptor signaling pathway | KEGG pathways | ko04660 | 102 | 3 | 7161 | 28 |
PTPN6,VAV3,PTPRC |
7.098e-03 | -4.95 | T cell receptor signaling pathway | KEGG pathways | hsa04660 | 102 | 3 | 7161 | 28 |
VAV3,PTPRC,PTPN6 |
7.109e-03 | -4.95 | regulation of humoral immune response | biological process | GO:0002920 | 48 | 2 | 18204 | 48 |
PTPRC,PTPN6 |
7.130e-03 | -4.94 | RRP1B (ribosomal RNA processing 1B) | protein interactions | 23076 | 304 | 4 | 19454 | 49 |
VMP1,PPP1R7,PTPN6,SYK |
7.251e-03 | -4.93 | negative regulation of protein phosphorylation | biological process | GO:0001933 | 292 | 4 | 18204 | 48 |
ATG14,PTPN6,CADM4,PTPRC |
7.325e-03 | -4.92 | SH2D2A (SH2 domain containing 2A) | protein interactions | 9047 | 51 | 2 | 19454 | 49 |
GAB1,SYK |
7.325e-03 | -4.92 | FCGR1A (Fc gamma receptor Ia) | protein interactions | 2209 | 51 | 2 | 19454 | 49 |
HCK,SYK |
7.325e-03 | -4.92 | IL4R (interleukin 4 receptor) | protein interactions | 3566 | 51 | 2 | 19454 | 49 |
RHBDF2,PTPN6 |
7.390e-03 | -4.91 | regulation of immune system process | biological process | GO:0002682 | 1584 | 10 | 18204 | 48 |
RHBDF2,MPP1,RBM47,HCK,PTPN6,DOCK8,SYK,PTPRC,TMEM131L,VAV3 |
7.390e-03 | -4.91 | bone | COSMIC cancer mutations | bone | 8157 | 31 | 16828 | 46 |
HCK,RHBDF2,PTPRC,PREX1,ASCC3,SMOX,PPFIBP2,VAV3,VMP1,DOCK8,DOCK2,NACC2,PTPN6,GAB1,MPP1,ATP10D,TMTC1,PREX2,DIAPH2,DAB2,KREMEN1,ACACB,TMCC3,ENTPD1,RAPGEF6,OSBPL8,GRK6,RBM47,PLXND1,STAB1,SEMA4B |
7.399e-03 | -4.91 | platelet aggregation | biological process | GO:0070527 | 49 | 2 | 18204 | 48 |
PTPN6,ENTPD1 |
7.512e-03 | -4.89 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 4 | 18204 | 48 |
DAB2,PTPN6,PTPRC,SYK |
7.517e-03 | -4.89 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 46 | 16828 | 46 |
BMP2K,PTGIR,RHBDF2,PREX1,DOCK2,VMP1,VAV3,ACER2,MPP1,CADM4,SLC16A10,PREX2,KREMEN1,TFEB,DAB2,ACACB,TMCC3,GRK6,SLC9A1,ATG14,SEMA4B,SH2B3,GALNT1,HCK,ASCC3,PTPRC,SMOX,DOCK8,FCHO2,PPFIBP2,ATP10D,PTPN6,GAB1,NACC2,TMTC1,DIAPH2,BLVRA,DISC1,ENTPD1,RAPGEF6,PLXND1,RBM47,PPP1R7,OSBPL8,STAB1,SYK |
7.538e-03 | -4.89 | SIGLEC11 (sialic acid binding Ig like lectin 11) | protein interactions | 114132 | 3 | 1 | 19454 | 49 |
PTPN6 |
7.538e-03 | -4.89 | Myo6 (myosin VI) | protein interactions | 315840 | 3 | 1 | 19454 | 49 |
DAB2 |
7.538e-03 | -4.89 | Cbl (Casitas B-lineage lymphoma) | protein interactions | 12402 | 3 | 1 | 19454 | 49 |
SYK |
7.538e-03 | -4.89 | ACER1 (alkaline ceramidase 1) | protein interactions | 125981 | 3 | 1 | 19454 | 49 |
MPP1 |
7.538e-03 | -4.89 | DYNLT2 (dynein light chain Tctex-type 2) | protein interactions | 6991 | 3 | 1 | 19454 | 49 |
CEMIP |
7.538e-03 | -4.89 | MAGEB3 (MAGE family member B3) | protein interactions | 4114 | 3 | 1 | 19454 | 49 |
PPP1R7 |
7.538e-03 | -4.89 | HERC2P2 (HERC2 pseudogene 2) | protein interactions | 400322 | 3 | 1 | 19454 | 49 |
DISC1 |
7.538e-03 | -4.89 | Srr (serine racemase) | protein interactions | 27364 | 3 | 1 | 19454 | 49 |
DISC1 |
7.538e-03 | -4.89 | PAQR8 (progestin and adipoQ receptor family member 8) | protein interactions | 85315 | 3 | 1 | 19454 | 49 |
MPP1 |
7.540e-03 | -4.89 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 8 | 19454 | 49 |
SH2B3,GAB1,TFEB,OSBPL8,RAPGEF6,PPFIBP2,TMCC3,DISC1 |
7.605e-03 | -4.88 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 2 | 19454 | 49 |
HCK,SYK |
7.626e-03 | -4.88 | PIGH (phosphatidylinositol glycan anchor biosynthesis class H) | protein interactions | 5283 | 160 | 3 | 19454 | 49 |
OSBPL8,TMEM131L,RHBDF2 |
7.636e-03 | -4.87 | organophosphate ester transport | biological process | GO:0015748 | 153 | 3 | 18204 | 48 |
VMP1,OSBPL8,ATP10D |
7.674e-03 | -4.87 | fatty acid beta-oxidation multienzyme complex | cellular component | GO:0036125 | 3 | 1 | 19108 | 49 |
ACACB |
7.674e-03 | -4.87 | mitochondrial fatty acid beta-oxidation multienzyme complex | cellular component | GO:0016507 | 3 | 1 | 19108 | 49 |
ACACB |
7.674e-03 | -4.87 | activating signal cointegrator 1 complex | cellular component | GO:0099053 | 3 | 1 | 19108 | 49 |
ASCC3 |
7.694e-03 | -4.87 | phospholipid translocation | biological process | GO:0045332 | 50 | 2 | 18204 | 48 |
VMP1,ATP10D |
7.816e-03 | -4.85 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 38 | 16828 | 46 |
FCHO2,DOCK8,DOCK2,PPFIBP2,VAV3,PTGIR,BMP2K,HCK,RHBDF2,PTPRC,PREX1,ASCC3,PREX2,BLVRA,DIAPH2,TFEB,KREMEN1,DAB2,MPP1,ATP10D,GAB1,NACC2,CADM4,SLC16A10,ENTPD1,TMCC3,ACACB,SEMA4B,STAB1,SH2B3,GALNT1,SYK,RAPGEF6,SLC9A1,PPP1R7,GRK6,RBM47,OSBPL8 |
7.828e-03 | -4.85 | skin-upper_leg-malignant_melanoma | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma | 850 | 7 | 16828 | 46 |
PREX2,DOCK8,DOCK2,VAV3,ATP10D,ASCC3,PTPRC |
7.890e-03 | -4.84 | serotonin secretion | biological process | GO:0001820 | 3 | 1 | 18204 | 48 |
SYK |
7.890e-03 | -4.84 | positive regulation of aldosterone biosynthetic process | biological process | GO:0032349 | 3 | 1 | 18204 | 48 |
DAB2 |
7.890e-03 | -4.84 | beta selection | biological process | GO:0043366 | 3 | 1 | 18204 | 48 |
SYK |
7.890e-03 | -4.84 | leukocyte migration involved in immune response | biological process | GO:0002522 | 3 | 1 | 18204 | 48 |
HCK |
7.890e-03 | -4.84 | positive regulation of mineralocorticoid secretion | biological process | GO:2000857 | 3 | 1 | 18204 | 48 |
DAB2 |
7.890e-03 | -4.84 | positive regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901896 | 3 | 1 | 18204 | 48 |
VMP1 |
7.890e-03 | -4.84 | positive regulation of clathrin-dependent endocytosis | biological process | GO:2000370 | 3 | 1 | 18204 | 48 |
DAB2 |
7.890e-03 | -4.84 | tyrosine transport | biological process | GO:0015828 | 3 | 1 | 18204 | 48 |
SLC16A10 |
7.890e-03 | -4.84 | positive regulation of aldosterone metabolic process | biological process | GO:0032346 | 3 | 1 | 18204 | 48 |
DAB2 |
7.890e-03 | -4.84 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 48 |
SLC9A1 |
7.890e-03 | -4.84 | protein localization to nuclear pore | biological process | GO:0090204 | 3 | 1 | 18204 | 48 |
OSBPL8 |
7.890e-03 | -4.84 | pyramidal neuron migration to cerebral cortex | biological process | GO:0021852 | 3 | 1 | 18204 | 48 |
DISC1 |
7.890e-03 | -4.84 | serotonin secretion involved in inflammatory response | biological process | GO:0002442 | 3 | 1 | 18204 | 48 |
SYK |
7.890e-03 | -4.84 | positive regulation of aldosterone secretion | biological process | GO:2000860 | 3 | 1 | 18204 | 48 |
DAB2 |
7.890e-03 | -4.84 | monocyte homeostasis | biological process | GO:0035702 | 3 | 1 | 18204 | 48 |
SH2B3 |
7.890e-03 | -4.84 | myeloid dendritic cell activation involved in immune response | biological process | GO:0002277 | 3 | 1 | 18204 | 48 |
DOCK2 |
7.890e-03 | -4.84 | serotonin production involved in inflammatory response | biological process | GO:0002351 | 3 | 1 | 18204 | 48 |
SYK |
7.890e-03 | -4.84 | membrane raft polarization | biological process | GO:0001766 | 3 | 1 | 18204 | 48 |
DOCK2 |
7.891e-03 | -4.84 | FCGR2A (Fc gamma receptor IIa) | protein interactions | 2212 | 53 | 2 | 19454 | 49 |
HCK,SYK |
7.913e-03 | -4.84 | positive regulation of monoatomic ion transmembrane transport | biological process | GO:0034767 | 155 | 3 | 18204 | 48 |
VMP1,SLC9A1,CEMIP |
7.913e-03 | -4.84 | myeloid leukocyte activation | biological process | GO:0002274 | 155 | 3 | 18204 | 48 |
PREX1,DOCK2,SYK |
7.916e-03 | -4.84 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 46 | 16828 | 46 |
ATG14,SLC9A1,GRK6,GALNT1,SH2B3,SEMA4B,ACACB,TMCC3,SLC16A10,CADM4,MPP1,ACER2,DAB2,TFEB,KREMEN1,PREX2,PREX1,RHBDF2,PTGIR,BMP2K,VAV3,VMP1,DOCK2,OSBPL8,PPP1R7,PLXND1,RBM47,RAPGEF6,SYK,STAB1,ENTPD1,TMTC1,GAB1,NACC2,PTPN6,ATP10D,DISC1,BLVRA,DIAPH2,PTPRC,ASCC3,HCK,PPFIBP2,FCHO2,DOCK8,SMOX |
7.916e-03 | -4.84 | PHK_A/B_su | interpro domains | IPR008734 | 3 | 1 | 18521 | 49 |
PHKB |
7.916e-03 | -4.84 | MiT/TFE_N | interpro domains | IPR031867 | 3 | 1 | 18521 | 49 |
TFEB |
7.916e-03 | -4.84 | KPBA/B_C | interpro domains | IPR045583 | 3 | 1 | 18521 | 49 |
PHKB |
7.916e-03 | -4.84 | PH_Vav | interpro domains | IPR037832 | 3 | 1 | 18521 | 49 |
VAV3 |
7.916e-03 | -4.84 | GH15-like | interpro domains | IPR011613 | 3 | 1 | 18521 | 49 |
PHKB |
7.916e-03 | -4.84 | Phe_ZIP_sf | interpro domains | IPR036290 | 3 | 1 | 18521 | 49 |
SH2B3 |
7.916e-03 | -4.84 | SH2B | interpro domains | IPR030523 | 3 | 1 | 18521 | 49 |
SH2B3 |
7.916e-03 | -4.84 | NHE_CaM-bd | interpro domains | IPR032103 | 3 | 1 | 18521 | 49 |
SLC9A1 |
7.916e-03 | -4.84 | DIA_GBD_sf | interpro domains | IPR044933 | 3 | 1 | 18521 | 49 |
DIAPH2 |
7.916e-03 | -4.84 | C2_Dock-C | interpro domains | IPR037808 | 3 | 1 | 18521 | 49 |
DOCK8 |
7.916e-03 | -4.84 | Phe_ZIP | interpro domains | IPR015012 | 3 | 1 | 18521 | 49 |
SH2B3 |
7.916e-03 | -4.84 | Muniscin_C | interpro domains | IPR018808 | 3 | 1 | 18521 | 49 |
FCHO2 |
7.916e-03 | -4.84 | ACER | interpro domains | IPR008901 | 3 | 1 | 18521 | 49 |
ACER2 |
7.938e-03 | -4.84 | polyamine oxidase activity | molecular function | GO:0046592 | 3 | 1 | 18094 | 48 |
SMOX |
7.938e-03 | -4.84 | L-tryptophan transmembrane transporter activity | molecular function | GO:0015196 | 3 | 1 | 18094 | 48 |
SLC16A10 |
7.938e-03 | -4.84 | apyrase activity | molecular function | GO:0004050 | 3 | 1 | 18094 | 48 |
ENTPD1 |
7.938e-03 | -4.84 | dihydroceramidase activity | molecular function | GO:0071633 | 3 | 1 | 18094 | 48 |
ACER2 |
7.938e-03 | -4.84 | glycosylceramide flippase activity | molecular function | GO:0140351 | 3 | 1 | 18094 | 48 |
ATP10D |
7.942e-03 | -4.84 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 46 |
ACER2,NACC2,TMTC1,PREX2,DIAPH2,KREMEN1,DAB2,HCK,RHBDF2,PTPRC,ASCC3,PREX1,VMP1,DOCK8,DOCK2,PPFIBP2,RAPGEF6,SLC9A1,PLXND1,RBM47,OSBPL8,ATG14,STAB1,GALNT1,ACACB |
7.980e-03 | -4.83 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 46 |
ACACB,GALNT1,STAB1,RBM47,SLC9A1,PLXND1,ATG14,OSBPL8,RAPGEF6,DOCK8,DOCK2,VMP1,PPFIBP2,PREX1,ASCC3,PTPRC,RHBDF2,HCK,KREMEN1,DAB2,DIAPH2,PREX2,TMTC1,ACER2,NACC2 |
8.071e-03 | -4.82 | MITF_TFEB_C_3_N | pfam domains | PF15951 | 3 | 1 | 17795 | 48 |
TFEB |
8.071e-03 | -4.82 | muHD | pfam domains | PF10291 | 3 | 1 | 17795 | 48 |
FCHO2 |
8.071e-03 | -4.82 | KPBB_C | pfam domains | PF19292 | 3 | 1 | 17795 | 48 |
PHKB |
8.071e-03 | -4.82 | Glyco_hydro_15 | pfam domains | PF00723 | 3 | 1 | 17795 | 48 |
PHKB |
8.071e-03 | -4.82 | NEXCaM_BD | pfam domains | PF16644 | 3 | 1 | 17795 | 48 |
SLC9A1 |
8.071e-03 | -4.82 | Phe_ZIP | pfam domains | PF08916 | 3 | 1 | 17795 | 48 |
SH2B3 |
8.071e-03 | -4.82 | Ceramidase | pfam domains | PF05875 | 3 | 1 | 17795 | 48 |
ACER2 |
8.159e-03 | -4.81 | HSPB8 (heat shock protein family B (small) member 8) | protein interactions | 26353 | 164 | 3 | 19454 | 49 |
RHBDF2,ASCC3,NACC2 |
8.239e-03 | -4.80 | LGALS1 (galectin 1) | protein interactions | 3956 | 317 | 4 | 19454 | 49 |
PLXND1,OSBPL8,HCK,PTPRC |
8.296e-03 | -4.79 | C8orf33 (chromosome 8 open reading frame 33) | protein interactions | 65265 | 165 | 3 | 19454 | 49 |
SYK,PTPN6,DISC1 |
8.296e-03 | -4.79 | NUBP2 (NUBP iron-sulfur cluster assembly factor 2, cytosolic) | protein interactions | 10101 | 165 | 3 | 19454 | 49 |
GAB1,GALNT1,GRK6 |
8.326e-03 | -4.79 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 19 | 16828 | 46 |
DOCK8,DOCK2,ACACB,PTPRC,PREX1,PREX2,BLVRA,DIAPH2,STAB1,TFEB,GALNT1,KREMEN1,DAB2,ACER2,ATP10D,GAB1,GRK6,OSBPL8,ATG14 |
8.468e-03 | -4.77 | autophagosome membrane | cellular component | GO:0000421 | 54 | 2 | 19108 | 49 |
VMP1,ATG14 |
8.483e-03 | -4.77 | phagocytosis | biological process | GO:0006909 | 159 | 3 | 18204 | 48 |
HCK,VAV3,SYK |
8.612e-03 | -4.75 | regulation of platelet activation | biological process | GO:0010543 | 53 | 2 | 18204 | 48 |
SH2B3,SYK |
8.612e-03 | -4.75 | positive regulation of calcium-mediated signaling | biological process | GO:0050850 | 53 | 2 | 18204 | 48 |
SLC9A1,SYK |
8.683e-03 | -4.75 | - | gene3d domains | 6.10.250.2020 | 3 | 1 | 14470 | 42 |
SLC9A1 |
8.683e-03 | -4.75 | - | gene3d domains | 1.20.58.630 | 3 | 1 | 14470 | 42 |
DIAPH2 |
8.683e-03 | -4.75 | - | gene3d domains | 6.10.30.30 | 3 | 1 | 14470 | 42 |
DIAPH2 |
8.683e-03 | -4.75 | - | gene3d domains | 6.10.140.110 | 3 | 1 | 14470 | 42 |
SH2B3 |
8.683e-03 | -4.75 | Formin, diaphanous GTPase-binding domain | gene3d domains | 1.10.20.40 | 3 | 1 | 14470 | 42 |
DIAPH2 |
8.688e-03 | -4.75 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 7 | 16828 | 46 |
STAB1,PREX2,SYK,HCK,RHBDF2,BMP2K,GRK6 |
8.713e-03 | -4.74 | RALBP1 (ralA binding protein 1) | protein interactions | 10928 | 168 | 3 | 19454 | 49 |
RBM47,BMP2K,HCK |
8.742e-03 | -4.74 | LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) | protein interactions | 55004 | 714 | 6 | 19454 | 49 |
DIAPH2,DAB2,FCHO2,BMP2K,GAB1,OSBPL8 |
8.776e-03 | -4.74 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 5 | 18204 | 48 |
VMP1,SLC9A1,PTPN6,CEMIP,OSBPL8 |
8.778e-03 | -4.74 | BCR signaling pathway | Pathway Interaction DB | bcr_5pathway | 66 | 3 | 2226 | 15 |
PTPRC,SYK,PTPN6 |
8.812e-03 | -4.73 | regulation of monoatomic cation transmembrane transport | biological process | GO:1904062 | 309 | 4 | 18204 | 48 |
VMP1,SLC9A1,CEMIP,PTPN6 |
8.847e-03 | -4.73 | PSI | smart domains | SM00423 | 42 | 2 | 9717 | 33 |
PLXND1,SEMA4B |
8.928e-03 | -4.72 | regulation of lipid storage | biological process | GO:0010883 | 54 | 2 | 18204 | 48 |
ACACB,OSBPL8 |
8.928e-03 | -4.72 | positive regulation of receptor-mediated endocytosis | biological process | GO:0048260 | 54 | 2 | 18204 | 48 |
DAB2,SYK |
8.928e-03 | -4.72 | positive regulation of dephosphorylation | biological process | GO:0035306 | 54 | 2 | 18204 | 48 |
PPP1R7,PTPRC |
9.076e-03 | -4.70 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 4 | 16828 | 46 |
DIAPH2,OSBPL8,VMP1,DOCK2 |
9.108e-03 | -4.70 | BCAP31 (B cell receptor associated protein 31) | protein interactions | 10134 | 512 | 5 | 19454 | 49 |
VMP1,SLC9A1,OSBPL8,TMEM131L,RHBDF2 |
9.177e-03 | -4.69 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 18 | 16828 | 46 |
TMCC3,DOCK2,ASCC3,PREX2,DIAPH2,STAB1,SH2B3,GALNT1,SYK,DAB2,RAPGEF6,PTPN6,GAB1,PLXND1,SLC9A1,SLC16A10,ATG14,TMTC1 |
9.177e-03 | -4.69 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 18 | 16828 | 46 |
DOCK2,TMCC3,ASCC3,DAB2,GALNT1,SYK,SH2B3,STAB1,PREX2,DIAPH2,ATG14,TMTC1,SLC16A10,PLXND1,SLC9A1,RAPGEF6,GAB1,PTPN6 |
9.209e-03 | -4.69 | negative regulation of phosphorylation | biological process | GO:0042326 | 313 | 4 | 18204 | 48 |
ATG14,PTPN6,CADM4,PTPRC |
9.249e-03 | -4.68 | autophagosome maturation | biological process | GO:0097352 | 55 | 2 | 18204 | 48 |
VMP1,ATG14 |
9.249e-03 | -4.68 | lipid translocation | biological process | GO:0034204 | 55 | 2 | 18204 | 48 |
ATP10D,VMP1 |
9.300e-03 | -4.68 | phospholipid binding | molecular function | GO:0005543 | 489 | 5 | 18094 | 48 |
SLC9A1,FCHO2,PREX1,OSBPL8,RAPGEF6 |
9.306e-03 | -4.68 | Interconversion of polyamines | REACTOME pathways | R-HSA-351200 | 3 | 1 | 10285 | 32 |
SMOX |
9.328e-03 | -4.67 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 13 | 19108 | 49 |
DIAPH2,PTPRC,DAB2,DOCK2,PTPN6,STAB1,DISC1,ATG14,FCHO2,RAPGEF6,SYK,CEMIP,HCK |
9.340e-03 | -4.67 | human chrXq21.33 | chromosome location | human chrXq21.33 | 5 | 1 | 26134 | 49 |
DIAPH2 |
9.340e-03 | -4.67 | human chr6q16.3 | chromosome location | human chr6q16.3 | 5 | 1 | 26134 | 49 |
ASCC3 |
9.342e-03 | -4.67 | cell differentiation | biological process | GO:0030154 | 3645 | 17 | 18204 | 48 |
PLXND1,PREX1,SH2B3,RAPGEF6,DAB2,HCK,DOCK2,RBM47,SEMA4B,SLC9A1,DIAPH2,PREX2,PTPRC,DISC1,SYK,OSBPL8,PTPN6 |
9.390e-03 | -4.67 | LRCH1 (leucine rich repeats and calponin homology domain containing 1) | protein interactions | 23143 | 58 | 2 | 19454 | 49 |
DOCK8,TMEM131L |
9.390e-03 | -4.67 | Sec24c (SEC24 homolog C, COPII coat complex component) | protein interactions | 218811 | 58 | 2 | 19454 | 49 |
DAB2,BMP2K |
9.391e-03 | -4.67 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 7 | 16828 | 46 |
ATP10D,PTPRC,ASCC3,PREX2,VAV3,DOCK2,DOCK8 |
9.419e-03 | -4.66 | cellular developmental process | biological process | GO:0048869 | 3648 | 17 | 18204 | 48 |
SEMA4B,RBM47,DOCK2,HCK,DAB2,PTPN6,OSBPL8,DISC1,SYK,PTPRC,DIAPH2,PREX2,SLC9A1,SH2B3,PLXND1,PREX1,RAPGEF6 |
9.437e-03 | -4.66 | CLTB (clathrin light chain B) | protein interactions | 1212 | 173 | 3 | 19454 | 49 |
FCHO2,DAB2,BMP2K |
9.512e-03 | -4.66 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 13 | 19108 | 49 |
FCHO2,ATG14,DISC1,RAPGEF6,SYK,CEMIP,HCK,DIAPH2,DAB2,DOCK2,PTPRC,STAB1,PTPN6 |
9.576e-03 | -4.65 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002823 | 56 | 2 | 18204 | 48 |
PTPN6,PTPRC |
9.576e-03 | -4.65 | leukocyte cell-cell adhesion | biological process | GO:0007159 | 56 | 2 | 18204 | 48 |
SYK,PTPRC |
9.586e-03 | -4.65 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 3 | 19454 | 49 |
PREX1,DOCK8,PPP1R7 |
9.608e-03 | -4.65 | GTPase binding | molecular function | GO:0051020 | 315 | 4 | 18094 | 48 |
DIAPH2,DOCK2,RAPGEF6,ATG14 |
9.633e-03 | -4.64 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 6 | 18204 | 48 |
DAB2,PPP1R7,ATG14,CEMIP,PTPRC,SYK |
9.633e-03 | -4.64 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 6 | 18204 | 48 |
PTPRC,SYK,ATG14,PPP1R7,CEMIP,DAB2 |
9.635e-03 | -4.64 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 38 | 16828 | 46 |
ENTPD1,TMCC3,ACACB,SEMA4B,SH2B3,STAB1,SYK,SLC9A1,GRK6,PLXND1,OSBPL8,ATG14,SMOX,DOCK8,DOCK2,VMP1,FCHO2,VAV3,PPFIBP2,BMP2K,RHBDF2,HCK,PREX1,ASCC3,PTPRC,BLVRA,DIAPH2,PREX2,KREMEN1,DAB2,ATP10D,ACER2,CADM4,GAB1,PTPN6,NACC2,SLC16A10,TMTC1 |
9.695e-03 | -4.64 | lipid transporter activity | molecular function | GO:0005319 | 166 | 3 | 18094 | 48 |
VMP1,OSBPL8,ATP10D |
9.743e-03 | -4.63 | regulation of protein phosphorylation | biological process | GO:0001932 | 917 | 7 | 18204 | 48 |
DAB2,CADM4,ATG14,PTPN6,CEMIP,SYK,PTPRC |
9.851e-03 | -4.62 | FBXO22 (F-box protein 22) | protein interactions | 26263 | 522 | 5 | 19454 | 49 |
MPP1,DIAPH2,ACACB,OSBPL8,ASCC3 |
9.852e-03 | -4.62 | cellular component assembly | biological process | GO:0022607 | 2472 | 13 | 18204 | 48 |
FCHO2,RAPGEF6,ATG14,VAV3,ACACB,PLXND1,PREX1,DISC1,SLC9A1,NACC2,DIAPH2,VMP1,DAB2 |
9.853e-03 | -4.62 | CLTA (clathrin light chain A) | protein interactions | 1211 | 334 | 4 | 19454 | 49 |
DOCK8,BMP2K,FCHO2,DAB2 |
9.871e-03 | -4.62 | cell-cell junction | cellular component | GO:0005911 | 513 | 5 | 19108 | 49 |
GAB1,CADM4,SLC9A1,PTPN6,MPP1 |
9.908e-03 | -4.61 | negative regulation of lymphocyte mediated immunity | biological process | GO:0002707 | 57 | 2 | 18204 | 48 |
PTPN6,PTPRC |
9.960e-03 | -4.61 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 8 | 18204 | 48 |
CADM4,DAB2,CEMIP,PPP1R7,PTPN6,ATG14,SYK,PTPRC |
1.001e-02 | -4.60 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 8 | 18204 | 48 |
CEMIP,PPP1R7,ATG14,PTPN6,PTPRC,SYK,CADM4,DAB2 |
1.002e-02 | -4.60 | CA2 (carbonic anhydrase 2) | protein interactions | 760 | 60 | 2 | 19454 | 49 |
VAV3,SLC9A1 |
1.004e-02 | -4.60 | wound healing | biological process | GO:0042060 | 321 | 4 | 18204 | 48 |
VAV3,SYK,ENTPD1,PTPN6 |
1.004e-02 | -4.60 | Map6 (microtubule-associated protein 6) | protein interactions | 29457 | 4 | 1 | 19454 | 49 |
PLXND1 |
1.004e-02 | -4.60 | H1-10-AS1 (H1-10 antisense RNA 1) | protein interactions | 339942 | 4 | 1 | 19454 | 49 |
PTPN6 |
1.004e-02 | -4.60 | OTOP1 (otopetrin 1) | protein interactions | 133060 | 4 | 1 | 19454 | 49 |
OSBPL8 |
1.004e-02 | -4.60 | MGAT3 (beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase) | protein interactions | 4248 | 4 | 1 | 19454 | 49 |
DISC1 |
1.004e-02 | -4.60 | PVALB (parvalbumin) | protein interactions | 5816 | 4 | 1 | 19454 | 49 |
ASCC3 |
1.004e-02 | -4.60 | Becn2 (beclin 2) | protein interactions | 226720 | 4 | 1 | 19454 | 49 |
ATG14 |
1.004e-02 | -4.60 | PLEKHD1 (pleckstrin homology and coiled-coil domain containing D1) | protein interactions | 400224 | 4 | 1 | 19454 | 49 |
SYK |
1.004e-02 | -4.60 | ORF23 (ORF23) | protein interactions | 4961503 | 4 | 1 | 19454 | 49 |
PPP1R7 |
1.004e-02 | -4.60 | FBXO41 (F-box protein 41) | protein interactions | 150726 | 4 | 1 | 19454 | 49 |
DISC1 |
1.005e-02 | -4.60 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 25 | 18204 | 48 |
DOCK8,DISC1,PTPRC,SYK,PTPN6,NACC2,SLC9A1,RBM47,DOCK2,SEMA4B,CEMIP,VAV3,PLXND1,ACACB,PPP1R7,OSBPL8,VMP1,HCK,DAB2,TFEB,GAB1,ATG14,BMP2K,ACER2,PREX1 |
1.014e-02 | -4.59 | cellular component organization | biological process | GO:0016043 | 5636 | 23 | 18204 | 48 |
DAB2,HCK,OSBPL8,VMP1,DIAPH2,PREX1,ATG14,FCHO2,TFEB,SEMA4B,DOCK2,ATP10D,PTPRC,DISC1,PREX2,PPFIBP2,SLC9A1,NACC2,ACACB,PLXND1,ASCC3,RAPGEF6,VAV3 |
1.019e-02 | -4.59 | DGCR2 (DiGeorge syndrome critical region gene 2) | protein interactions | 9993 | 178 | 3 | 19454 | 49 |
OSBPL8,ASCC3,SLC9A1 |
1.022e-02 | -4.58 | omegasome membrane | cellular component | GO:1903349 | 4 | 1 | 19108 | 49 |
ATG14 |
1.022e-02 | -4.58 | central region of growth cone | cellular component | GO:0090724 | 4 | 1 | 19108 | 49 |
DISC1 |
1.037e-02 | -4.57 | C2 domain | gene3d domains | 2.60.40.150 | 156 | 3 | 14470 | 42 |
DOCK2,ASCC3,DOCK8 |
1.044e-02 | -4.56 | endomembrane system | cellular component | GO:0012505 | 4764 | 20 | 19108 | 49 |
GALNT1,HCK,CEMIP,ACER2,DISC1,OSBPL8,ATG14,FCHO2,SMOX,PTPN6,TMCC3,TMTC1,ATP10D,RHBDF2,PTPRC,TMEM131L,DOCK2,DAB2,DIAPH2,VMP1 |
1.044e-02 | -4.56 | C2_domain_sf | interpro domains | IPR035892 | 171 | 3 | 18521 | 49 |
DOCK2,DOCK8,ASCC3 |
1.051e-02 | -4.56 | respiratory burst after phagocytosis | biological process | GO:0045728 | 4 | 1 | 18204 | 48 |
HCK |
1.051e-02 | -4.56 | positive regulation of steroid hormone biosynthetic process | biological process | GO:0090031 | 4 | 1 | 18204 | 48 |
DAB2 |
1.051e-02 | -4.56 | negative regulation of cell adhesion involved in substrate-bound cell migration | biological process | GO:0006933 | 4 | 1 | 18204 | 48 |
PTPRC |
1.051e-02 | -4.56 | DN2 thymocyte differentiation | biological process | GO:1904155 | 4 | 1 | 18204 | 48 |
PTPRC |
1.051e-02 | -4.56 | phenylalanine transport | biological process | GO:0015823 | 4 | 1 | 18204 | 48 |
SLC16A10 |
1.051e-02 | -4.56 | negative regulation of mast cell activation involved in immune response | biological process | GO:0033007 | 4 | 1 | 18204 | 48 |
PTPN6 |
1.051e-02 | -4.56 | cellular response to molecule of fungal origin | biological process | GO:0071226 | 4 | 1 | 18204 | 48 |
SYK |
1.051e-02 | -4.56 | polyamine catabolic process | biological process | GO:0006598 | 4 | 1 | 18204 | 48 |
SMOX |
1.051e-02 | -4.56 | plasma membrane lactate transport | biological process | GO:0035879 | 4 | 1 | 18204 | 48 |
ACACB |
1.051e-02 | -4.56 | regulation of protein tyrosine phosphatase activity | biological process | GO:1903613 | 4 | 1 | 18204 | 48 |
PTPRC |
1.051e-02 | -4.56 | positive regulation of mast cell cytokine production | biological process | GO:0032765 | 4 | 1 | 18204 | 48 |
SYK |
1.051e-02 | -4.56 | positive regulation of establishment of T cell polarity | biological process | GO:1903905 | 4 | 1 | 18204 | 48 |
DOCK8 |
1.051e-02 | -4.56 | dichotomous subdivision of terminal units involved in salivary gland branching | biological process | GO:0060666 | 4 | 1 | 18204 | 48 |
PLXND1 |
1.054e-02 | -4.55 | VTT_dom | interpro domains | IPR032816 | 4 | 1 | 18521 | 49 |
VMP1 |
1.054e-02 | -4.55 | COA_CT_N | interpro domains | IPR011762 | 4 | 1 | 18521 | 49 |
ACACB |
1.054e-02 | -4.55 | FAS1_domain | interpro domains | IPR000782 | 4 | 1 | 18521 | 49 |
STAB1 |
1.054e-02 | -4.55 | AcCoA_carboxyl_beta | interpro domains | IPR034733 | 4 | 1 | 18521 | 49 |
ACACB |
1.054e-02 | -4.55 | Sec63-dom | interpro domains | IPR004179 | 4 | 1 | 18521 | 49 |
ASCC3 |
1.054e-02 | -4.55 | FAS1_dom_sf | interpro domains | IPR036378 | 4 | 1 | 18521 | 49 |
STAB1 |
1.054e-02 | -4.55 | TEX28/TMCC | interpro domains | IPR019394 | 4 | 1 | 18521 | 49 |
TMCC3 |
1.054e-02 | -4.55 | Gfo/Idh/MocA-like_OxRdtase_N | interpro domains | IPR000683 | 4 | 1 | 18521 | 49 |
BLVRA |
1.054e-02 | -4.55 | Gab1-4-like | interpro domains | IPR046355 | 4 | 1 | 18521 | 49 |
GAB1 |
1.054e-02 | -4.55 | MiT/TFE_C | interpro domains | IPR021802 | 4 | 1 | 18521 | 49 |
TFEB |
1.054e-02 | -4.55 | G8_domain | interpro domains | IPR019316 | 4 | 1 | 18521 | 49 |
CEMIP |
1.054e-02 | -4.55 | COA_CT_C | interpro domains | IPR011763 | 4 | 1 | 18521 | 49 |
ACACB |
1.054e-02 | -4.55 | TMTC_DUF1736 | interpro domains | IPR013618 | 4 | 1 | 18521 | 49 |
TMTC1 |
1.057e-02 | -4.55 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | molecular function | GO:0016647 | 4 | 1 | 18094 | 48 |
SMOX |
1.057e-02 | -4.55 | stem cell factor receptor binding | molecular function | GO:0005173 | 4 | 1 | 18094 | 48 |
SH2B3 |
1.057e-02 | -4.55 | beta-adrenergic receptor kinase activity | molecular function | GO:0047696 | 4 | 1 | 18094 | 48 |
GRK6 |
1.057e-02 | -4.55 | CDP phosphatase activity | molecular function | GO:0036384 | 4 | 1 | 18094 | 48 |
ENTPD1 |
1.057e-02 | -4.55 | IDP phosphatase activity | molecular function | GO:1990003 | 4 | 1 | 18094 | 48 |
ENTPD1 |
1.067e-02 | -4.54 | PPP1R2 (protein phosphatase 1 regulatory inhibitor subunit 2) | protein interactions | 5504 | 62 | 2 | 19454 | 49 |
PPP1R7,BMP2K |
1.074e-02 | -4.53 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 28 | 16828 | 46 |
GALNT1,SYK,STAB1,GRK6,RBM47,PLXND1,SLC9A1,OSBPL8,RAPGEF6,ACACB,KREMEN1,DAB2,PREX2,SLC16A10,TMTC1,MPP1,ATP10D,NACC2,GAB1,VMP1,DOCK8,DOCK2,PPFIBP2,SMOX,PTPRC,PREX1,ASCC3,BMP2K |
1.074e-02 | -4.53 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 28 | 16828 | 46 |
ACACB,STAB1,SYK,GALNT1,RAPGEF6,OSBPL8,SLC9A1,PLXND1,GRK6,RBM47,SMOX,PPFIBP2,DOCK2,DOCK8,VMP1,BMP2K,ASCC3,PREX1,PTPRC,PREX2,DAB2,KREMEN1,NACC2,GAB1,ATP10D,MPP1,TMTC1,SLC16A10 |
1.075e-02 | -4.53 | Carboxyl_trans | pfam domains | PF01039 | 4 | 1 | 17795 | 48 |
ACACB |
1.075e-02 | -4.53 | TMTC_DUF1736 | pfam domains | PF08409 | 4 | 1 | 17795 | 48 |
TMTC1 |
1.075e-02 | -4.53 | SNARE_assoc | pfam domains | PF09335 | 4 | 1 | 17795 | 48 |
VMP1 |
1.075e-02 | -4.53 | DUF3371 | pfam domains | PF11851 | 4 | 1 | 17795 | 48 |
TFEB |
1.075e-02 | -4.53 | Fasciclin | pfam domains | PF02469 | 4 | 1 | 17795 | 48 |
STAB1 |
1.075e-02 | -4.53 | Tmemb_cc2 | pfam domains | PF10267 | 4 | 1 | 17795 | 48 |
TMCC3 |
1.075e-02 | -4.53 | G8 | pfam domains | PF10162 | 4 | 1 | 17795 | 48 |
CEMIP |
1.075e-02 | -4.53 | GFO_IDH_MocA | pfam domains | PF01408 | 4 | 1 | 17795 | 48 |
BLVRA |
1.075e-02 | -4.53 | Sec63 | pfam domains | PF02889 | 4 | 1 | 17795 | 48 |
ASCC3 |
1.080e-02 | -4.53 | positive regulation of cell-cell adhesion | biological process | GO:0022409 | 328 | 4 | 18204 | 48 |
PTPN6,DOCK8,PTPRC,SYK |
1.083e-02 | -4.53 | ASCC3 (activating signal cointegrator 1 complex subunit 3) | protein interactions | 10973 | 182 | 3 | 19454 | 49 |
ASCC3,PTPN6,ENTPD1 |
1.087e-02 | -4.52 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 30 | 16828 | 46 |
SH2B3,STAB1,SEMA4B,SYK,GALNT1,RAPGEF6,OSBPL8,ATG14,SLC9A1,GRK6,PLXND1,ACACB,DIAPH2,PREX2,DAB2,DISC1,KREMEN1,TFEB,ATP10D,MPP1,TMTC1,SLC16A10,SMOX,VAV3,DOCK2,FCHO2,VMP1,PREX1,ASCC3,PTPRC |
1.089e-02 | -4.52 | skin-face-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-face-malignant_melanoma-superficial_spreading | 4 | 1 | 16828 | 46 |
PREX2 |
1.089e-02 | -4.52 | idiopathic_erythrocytosis | COSMIC cancer mutations | idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.089e-02 | -4.52 | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.089e-02 | -4.52 | skin-lower_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-nodular | 4 | 1 | 16828 | 46 |
PREX2 |
1.091e-02 | -4.52 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 11 | 16828 | 46 |
RAPGEF6,PTPN6,GAB1,PPP1R7,TFEB,KREMEN1,SYK,ACACB,PTGIR,SMOX,VAV3 |
1.091e-02 | -4.52 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 11 | 16828 | 46 |
SMOX,VAV3,PTGIR,ACACB,TFEB,KREMEN1,SYK,RAPGEF6,PTPN6,GAB1,PPP1R7 |
1.091e-02 | -4.52 | regulation of leukocyte differentiation | biological process | GO:1902105 | 329 | 4 | 18204 | 48 |
PTPRC,SYK,TMEM131L,PTPN6 |
1.101e-02 | -4.51 | CD3E (CD3 epsilon subunit of T-cell receptor complex) | protein interactions | 916 | 63 | 2 | 19454 | 49 |
SYK,TMEM131L |
1.101e-02 | -4.51 | IFNAR1 (interferon alpha and beta receptor subunit 1) | protein interactions | 3454 | 63 | 2 | 19454 | 49 |
PTPRC,PTPN6 |
1.101e-02 | -4.51 | PAG1 (phosphoprotein membrane anchor with glycosphingolipid microdomains 1) | protein interactions | 55824 | 63 | 2 | 19454 | 49 |
PTPN6,SYK |
1.104e-02 | -4.51 | specific granule lumen | cellular component | GO:0035580 | 62 | 2 | 19108 | 49 |
PTPN6,DOCK2 |
1.110e-02 | -4.50 | IL-6 signaling pathway | WikiPathways | WP364 | 43 | 2 | 5310 | 20 |
HCK,GAB1 |
1.115e-02 | -4.50 | CORO1B (coronin 1B) | protein interactions | 57175 | 184 | 3 | 19454 | 49 |
RHBDF2,PHKB,VMP1 |
1.128e-02 | -4.48 | vacuolar localization | biological process | GO:1990849 | 61 | 2 | 18204 | 48 |
SYK,TFEB |
1.128e-02 | -4.48 | lysosome localization | biological process | GO:0032418 | 61 | 2 | 18204 | 48 |
SYK,TFEB |
1.128e-02 | -4.48 | negative regulation of adaptive immune response | biological process | GO:0002820 | 61 | 2 | 18204 | 48 |
PTPRC,PTPN6 |
1.131e-02 | -4.48 | SMAP2 (small ArfGAP2) | protein interactions | 64744 | 185 | 3 | 19454 | 49 |
BMP2K,DAB2,RBM47 |
1.132e-02 | -4.48 | regulation of immune response | biological process | GO:0050776 | 944 | 7 | 18204 | 48 |
VAV3,PTPRC,SYK,PTPN6,HCK,RBM47,RHBDF2 |
1.133e-02 | -4.48 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 28 | 16828 | 46 |
PTGIR,PTPRC,PREX1,ASCC3,VMP1,FCHO2,DOCK2,PPFIBP2,VAV3,MPP1,ATP10D,NACC2,CADM4,GAB1,SLC16A10,TMTC1,PREX2,BLVRA,DIAPH2,ACACB,TMCC3,PPP1R7,PLXND1,ATG14,OSBPL8,SEMA4B,SH2B3,STAB1 |
1.134e-02 | -4.48 | LRCH2 (leucine rich repeats and calponin homology domain containing 2) | protein interactions | 57631 | 64 | 2 | 19454 | 49 |
DOCK2,DOCK8 |
1.134e-02 | -4.48 | TBXA2R (thromboxane A2 receptor) | protein interactions | 6915 | 64 | 2 | 19454 | 49 |
PTGIR,GRK6 |
1.134e-02 | -4.48 | EVA1C (eva-1 homolog C) | protein interactions | 59271 | 64 | 2 | 19454 | 49 |
ACACB,RHBDF2 |
1.135e-02 | -4.48 | negative regulation of Wnt signaling pathway | biological process | GO:0030178 | 177 | 3 | 18204 | 48 |
DAB2,KREMEN1,TMEM131L |
1.136e-02 | -4.48 | Tyr_Pase_cat | interpro domains | IPR003595 | 61 | 2 | 18521 | 49 |
PTPN6,PTPRC |
1.148e-02 | -4.47 | Actb (actin, beta) | protein interactions | 11461 | 186 | 3 | 19454 | 49 |
DAB2,FCHO2,BMP2K |
1.155e-02 | -4.46 | SHC1 (SHC adaptor protein 1) | protein interactions | 6464 | 350 | 4 | 19454 | 49 |
VAV3,GAB1,PTPN6,SYK |
1.156e-02 | -4.46 | FAS1 domain | gene3d domains | 2.30.180.10 | 4 | 1 | 14470 | 42 |
STAB1 |
1.156e-02 | -4.46 | Sec63 N-terminal domain-like domain | gene3d domains | 1.10.3380.10 | 4 | 1 | 14470 | 42 |
ASCC3 |
1.163e-02 | -4.45 | cell population proliferation | biological process | GO:0008283 | 726 | 6 | 18204 | 48 |
PTPN6,PTPRC,DISC1,DOCK8,DOCK2,ASCC3 |
1.163e-02 | -4.45 | EGF receptor (ErbB1) signaling pathway | Pathway Interaction DB | erbb1_receptor_proximal_pathway | 25 | 2 | 2226 | 15 |
PTPN6,GAB1 |
1.164e-02 | -4.45 | regulation of immunoglobulin mediated immune response | biological process | GO:0002889 | 62 | 2 | 18204 | 48 |
PTPN6,PTPRC |
1.164e-02 | -4.45 | regulation of membrane lipid distribution | biological process | GO:0097035 | 62 | 2 | 18204 | 48 |
ATP10D,VMP1 |
1.164e-02 | -4.45 | regulation of B cell mediated immunity | biological process | GO:0002712 | 62 | 2 | 18204 | 48 |
PTPN6,PTPRC |
1.164e-02 | -4.45 | regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900024 | 62 | 2 | 18204 | 48 |
PREX1,DAB2 |
1.168e-02 | -4.45 | RPS6KA6 (ribosomal protein S6 kinase A6) | protein interactions | 27330 | 65 | 2 | 19454 | 49 |
MPP1,SLC9A1 |
1.168e-02 | -4.45 | LRRC55 (leucine rich repeat containing 55) | protein interactions | 219527 | 65 | 2 | 19454 | 49 |
SLC9A1,SLC16A10 |
1.175e-02 | -4.44 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 22 | 16828 | 46 |
ACACB,HCK,BMP2K,PREX1,PTPRC,VAV3,PPFIBP2,VMP1,PTPN6,GAB1,RAPGEF6,MPP1,PLXND1,GRK6,PPP1R7,SEMA4B,DIAPH2,PREX2,DAB2,KREMEN1,SYK,TFEB |
1.175e-02 | -4.44 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 22 | 16828 | 46 |
PLXND1,PPP1R7,GRK6,PTPN6,GAB1,RAPGEF6,MPP1,DAB2,KREMEN1,SYK,TFEB,DIAPH2,SEMA4B,PREX2,PREX1,PTPRC,ACACB,HCK,BMP2K,VAV3,PPFIBP2,VMP1 |
1.178e-02 | -4.44 | SH3_2 | pfam domains | PF07653 | 61 | 2 | 17795 | 48 |
DOCK2,VAV3 |
1.188e-02 | -4.43 | phosphatidylinositol phosphate binding | molecular function | GO:1901981 | 179 | 3 | 18094 | 48 |
OSBPL8,FCHO2,SLC9A1 |
1.205e-02 | -4.42 | regulation of T cell proliferation | biological process | GO:0042129 | 181 | 3 | 18204 | 48 |
TMEM131L,PTPRC,PTPN6 |
1.208e-02 | -4.42 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 48 |
DAB2,KREMEN1,DISC1,TMEM131L |
1.210e-02 | -4.41 | small_intestine-carcinoid-endocrine_tumour | COSMIC cancer mutations | small_intestine-carcinoid-endocrine_tumour | 175 | 3 | 16828 | 46 |
ASCC3,VMP1,PLXND1 |
1.217e-02 | -4.41 | response to chemical | biological process | GO:0042221 | 3743 | 17 | 18204 | 48 |
DAB2,HCK,SEMA4B,DOCK2,SMOX,SLC9A1,PTPN6,PTPRC,SYK,DOCK8,ACACB,PREX1,ACER2,PTGIR,SH2B3,VAV3,GAB1 |
1.230e-02 | -4.40 | Factors involved in megakaryocyte development and platelet production | REACTOME pathways | R-HSA-983231 | 156 | 3 | 10285 | 32 |
SH2B3,DOCK8,DOCK2 |
1.232e-02 | -4.40 | positive regulation of proteolysis | biological process | GO:0045862 | 341 | 4 | 18204 | 48 |
DAB2,ACER2,DISC1,SYK |
1.235e-02 | -4.39 | TMT1A (thiol methyltransferase 1A) | protein interactions | 25840 | 357 | 4 | 19454 | 49 |
OSBPL8,TMEM131L,VMP1,SLC9A1 |
1.237e-02 | -4.39 | regulation of B cell proliferation | biological process | GO:0030888 | 64 | 2 | 18204 | 48 |
PTPRC,VAV3 |
1.237e-02 | -4.39 | actin polymerization or depolymerization | biological process | GO:0008154 | 64 | 2 | 18204 | 48 |
PREX1,DIAPH2 |
1.238e-02 | -4.39 | ADXRDTASE | prints domains | PR00419 | 5 | 1 | 5227 | 13 |
SMOX |
1.238e-02 | -4.39 | DUSP2 (dual specificity phosphatase 2) | protein interactions | 1844 | 67 | 2 | 19454 | 49 |
ASCC3,TMEM131L |
1.239e-02 | -4.39 | Scavenging by Class H Receptors | REACTOME pathways | R-HSA-3000497 | 4 | 1 | 10285 | 32 |
STAB1 |
1.239e-02 | -4.39 | ALKBH3 mediated reversal of alkylation damage | REACTOME pathways | R-HSA-112126 | 4 | 1 | 10285 | 32 |
ASCC3 |
1.239e-02 | -4.39 | Amine Oxidase reactions | REACTOME pathways | R-HSA-140179 | 4 | 1 | 10285 | 32 |
SMOX |
1.242e-02 | -4.39 | G8 | prosite domains | PS51484 | 4 | 1 | 12186 | 38 |
CEMIP |
1.242e-02 | -4.39 | FAS1 | prosite domains | PS50213 | 4 | 1 | 12186 | 38 |
STAB1 |
1.242e-02 | -4.39 | COA_CT_CTER | prosite domains | PS50989 | 4 | 1 | 12186 | 38 |
ACACB |
1.242e-02 | -4.39 | COA_CT_NTER | prosite domains | PS50980 | 4 | 1 | 12186 | 38 |
ACACB |
1.244e-02 | -4.39 | angiogenesis | biological process | GO:0001525 | 342 | 4 | 18204 | 48 |
VAV3,PLXND1,GAB1,SYK |
1.246e-02 | -4.39 | EMD (emerin) | protein interactions | 2010 | 771 | 6 | 19454 | 49 |
SLC9A1,TMCC3,VMP1,TMEM131L,OSBPL8,RHBDF2 |
1.246e-02 | -4.39 | KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1) | protein interactions | 10657 | 358 | 4 | 19454 | 49 |
DISC1,DOCK2,PTPN6,HCK |
1.251e-02 | -4.38 | phospholipid transporter activity | molecular function | GO:0005548 | 64 | 2 | 18094 | 48 |
VMP1,OSBPL8 |
1.253e-02 | -4.38 | FER1L4 (fer-1 like family member 4 (pseudogene)) | protein interactions | 80307 | 5 | 1 | 19454 | 49 |
CEMIP |
1.253e-02 | -4.38 | ADCY10 (adenylate cyclase 10) | protein interactions | 55811 | 5 | 1 | 19454 | 49 |
PTGIR |
1.268e-02 | -4.37 | BRICD5 (BRICHOS domain containing 5) | protein interactions | 283870 | 193 | 3 | 19454 | 49 |
SEMA4B,CADM4,TMEM131L |
1.274e-02 | -4.36 | T cell differentiation in thymus | biological process | GO:0033077 | 65 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
1.274e-02 | -4.36 | regulation of interleukin-10 production | biological process | GO:0032653 | 65 | 2 | 18204 | 48 |
SYK,RBM47 |
1.274e-02 | -4.36 | positive regulation of response to stimulus | biological process | GO:0048584 | 2266 | 12 | 18204 | 48 |
BMP2K,VAV3,HCK,DAB2,RBM47,SLC9A1,NACC2,DISC1,PTPRC,SYK,OSBPL8,PTPN6 |
1.275e-02 | -4.36 | lung-carcinoma-undifferentiated_carcinoma | COSMIC cancer mutations | lung-carcinoma-undifferentiated_carcinoma | 1408 | 9 | 16828 | 46 |
PTGIR,RAPGEF6,GAB1,PTPN6,PPP1R7,TFEB,SYK,KREMEN1,VAV3 |
1.276e-02 | -4.36 | B cell receptor complex | cellular component | GO:0019815 | 5 | 1 | 19108 | 49 |
SYK |
1.276e-02 | -4.36 | phosphorylase kinase complex | cellular component | GO:0005964 | 5 | 1 | 19108 | 49 |
PHKB |
1.276e-02 | -4.36 | omegasome | cellular component | GO:1990462 | 5 | 1 | 19108 | 49 |
ATG14 |
1.276e-02 | -4.36 | apolipoprotein B mRNA editing enzyme complex | cellular component | GO:0030895 | 5 | 1 | 19108 | 49 |
RBM47 |
1.276e-02 | -4.36 | alpha-beta T cell receptor complex | cellular component | GO:0042105 | 5 | 1 | 19108 | 49 |
PTPN6 |
1.278e-02 | -4.36 | regulation of T cell differentiation | biological process | GO:0045580 | 185 | 3 | 18204 | 48 |
SYK,PTPRC,TMEM131L |
1.278e-02 | -4.36 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051897 | 185 | 3 | 18204 | 48 |
VAV3,OSBPL8,PTPN6 |
1.285e-02 | -4.35 | CNPY3 (canopy FGF signaling regulator 3) | protein interactions | 10695 | 194 | 3 | 19454 | 49 |
VMP1,DIAPH2,HCK |
1.298e-02 | -4.34 | RPN1 (ribophorin I) | protein interactions | 6184 | 778 | 6 | 19454 | 49 |
OSBPL8,STAB1,TMEM131L,DOCK8,VMP1,SLC9A1 |
1.303e-02 | -4.34 | Myh9 (myosin, heavy polypeptide 9, non-muscle) | protein interactions | 17886 | 195 | 3 | 19454 | 49 |
BMP2K,FCHO2,DAB2 |
1.305e-02 | -4.34 | human chr8q13.2 | chromosome location | human chr8q13.2 | 7 | 1 | 26134 | 49 |
PREX2 |
1.306e-02 | -4.34 | regulation of monoatomic ion transmembrane transport | biological process | GO:0034765 | 347 | 4 | 18204 | 48 |
VMP1,SLC9A1,CEMIP,PTPN6 |
1.310e-02 | -4.34 | ACAA1 (acetyl-CoA acyltransferase 1) | protein interactions | 30 | 69 | 2 | 19454 | 49 |
ACACB,PPP1R7 |
1.310e-02 | -4.34 | PPP4R3B (protein phosphatase 4 regulatory subunit 3B) | protein interactions | 57223 | 69 | 2 | 19454 | 49 |
SYK,OSBPL8 |
1.310e-02 | -4.34 | FAM8A1 (family with sequence similarity 8 member A1) | protein interactions | 51439 | 69 | 2 | 19454 | 49 |
PTGIR,OSBPL8 |
1.310e-02 | -4.34 | PABPC3 (poly(A) binding protein cytoplasmic 3) | protein interactions | 5042 | 69 | 2 | 19454 | 49 |
GAB1,CEMIP |
1.312e-02 | -4.33 | negative regulation of immature T cell proliferation | biological process | GO:0033087 | 5 | 1 | 18204 | 48 |
TMEM131L |
1.312e-02 | -4.33 | positive regulation of protein kinase C activity | biological process | GO:1900020 | 5 | 1 | 18204 | 48 |
CEMIP |
1.312e-02 | -4.33 | spermine metabolic process | biological process | GO:0008215 | 5 | 1 | 18204 | 48 |
SMOX |
1.312e-02 | -4.33 | epididymis development | biological process | GO:1905867 | 5 | 1 | 18204 | 48 |
PTPN6 |
1.312e-02 | -4.33 | thrombopoietin-mediated signaling pathway | biological process | GO:0038163 | 5 | 1 | 18204 | 48 |
SH2B3 |
1.312e-02 | -4.33 | regulation of mast cell activation involved in immune response | biological process | GO:0033006 | 5 | 1 | 18204 | 48 |
PTPN6 |
1.312e-02 | -4.33 | positive regulation of Fc receptor mediated stimulatory signaling pathway | biological process | GO:0060369 | 5 | 1 | 18204 | 48 |
PTPRC |
1.312e-02 | -4.33 | positive regulation of the force of heart contraction | biological process | GO:0098735 | 5 | 1 | 18204 | 48 |
SLC9A1 |
1.312e-02 | -4.33 | response to molecule of fungal origin | biological process | GO:0002238 | 5 | 1 | 18204 | 48 |
SYK |
1.312e-02 | -4.33 | negative regulation of immature T cell proliferation in thymus | biological process | GO:0033088 | 5 | 1 | 18204 | 48 |
TMEM131L |
1.312e-02 | -4.33 | regulation of protein kinase C activity | biological process | GO:1900019 | 5 | 1 | 18204 | 48 |
CEMIP |
1.312e-02 | -4.33 | myeloid cell activation involved in immune response | biological process | GO:0002275 | 66 | 2 | 18204 | 48 |
SYK,DOCK2 |
1.312e-02 | -4.33 | homotypic cell-cell adhesion | biological process | GO:0034109 | 66 | 2 | 18204 | 48 |
PTPN6,ENTPD1 |
1.316e-02 | -4.33 | HnRNP_R/Q_splicing_fac | interpro domains | IPR006535 | 5 | 1 | 18521 | 49 |
RBM47 |
1.316e-02 | -4.33 | WSC_carb-bd | interpro domains | IPR002889 | 5 | 1 | 18521 | 49 |
KREMEN1 |
1.316e-02 | -4.33 | Biotin_COase_C | interpro domains | IPR005482 | 5 | 1 | 18521 | 49 |
ACACB |
1.316e-02 | -4.33 | DOCK_N | interpro domains | IPR032376 | 5 | 1 | 18521 | 49 |
DOCK2 |
1.316e-02 | -4.33 | BC-like_N | interpro domains | IPR005481 | 5 | 1 | 18521 | 49 |
ACACB |
1.316e-02 | -4.33 | DOCK_N_sub1 | interpro domains | IPR042455 | 5 | 1 | 18521 | 49 |
DOCK2 |
1.316e-02 | -4.33 | Biotin_carboxylation_dom | interpro domains | IPR011764 | 5 | 1 | 18521 | 49 |
ACACB |
1.319e-02 | -4.33 | endoplasmic reticulum | cellular component | GO:0005783 | 2051 | 11 | 19108 | 49 |
VMP1,DIAPH2,ATG14,OSBPL8,TMEM131L,RHBDF2,ATP10D,TMCC3,TMTC1,CEMIP,GALNT1 |
1.320e-02 | -4.33 | ER retention sequence binding | molecular function | GO:0046923 | 5 | 1 | 18094 | 48 |
CEMIP |
1.320e-02 | -4.33 | biotin binding | molecular function | GO:0009374 | 5 | 1 | 18094 | 48 |
ACACB |
1.327e-02 | -4.32 | heme degradation | BIOCYC pathways | META_PWY-5874 | 2 | 1 | 902 | 6 |
BLVRA |
1.327e-02 | -4.32 | spermine and spermidine degradation I | BIOCYC pathways | META_PWY-6117 | 2 | 1 | 902 | 6 |
SMOX |
1.332e-02 | -4.32 | undifferentiated_carcinoma | COSMIC cancer mutations | undifferentiated_carcinoma | 1418 | 9 | 16828 | 46 |
PTPN6,GAB1,RAPGEF6,PTGIR,PPP1R7,VAV3,KREMEN1,SYK,TFEB |
1.339e-02 | -4.31 | PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) | protein interactions | 8503 | 197 | 3 | 19454 | 49 |
GAB1,HCK,DISC1 |
1.342e-02 | -4.31 | DOCK_N | pfam domains | PF16172 | 5 | 1 | 17795 | 48 |
DOCK2 |
1.342e-02 | -4.31 | Biotin_carb_N | pfam domains | PF00289 | 5 | 1 | 17795 | 48 |
ACACB |
1.342e-02 | -4.31 | WSC | pfam domains | PF01822 | 5 | 1 | 17795 | 48 |
KREMEN1 |
1.342e-02 | -4.31 | Biotin_carb_C | pfam domains | PF02785 | 5 | 1 | 17795 | 48 |
ACACB |
1.346e-02 | -4.31 | ITGB3 (integrin subunit beta 3) | protein interactions | 3690 | 70 | 2 | 19454 | 49 |
SYK,DAB2 |
1.346e-02 | -4.31 | IL6ST (interleukin 6 cytokine family signal transducer) | protein interactions | 3572 | 70 | 2 | 19454 | 49 |
HCK,PTPN6 |
1.352e-02 | -4.30 | Sec63 | smart domains | SM00973 | 4 | 1 | 9717 | 33 |
ASCC3 |
1.352e-02 | -4.30 | FAS1 | smart domains | SM00554 | 4 | 1 | 9717 | 33 |
STAB1 |
1.352e-02 | -4.30 | G8 | smart domains | SM01225 | 4 | 1 | 9717 | 33 |
CEMIP |
1.353e-02 | -4.30 | regulation of tumor necrosis factor production | biological process | GO:0032680 | 189 | 3 | 18204 | 48 |
PTPRC,SYK,PTPN6 |
1.354e-02 | -4.30 | NTRK3 (neurotrophic receptor tyrosine kinase 3) | protein interactions | 4916 | 367 | 4 | 19454 | 49 |
GAB1,OSBPL8,FCHO2,RAPGEF6 |
1.355e-02 | -4.30 | phosphatase binding | molecular function | GO:0019902 | 188 | 3 | 18094 | 48 |
SLC9A1,SYK,CADM4 |
1.359e-02 | -4.30 | skin-lower_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-superficial_spreading | 5 | 1 | 16828 | 46 |
PREX2 |
1.363e-02 | -4.30 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 3 | 16828 | 46 |
TMCC3,PREX1,OSBPL8 |
1.370e-02 | -4.29 | regulation of cellular component size | biological process | GO:0032535 | 352 | 4 | 18204 | 48 |
DISC1,VAV3,PREX1,HCK |
1.383e-02 | -4.28 | CX3CL1 (C-X3-C motif chemokine ligand 1) | protein interactions | 6376 | 71 | 2 | 19454 | 49 |
RHBDF2,SLC9A1 |
1.384e-02 | -4.28 | ORF3a (ORF3a protein) | protein interactions | 43740569 | 789 | 6 | 19454 | 49 |
PLXND1,RHBDF2,OSBPL8,SEMA4B,BLVRA,GRK6 |
1.388e-02 | -4.28 | regulation of antigen receptor-mediated signaling pathway | biological process | GO:0050854 | 68 | 2 | 18204 | 48 |
PTPN6,PTPRC |
1.388e-02 | -4.28 | negative regulation of leukocyte mediated immunity | biological process | GO:0002704 | 68 | 2 | 18204 | 48 |
PTPRC,PTPN6 |
1.388e-02 | -4.28 | cell-cell recognition | biological process | GO:0009988 | 68 | 2 | 18204 | 48 |
DOCK8,DOCK2 |
1.389e-02 | -4.28 | CDC42 (cell division cycle 42) | protein interactions | 998 | 1280 | 8 | 19454 | 49 |
DIAPH2,DOCK8,OSBPL8,PREX2,GRK6,SLC9A1,FCHO2,PREX1 |
1.391e-02 | -4.27 | negative regulation of leukocyte activation | biological process | GO:0002695 | 191 | 3 | 18204 | 48 |
PTPN6,TMEM131L,PTPRC |
1.392e-02 | -4.27 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 49 |
BMP2K,DISC1,FCHO2,DAB2 |
1.413e-02 | -4.26 | positive regulation of immune system process | biological process | GO:0002684 | 986 | 7 | 18204 | 48 |
RBM47,HCK,PTPN6,DOCK8,SYK,PTPRC,VAV3 |
1.417e-02 | -4.26 | NHLRC2 (NHL repeat containing 2) | protein interactions | 374354 | 372 | 4 | 19454 | 49 |
MPP1,BLVRA,TFEB,SYK |
1.420e-02 | -4.25 | FANCL (FA complementation group L) | protein interactions | 55120 | 72 | 2 | 19454 | 49 |
DOCK8,PPP1R7 |
1.420e-02 | -4.25 | Ppp1cb (protein phosphatase 1 catalytic subunit beta) | protein interactions | 19046 | 72 | 2 | 19454 | 49 |
DAB2,BMP2K |
1.427e-02 | -4.25 | regulation of cardiac muscle hypertrophy | biological process | GO:0010611 | 69 | 2 | 18204 | 48 |
ACACB,SLC9A1 |
1.430e-02 | -4.25 | MYO6 (myosin VI) | protein interactions | 4646 | 373 | 4 | 19454 | 49 |
DOCK8,DAB2,FCHO2,BMP2K |
1.430e-02 | -4.25 | vacuole organization | biological process | GO:0007033 | 193 | 3 | 18204 | 48 |
VMP1,ATG14,TFEB |
1.433e-02 | -4.25 | Natural killer cell mediated cytotoxicity | KEGG pathways | ko04650 | 132 | 3 | 7161 | 28 |
SYK,PTPN6,VAV3 |
1.433e-02 | -4.25 | Natural killer cell mediated cytotoxicity | KEGG pathways | hsa04650 | 132 | 3 | 7161 | 28 |
VAV3,PTPN6,SYK |
1.443e-02 | -4.24 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 48 |
PTPRC,DOCK2,RHBDF2,RAPGEF6,FCHO2 |
1.443e-02 | -4.24 | - | gene3d domains | 1.10.287.2720 | 5 | 1 | 14470 | 42 |
OSBPL8 |
1.443e-02 | -4.24 | Formin, FH3 diaphanous domain | gene3d domains | 1.10.238.150 | 5 | 1 | 14470 | 42 |
DIAPH2 |
1.443e-02 | -4.24 | Dedicator of cytokinesis N-terminal subdomain | gene3d domains | 1.20.1270.350 | 5 | 1 | 14470 | 42 |
DOCK2 |
1.448e-02 | -4.23 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 46 | 16828 | 46 |
ENTPD1,SYK,STAB1,OSBPL8,PPP1R7,RBM47,PLXND1,RAPGEF6,PPFIBP2,FCHO2,DOCK8,SMOX,PTPRC,ASCC3,HCK,DISC1,BLVRA,DIAPH2,TMTC1,NACC2,PTPN6,GAB1,ATP10D,TMCC3,ACACB,GALNT1,SH2B3,SEMA4B,ATG14,GRK6,SLC9A1,VAV3,VMP1,DOCK2,PREX1,RHBDF2,BMP2K,PTGIR,DAB2,TFEB,KREMEN1,PREX2,SLC16A10,CADM4,MPP1,ACER2 |
1.449e-02 | -4.23 | positive regulation of protein modification process | biological process | GO:0031401 | 762 | 6 | 18204 | 48 |
CEMIP,PPP1R7,ATG14,PTPRC,SYK,DAB2 |
1.458e-02 | -4.23 | STAMBPL1 (STAM binding protein like 1) | protein interactions | 57559 | 73 | 2 | 19454 | 49 |
RBM47,BMP2K |
1.458e-02 | -4.23 | THBS3 (thrombospondin 3) | protein interactions | 7059 | 73 | 2 | 19454 | 49 |
BLVRA,ASCC3 |
1.458e-02 | -4.23 | FCHO1 (FCH and mu domain containing endocytic adaptor 1) | protein interactions | 23149 | 73 | 2 | 19454 | 49 |
FCHO2,DAB2 |
1.470e-02 | -4.22 | regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903555 | 195 | 3 | 18204 | 48 |
PTPN6,SYK,PTPRC |
1.472e-02 | -4.22 | regulation of phosphorylation | biological process | GO:0042325 | 994 | 7 | 18204 | 48 |
CADM4,DAB2,CEMIP,ATG14,PTPN6,PTPRC,SYK |
1.483e-02 | -4.21 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 46 |
DAB2,TMCC3,STAB1,RBM47,OSBPL8,PTPRC,PREX1,RHBDF2 |
1.484e-02 | -4.21 | NRAGE signals death through JNK | REACTOME pathways | R-HSA-193648 | 60 | 2 | 10285 | 32 |
VAV3,PREX1 |
1.489e-02 | -4.21 | TNFRSF1A (TNF receptor superfamily member 1A) | protein interactions | 7132 | 205 | 3 | 19454 | 49 |
GRK6,PTPN6,SYK |
1.496e-02 | -4.20 | C2CD6 (C2 calcium dependent domain containing 6) | protein interactions | 151254 | 74 | 2 | 19454 | 49 |
DISC1,ACACB |
1.500e-02 | -4.20 | LAMP2 (lysosomal associated membrane protein 2) | protein interactions | 3920 | 580 | 5 | 19454 | 49 |
ATG14,OSBPL8,FCHO2,VMP1,MPP1 |
1.502e-02 | -4.20 | echA1 (enoyl-CoA hydratase EchA1) | protein interactions | 886723 | 6 | 1 | 19454 | 49 |
PTPN6 |
1.502e-02 | -4.20 | RXFP2 (relaxin family peptide receptor 2) | protein interactions | 122042 | 6 | 1 | 19454 | 49 |
OSBPL8 |
1.502e-02 | -4.20 | ASIC5 (acid sensing ion channel subunit family member 5) | protein interactions | 51802 | 6 | 1 | 19454 | 49 |
BLVRA |
1.502e-02 | -4.20 | CCDC181 (coiled-coil domain containing 181) | protein interactions | 57821 | 6 | 1 | 19454 | 49 |
PPP1R7 |
1.502e-02 | -4.20 | CD300LF (CD300 molecule like family member f) | protein interactions | 146722 | 6 | 1 | 19454 | 49 |
PTPN6 |
1.502e-02 | -4.20 | CROCC2 (ciliary rootlet coiled-coil, rootletin family member 2) | protein interactions | 728763 | 6 | 1 | 19454 | 49 |
CEMIP |
1.511e-02 | -4.19 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 48 |
FCHO2,RAPGEF6,RHBDF2 |
1.521e-02 | -4.19 | lamellipodium | cellular component | GO:0030027 | 203 | 3 | 19108 | 49 |
DOCK8,SLC9A1,PLXND1 |
1.521e-02 | -4.19 | MKRN2 (makorin ring finger protein 2) | protein interactions | 23609 | 380 | 4 | 19454 | 49 |
ASCC3,CEMIP,SEMA4B,RBM47 |
1.524e-02 | -4.18 | phosphatidylserine binding | molecular function | GO:0001786 | 71 | 2 | 18094 | 48 |
FCHO2,OSBPL8 |
1.528e-02 | -4.18 | GTSE1 (G2 and S-phase expressed 1) | protein interactions | 51512 | 207 | 3 | 19454 | 49 |
BMP2K,DAB2,FCHO2 |
1.529e-02 | -4.18 | mRNA editing complex | cellular component | GO:0045293 | 6 | 1 | 19108 | 49 |
RBM47 |
1.531e-02 | -4.18 | Regulation of actin dynamics for phagocytic cup formation | REACTOME pathways | R-HSA-2029482 | 61 | 2 | 10285 | 32 |
VAV3,SYK |
1.532e-02 | -4.18 | mononuclear cell differentiation | biological process | GO:1903131 | 364 | 4 | 18204 | 48 |
PREX1,SYK,PTPRC,DOCK2 |
1.541e-02 | -4.17 | positive regulation of protein metabolic process | biological process | GO:0051247 | 1247 | 8 | 18204 | 48 |
PTPRC,DISC1,SYK,CEMIP,PPP1R7,ATG14,DAB2,ACER2 |
1.546e-02 | -4.17 | Hyaluronan biosynthesis and export | REACTOME pathways | R-HSA-2142850 | 5 | 1 | 10285 | 32 |
CEMIP |
1.546e-02 | -4.17 | MET activates PTPN11 | REACTOME pathways | R-HSA-8865999 | 5 | 1 | 10285 | 32 |
GAB1 |
1.547e-02 | -4.17 | cell-cell contact zone | cellular component | GO:0044291 | 74 | 2 | 19108 | 49 |
CADM4,SLC9A1 |
1.548e-02 | -4.17 | regulation of muscle hypertrophy | biological process | GO:0014743 | 72 | 2 | 18204 | 48 |
SLC9A1,ACACB |
1.548e-02 | -4.17 | negative regulation of protein binding | biological process | GO:0032091 | 72 | 2 | 18204 | 48 |
DISC1,DAB2 |
1.548e-02 | -4.17 | HSD17B11 (hydroxysteroid 17-beta dehydrogenase 11) | protein interactions | 51170 | 382 | 4 | 19454 | 49 |
OSBPL8,TMEM131L,VMP1,SLC9A1 |
1.550e-02 | -4.17 | CPSASE_1 | prosite domains | PS00866 | 5 | 1 | 12186 | 38 |
ACACB |
1.550e-02 | -4.17 | WSC | prosite domains | PS51212 | 5 | 1 | 12186 | 38 |
KREMEN1 |
1.550e-02 | -4.17 | BC | prosite domains | PS50979 | 5 | 1 | 12186 | 38 |
ACACB |
1.552e-02 | -4.17 | ameboidal-type cell migration | biological process | GO:0001667 | 199 | 3 | 18204 | 48 |
GAB1,SEMA4B,PLXND1 |
1.567e-02 | -4.16 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 8 | 16828 | 46 |
ACACB,RHBDF2,HCK,DIAPH2,ENTPD1,SEMA4B,DOCK2,SYK |
1.572e-02 | -4.15 | negative regulation of fatty acid beta-oxidation | biological process | GO:0031999 | 6 | 1 | 18204 | 48 |
ACACB |
1.572e-02 | -4.15 | malonyl-CoA metabolic process | biological process | GO:2001293 | 6 | 1 | 18204 | 48 |
ACACB |
1.572e-02 | -4.15 | regulation of establishment of T cell polarity | biological process | GO:1903903 | 6 | 1 | 18204 | 48 |
DOCK8 |
1.572e-02 | -4.15 | regulation of mast cell cytokine production | biological process | GO:0032763 | 6 | 1 | 18204 | 48 |
SYK |
1.572e-02 | -4.15 | tryptophan transport | biological process | GO:0015827 | 6 | 1 | 18204 | 48 |
SLC16A10 |
1.572e-02 | -4.15 | regulation of mineralocorticoid secretion | biological process | GO:2000855 | 6 | 1 | 18204 | 48 |
DAB2 |
1.572e-02 | -4.15 | negative regulation of sequestering of triglyceride | biological process | GO:0010891 | 6 | 1 | 18204 | 48 |
OSBPL8 |
1.572e-02 | -4.15 | radial glia-guided pyramidal neuron migration | biological process | GO:0140650 | 6 | 1 | 18204 | 48 |
DISC1 |
1.572e-02 | -4.15 | regulation of aldosterone secretion | biological process | GO:2000858 | 6 | 1 | 18204 | 48 |
DAB2 |
1.572e-02 | -4.15 | intracellular glutamate homeostasis | biological process | GO:0090461 | 6 | 1 | 18204 | 48 |
ACACB |
1.573e-02 | -4.15 | CST9L (cystatin 9 like) | protein interactions | 128821 | 76 | 2 | 19454 | 49 |
GALNT1,SEMA4B |
1.573e-02 | -4.15 | PGM3 (phosphoglucomutase 3) | protein interactions | 5238 | 76 | 2 | 19454 | 49 |
DISC1,BLVRA |
1.577e-02 | -4.15 | DOCK_C/D_N | interpro domains | IPR021816 | 6 | 1 | 18521 | 49 |
DOCK8 |
1.577e-02 | -4.15 | CAMSAP-like_CH_dom | interpro domains | IPR022613 | 6 | 1 | 18521 | 49 |
VAV3 |
1.577e-02 | -4.15 | Rudment_hybrid_motif | interpro domains | IPR011054 | 6 | 1 | 18521 | 49 |
ACACB |
1.577e-02 | -4.15 | WxxW_domain | interpro domains | IPR025155 | 6 | 1 | 18521 | 49 |
CEMIP |
1.577e-02 | -4.15 | Liprin | interpro domains | IPR029515 | 6 | 1 | 18521 | 49 |
PPFIBP2 |
1.581e-02 | -4.15 | phosphatidylinositol 3-kinase inhibitor activity | molecular function | GO:0141039 | 6 | 1 | 18094 | 48 |
ATG14 |
1.581e-02 | -4.15 | ceramidase activity | molecular function | GO:0102121 | 6 | 1 | 18094 | 48 |
ACER2 |
1.581e-02 | -4.15 | ADP phosphatase activity | molecular function | GO:0043262 | 6 | 1 | 18094 | 48 |
ENTPD1 |
1.581e-02 | -4.15 | CoA carboxylase activity | molecular function | GO:0016421 | 6 | 1 | 18094 | 48 |
ACACB |
1.581e-02 | -4.15 | CTPase activity | molecular function | GO:0043273 | 6 | 1 | 18094 | 48 |
ENTPD1 |
1.581e-02 | -4.15 | protein phosphatase 2B binding | molecular function | GO:0030346 | 6 | 1 | 18094 | 48 |
SLC9A1 |
1.585e-02 | -4.14 | kidney | COSMIC cancer mutations | kidney | 15380 | 46 | 16828 | 46 |
DAB2,TFEB,KREMEN1,PREX2,SLC16A10,CADM4,MPP1,ACER2,VAV3,VMP1,DOCK2,PREX1,RHBDF2,BMP2K,PTGIR,GALNT1,SH2B3,SEMA4B,ATG14,GRK6,SLC9A1,TMCC3,ACACB,DISC1,BLVRA,DIAPH2,TMTC1,GAB1,NACC2,PTPN6,ATP10D,PPFIBP2,FCHO2,DOCK8,SMOX,PTPRC,ASCC3,HCK,SYK,STAB1,OSBPL8,PLXND1,RBM47,PPP1R7,RAPGEF6,ENTPD1 |
1.588e-02 | -4.14 | positive regulation of alpha-beta T cell activation | biological process | GO:0046635 | 73 | 2 | 18204 | 48 |
PTPRC,SYK |
1.588e-02 | -4.14 | endothelial cell migration | biological process | GO:0043542 | 73 | 2 | 18204 | 48 |
GAB1,PLXND1 |
1.588e-02 | -4.14 | positive regulation of phagocytosis | biological process | GO:0050766 | 73 | 2 | 18204 | 48 |
PTPRC,DOCK2 |
1.607e-02 | -4.13 | cargo receptor activity | molecular function | GO:0038024 | 73 | 2 | 18094 | 48 |
DAB2,STAB1 |
1.608e-02 | -4.13 | DOCK_C-D_N | pfam domains | PF11878 | 6 | 1 | 17795 | 48 |
DOCK8 |
1.608e-02 | -4.13 | CAMSAP_CH | pfam domains | PF11971 | 6 | 1 | 17795 | 48 |
VAV3 |
1.608e-02 | -4.13 | Mucin2_WxxW | pfam domains | PF13330 | 6 | 1 | 17795 | 48 |
CEMIP |
1.613e-02 | -4.13 | SNX18 (sorting nexin 18) | protein interactions | 112574 | 77 | 2 | 19454 | 49 |
ATG14,DISC1 |
1.617e-02 | -4.12 | Endoderm Differentiation | WikiPathways | WP2853 | 145 | 3 | 5310 | 20 |
DAB2,ASCC3,VAV3 |
1.619e-02 | -4.12 | humerus | COSMIC cancer mutations | humerus | 546 | 5 | 16828 | 46 |
VMP1,DOCK2,OSBPL8,PPFIBP2,DIAPH2 |
1.623e-02 | -4.12 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 23 | 18204 | 48 |
DIAPH2,VMP1,OSBPL8,HCK,DAB2,ATG14,FCHO2,TFEB,PREX1,PREX2,NACC2,PPFIBP2,SLC9A1,DISC1,PTPRC,ATP10D,SEMA4B,DOCK2,VAV3,RAPGEF6,PLXND1,ACACB,ASCC3 |
1.627e-02 | -4.12 | SEC23B (SEC23 homolog B, COPII coat complex component) | protein interactions | 10483 | 212 | 3 | 19454 | 49 |
GALNT1,DAB2,SYK |
1.629e-02 | -4.12 | skin-head_neck-malignant_melanoma | COSMIC cancer mutations | skin-head_neck-malignant_melanoma | 6 | 1 | 16828 | 46 |
PREX2 |
1.629e-02 | -4.12 | skin-forearm-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-forearm-malignant_melanoma-superficial_spreading | 6 | 1 | 16828 | 46 |
PREX2 |
1.630e-02 | -4.12 | organelle localization by membrane tethering | biological process | GO:0140056 | 74 | 2 | 18204 | 48 |
ATG14,VMP1 |
1.630e-02 | -4.12 | negative regulation of T cell proliferation | biological process | GO:0042130 | 74 | 2 | 18204 | 48 |
PTPN6,TMEM131L |
1.636e-02 | -4.11 | negative regulation of cell-cell adhesion | biological process | GO:0022408 | 203 | 3 | 18204 | 48 |
TMEM131L,PTPN6,SH2B3 |
1.639e-02 | -4.11 | regulation of apoptotic process | biological process | GO:0042981 | 1518 | 9 | 18204 | 48 |
PLXND1,DAB2,ACER2,HCK,PTPN6,PTPRC,DOCK8,SLC9A1,NACC2 |
1.641e-02 | -4.11 | Tyr_Pase_AS | interpro domains | IPR016130 | 74 | 2 | 18521 | 49 |
PTPN6,PTPRC |
1.645e-02 | -4.11 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 25 | 16828 | 46 |
ATP10D,ACER2,MPP1,SLC16A10,TMTC1,PREX2,DAB2,BMP2K,HCK,PREX1,ASCC3,PTPRC,DOCK2,DOCK8,FCHO2,PPFIBP2,SLC9A1,RBM47,GRK6,PLXND1,SH2B3,STAB1,SYK,ACACB,TMCC3 |
1.645e-02 | -4.11 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 25 | 16828 | 46 |
ACACB,TMCC3,GRK6,PLXND1,RBM47,SLC9A1,SYK,SH2B3,STAB1,PTPRC,ASCC3,PREX1,BMP2K,HCK,FCHO2,DOCK8,DOCK2,PPFIBP2,SLC16A10,TMTC1,MPP1,ACER2,ATP10D,DAB2,PREX2 |
1.648e-02 | -4.11 | DCAF6 (DDB1 and CUL4 associated factor 6) | protein interactions | 55827 | 213 | 3 | 19454 | 49 |
DAB2,ACACB,DOCK8 |
1.669e-02 | -4.09 | BAG2 (BAG cochaperone 2) | protein interactions | 9532 | 596 | 5 | 19454 | 49 |
RAPGEF6,DISC1,TFEB,HCK,ASCC3 |
1.672e-02 | -4.09 | negative regulation of ERK1 and ERK2 cascade | biological process | GO:0070373 | 75 | 2 | 18204 | 48 |
PTPRC,DAB2 |
1.672e-02 | -4.09 | regulation of calcium ion transmembrane transporter activity | biological process | GO:1901019 | 75 | 2 | 18204 | 48 |
SLC9A1,VMP1 |
1.672e-02 | -4.09 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0043491 | 75 | 2 | 18204 | 48 |
PREX2,ATG14 |
1.675e-02 | -4.09 | human chr9p22.1 | chromosome location | human chr9p22.1 | 9 | 1 | 26134 | 49 |
ACER2 |
1.675e-02 | -4.09 | human chr12q24.12 | chromosome location | human chr12q24.12 | 9 | 1 | 26134 | 49 |
SH2B3 |
1.687e-02 | -4.08 | WSC | smart domains | SM00321 | 5 | 1 | 9717 | 33 |
KREMEN1 |
1.687e-02 | -4.08 | Biotin_carb_C | smart domains | SM00878 | 5 | 1 | 9717 | 33 |
ACACB |
1.693e-02 | -4.08 | CANT1 (calcium activated nucleotidase 1) | protein interactions | 124583 | 79 | 2 | 19454 | 49 |
TMEM131L,RHBDF2 |
1.710e-02 | -4.07 | MAGED2 (MAGE family member D2) | protein interactions | 10916 | 216 | 3 | 19454 | 49 |
GRK6,DOCK8,PTPN6 |
1.713e-02 | -4.07 | negative regulation of cell population proliferation | biological process | GO:0008285 | 791 | 6 | 18204 | 48 |
TMEM131L,PTPN6,NACC2,SH2B3,PTGIR,DAB2 |
1.714e-02 | -4.07 | regulation of receptor signaling pathway via JAK-STAT | biological process | GO:0046425 | 76 | 2 | 18204 | 48 |
SH2B3,PTPRC |
1.718e-02 | -4.06 | positive regulation of protein phosphorylation | biological process | GO:0001934 | 574 | 5 | 18204 | 48 |
DAB2,PTPRC,SYK,ATG14,CEMIP |
1.721e-02 | -4.06 | negative regulation of phosphate metabolic process | biological process | GO:0045936 | 377 | 4 | 18204 | 48 |
ATG14,PTPN6,CADM4,PTPRC |
1.729e-02 | -4.06 | GPCRKINASE | prints domains | PR00717 | 7 | 1 | 5227 | 13 |
GRK6 |
1.729e-02 | -4.06 | BEN domain | gene3d domains | 1.10.10.2590 | 6 | 1 | 14470 | 42 |
NACC2 |
1.735e-02 | -4.05 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 11 | 16828 | 46 |
ATP10D,SLC9A1,RBM47,OSBPL8,TMTC1,PREX2,TFEB,DAB2,HCK,ASCC3,VAV3 |
1.735e-02 | -4.05 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 11 | 16828 | 46 |
VAV3,HCK,ASCC3,PREX2,DAB2,TFEB,ATP10D,OSBPL8,TMTC1,SLC9A1,RBM47 |
1.735e-02 | -4.05 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 13 |
VAV3,HCK |
1.736e-02 | -4.05 | negative regulation of phosphorus metabolic process | biological process | GO:0010563 | 378 | 4 | 18204 | 48 |
CADM4,PTPRC,PTPN6,ATG14 |
1.750e-02 | -4.05 | MYT1L (myelin transcription factor 1 like) | protein interactions | 23040 | 7 | 1 | 19454 | 49 |
DISC1 |
1.750e-02 | -4.05 | LAIR1 (leukocyte associated immunoglobulin like receptor 1) | protein interactions | 3903 | 7 | 1 | 19454 | 49 |
PTPN6 |
1.750e-02 | -4.05 | C11orf71 (chromosome 11 open reading frame 71) | protein interactions | 54494 | 7 | 1 | 19454 | 49 |
NACC2 |
1.750e-02 | -4.05 | ZCCHC24 (zinc finger CCHC-type containing 24) | protein interactions | 219654 | 7 | 1 | 19454 | 49 |
RBM47 |
1.750e-02 | -4.05 | XKR8 (XK related 8) | protein interactions | 55113 | 7 | 1 | 19454 | 49 |
PTGIR |
1.750e-02 | -4.05 | TDRD9 (tudor domain containing 9) | protein interactions | 122402 | 7 | 1 | 19454 | 49 |
SEMA4B |
1.750e-02 | -4.05 | SIGLEC9 (sialic acid binding Ig like lectin 9) | protein interactions | 27180 | 7 | 1 | 19454 | 49 |
PTPN6 |
1.750e-02 | -4.05 | NSUN7 (NOP2/Sun RNA methyltransferase family member 7) | protein interactions | 79730 | 7 | 1 | 19454 | 49 |
PTPN6 |
1.752e-02 | -4.04 | TRAF3 (TNF receptor associated factor 3) | protein interactions | 7187 | 218 | 3 | 19454 | 49 |
VAV3,PTPN6,SYK |
1.757e-02 | -4.04 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 48 |
PLXND1,DISC1 |
1.757e-02 | -4.04 | autophagosome assembly | biological process | GO:0000045 | 77 | 2 | 18204 | 48 |
VMP1,ATG14 |
1.757e-02 | -4.04 | positive regulation of cell killing | biological process | GO:0031343 | 77 | 2 | 18204 | 48 |
PTPRC,SYK |
1.761e-02 | -4.04 | EPHA forward signaling | Pathway Interaction DB | epha_fwdpathway | 31 | 2 | 2226 | 15 |
VAV3,HCK |
1.772e-02 | -4.03 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 44 | 16828 | 46 |
ENTPD1,OSBPL8,PPP1R7,RBM47,PLXND1,RAPGEF6,SYK,STAB1,PTPRC,ASCC3,HCK,PPFIBP2,FCHO2,DOCK8,SMOX,TMTC1,GAB1,NACC2,PTPN6,ATP10D,DISC1,BLVRA,DIAPH2,ACACB,TMCC3,ATG14,SLC9A1,GALNT1,SH2B3,SEMA4B,PREX1,RHBDF2,BMP2K,PTGIR,VAV3,VMP1,DOCK2,SLC16A10,ACER2,MPP1,DAB2,TFEB,KREMEN1,PREX2 |
1.774e-02 | -4.03 | TENT5A (terminal nucleotidyltransferase 5A) | protein interactions | 55603 | 81 | 2 | 19454 | 49 |
SYK,TMEM131L |
1.776e-02 | -4.03 | anatomical structure development | biological process | GO:0048856 | 5207 | 21 | 18204 | 48 |
KREMEN1,VAV3,TFEB,GAB1,RAPGEF6,PREX1,PLXND1,SH2B3,SLC9A1,DIAPH2,VMP1,PREX2,PTPRC,SYK,DISC1,PTPN6,HCK,DAB2,RBM47,DOCK2,SEMA4B |
1.776e-02 | -4.03 | Interferon type I signaling pathways | WikiPathways | WP585 | 55 | 2 | 5310 | 20 |
PTPRC,PTPN6 |
1.782e-02 | -4.03 | cortical endoplasmic reticulum | cellular component | GO:0032541 | 7 | 1 | 19108 | 49 |
OSBPL8 |
1.800e-02 | -4.02 | regulation of protein dephosphorylation | biological process | GO:0035304 | 78 | 2 | 18204 | 48 |
PTPRC,PPP1R7 |
1.801e-02 | -4.02 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 8 | 18204 | 48 |
HCK,DAB2,DOCK2,VAV3,SYK,FCHO2,STAB1,ATG14 |
1.806e-02 | -4.01 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 7 | 19454 | 49 |
PPFIBP2,TMCC3,RAPGEF6,RHBDF2,GAB1,OSBPL8,TFEB |
1.806e-02 | -4.01 | PTPc_motif | smart domains | SM00404 | 61 | 2 | 9717 | 33 |
PTPRC,PTPN6 |
1.818e-02 | -4.01 | molecular function regulator activity | molecular function | GO:0098772 | 2079 | 11 | 18094 | 48 |
ATG14,PTGIR,PREX1,PREX2,VAV3,DOCK2,PPP1R7,SEMA4B,RAPGEF6,BMP2K,DOCK8 |
1.825e-02 | -4.00 | ovary | COSMIC cancer mutations | ovary | 14770 | 45 | 16828 | 46 |
ENTPD1,SYK,STAB1,OSBPL8,PPP1R7,PLXND1,RBM47,RAPGEF6,PPFIBP2,DOCK8,FCHO2,SMOX,ASCC3,PTPRC,HCK,BLVRA,DIAPH2,TMTC1,GAB1,PTPN6,NACC2,ATP10D,TMCC3,ACACB,GALNT1,SH2B3,SEMA4B,ATG14,GRK6,SLC9A1,VAV3,DOCK2,VMP1,PREX1,RHBDF2,BMP2K,PTGIR,DAB2,KREMEN1,TFEB,PREX2,SLC16A10,CADM4,ACER2,MPP1 |
1.826e-02 | -4.00 | EGFR (epidermal growth factor receptor) | protein interactions | 1956 | 3105 | 14 | 19454 | 49 |
ACACB,VMP1,DAB2,SH2B3,GAB1,HCK,RHBDF2,SYK,MPP1,VAV3,PPP1R7,FCHO2,PTPN6,ASCC3 |
1.829e-02 | -4.00 | cytokine-mediated signaling pathway | biological process | GO:0019221 | 384 | 4 | 18204 | 48 |
SYK,PTPN6,SH2B3,HCK |
1.829e-02 | -4.00 | WH_DNA-bd_sf | interpro domains | IPR036390 | 211 | 3 | 18521 | 49 |
PREX2,ASCC3,PREX1 |
1.832e-02 | -4.00 | cellular response to interleukin-3 | biological process | GO:0036016 | 7 | 1 | 18204 | 48 |
SH2B3 |
1.832e-02 | -4.00 | platelet degranulation | biological process | GO:0002576 | 7 | 1 | 18204 | 48 |
SYK |
1.832e-02 | -4.00 | response to interleukin-3 | biological process | GO:0036015 | 7 | 1 | 18204 | 48 |
SH2B3 |
1.832e-02 | -4.00 | hyaluronan biosynthetic process | biological process | GO:0030213 | 7 | 1 | 18204 | 48 |
CEMIP |
1.832e-02 | -4.00 | positive regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002925 | 7 | 1 | 18204 | 48 |
PTPRC |
1.832e-02 | -4.00 | positive regulation of corticosteroid hormone secretion | biological process | GO:2000848 | 7 | 1 | 18204 | 48 |
DAB2 |
1.832e-02 | -4.00 | regulation of arachidonic acid secretion | biological process | GO:0090237 | 7 | 1 | 18204 | 48 |
SYK |
1.832e-02 | -4.00 | regulation of ATPase-coupled calcium transmembrane transporter activity | biological process | GO:1901894 | 7 | 1 | 18204 | 48 |
VMP1 |
1.832e-02 | -4.00 | interleukin-3-mediated signaling pathway | biological process | GO:0038156 | 7 | 1 | 18204 | 48 |
SYK |
1.832e-02 | -4.00 | macropinocytosis | biological process | GO:0044351 | 7 | 1 | 18204 | 48 |
DOCK2 |
1.832e-02 | -4.00 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | biological process | GO:1902231 | 7 | 1 | 18204 | 48 |
NACC2 |
1.832e-02 | -4.00 | mitochondrion-endoplasmic reticulum membrane tethering | biological process | GO:1990456 | 7 | 1 | 18204 | 48 |
VMP1 |
1.832e-02 | -4.00 | ribosome-associated ubiquitin-dependent protein catabolic process | biological process | GO:1990116 | 7 | 1 | 18204 | 48 |
ASCC3 |
1.832e-02 | -4.00 | regulation of cardiac muscle cell membrane potential | biological process | GO:0086036 | 7 | 1 | 18204 | 48 |
SLC9A1 |
1.832e-02 | -4.00 | negative regulation of microglial cell activation | biological process | GO:1903979 | 7 | 1 | 18204 | 48 |
PTPRC |
1.834e-02 | -4.00 | positive regulation of monoatomic ion transport | biological process | GO:0043270 | 212 | 3 | 18204 | 48 |
VMP1,SLC9A1,CEMIP |
1.835e-02 | -4.00 | endoplasmic reticulum-Golgi intermediate compartment membrane | cellular component | GO:0033116 | 81 | 2 | 19108 | 49 |
VMP1,GALNT1 |
1.838e-02 | -4.00 | CbamoylP_synth_lsu-like_ATP-bd | interpro domains | IPR005479 | 7 | 1 | 18521 | 49 |
ACACB |
1.838e-02 | -4.00 | GPCR_kinase | interpro domains | IPR000239 | 7 | 1 | 18521 | 49 |
GRK6 |
1.838e-02 | -4.00 | ILEI/PANDER_dom | interpro domains | IPR039477 | 7 | 1 | 18521 | 49 |
CEMIP |
1.838e-02 | -4.00 | U2A'_phosphoprotein32A_C | interpro domains | IPR003603 | 7 | 1 | 18521 | 49 |
PPP1R7 |
1.838e-02 | -4.00 | PDGFRB (platelet derived growth factor receptor beta) | protein interactions | 5159 | 222 | 3 | 19454 | 49 |
VAV3,GAB1,PTPN6 |
1.839e-02 | -4.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 45 | 16828 | 46 |
DOCK2,VMP1,VAV3,PREX1,PTGIR,BMP2K,RHBDF2,KREMEN1,TFEB,DAB2,PREX2,SLC16A10,MPP1,ACER2,CADM4,TMCC3,ACACB,GALNT1,SEMA4B,SH2B3,GRK6,SLC9A1,ATG14,DOCK8,FCHO2,PPFIBP2,SMOX,ASCC3,PTPRC,HCK,DISC1,BLVRA,DIAPH2,TMTC1,ATP10D,GAB1,NACC2,PTPN6,ENTPD1,SYK,STAB1,RBM47,PLXND1,PPP1R7,RAPGEF6 |
1.839e-02 | -4.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 45 | 16828 | 46 |
GAB1,PTPN6,NACC2,ATP10D,TMTC1,DIAPH2,BLVRA,DISC1,HCK,PTPRC,ASCC3,SMOX,PPFIBP2,FCHO2,DOCK8,RAPGEF6,PPP1R7,PLXND1,RBM47,STAB1,SYK,ENTPD1,CADM4,MPP1,ACER2,SLC16A10,PREX2,DAB2,TFEB,KREMEN1,RHBDF2,PTGIR,BMP2K,PREX1,VAV3,VMP1,DOCK2,ATG14,SLC9A1,GRK6,SH2B3,SEMA4B,GALNT1,ACACB,TMCC3 |
1.839e-02 | -4.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 45 | 16828 | 46 |
ATG14,SLC9A1,GRK6,SH2B3,SEMA4B,GALNT1,ACACB,TMCC3,CADM4,MPP1,ACER2,SLC16A10,PREX2,DAB2,TFEB,KREMEN1,RHBDF2,BMP2K,PTGIR,PREX1,VAV3,VMP1,DOCK2,RAPGEF6,RBM47,PPP1R7,PLXND1,STAB1,SYK,ENTPD1,NACC2,GAB1,PTPN6,ATP10D,TMTC1,BLVRA,DIAPH2,DISC1,HCK,PTPRC,ASCC3,SMOX,PPFIBP2,FCHO2,DOCK8 |
1.839e-02 | -4.00 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 45 | 16828 | 46 |
TMCC3,ACACB,GALNT1,SEMA4B,SH2B3,SLC9A1,GRK6,ATG14,DOCK2,VMP1,VAV3,PREX1,BMP2K,PTGIR,RHBDF2,KREMEN1,TFEB,DAB2,PREX2,SLC16A10,MPP1,ACER2,CADM4,ENTPD1,SYK,STAB1,PLXND1,PPP1R7,RBM47,RAPGEF6,DOCK8,FCHO2,PPFIBP2,SMOX,ASCC3,PTPRC,HCK,DISC1,BLVRA,DIAPH2,TMTC1,ATP10D,NACC2,GAB1,PTPN6 |
1.843e-02 | -3.99 | G protein-coupled receptor kinase activity | molecular function | GO:0004703 | 7 | 1 | 18094 | 48 |
GRK6 |
1.843e-02 | -3.99 | N-acylsphingosine amidohydrolase activity | molecular function | GO:0017040 | 7 | 1 | 18094 | 48 |
ACER2 |
1.843e-02 | -3.99 | ligase activity, forming carbon-carbon bonds | molecular function | GO:0016885 | 7 | 1 | 18094 | 48 |
ACACB |
1.844e-02 | -3.99 | myeloid cell development | biological process | GO:0061515 | 79 | 2 | 18204 | 48 |
SH2B3,PTPN6 |
1.844e-02 | -3.99 | classic | COSMIC cancer mutations | classic | 14774 | 45 | 16828 | 46 |
RHBDF2,BMP2K,PTGIR,PREX1,VAV3,DOCK2,VMP1,CADM4,MPP1,ACER2,SLC16A10,PREX2,DAB2,KREMEN1,TFEB,ACACB,TMCC3,ATG14,SLC9A1,GRK6,SH2B3,SEMA4B,GALNT1,HCK,ASCC3,PTPRC,SMOX,PPFIBP2,DOCK8,FCHO2,PTPN6,NACC2,GAB1,ATP10D,TMTC1,DIAPH2,BLVRA,DISC1,ENTPD1,RAPGEF6,PPP1R7,RBM47,PLXND1,STAB1,SYK |
1.847e-02 | -3.99 | AP2M1 (adaptor related protein complex 2 subunit mu 1) | protein interactions | 1173 | 403 | 4 | 19454 | 49 |
DAB2,FCHO2,MPP1,BMP2K |
1.847e-02 | -3.99 | CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2) | protein interactions | 830 | 403 | 4 | 19454 | 49 |
BMP2K,VMP1,DAB2,FCHO2 |
1.853e-02 | -3.99 | Heme degradation | REACTOME pathways | R-HSA-189483 | 6 | 1 | 10285 | 32 |
BLVRA |
1.853e-02 | -3.99 | CD22 mediated BCR regulation | REACTOME pathways | R-HSA-5690714 | 6 | 1 | 10285 | 32 |
PTPN6 |
1.853e-02 | -3.99 | MET activates PI3K/AKT signaling | REACTOME pathways | R-HSA-8851907 | 6 | 1 | 10285 | 32 |
GAB1 |
1.853e-02 | -3.99 | Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling | REACTOME pathways | R-HSA-5339717 | 6 | 1 | 10285 | 32 |
KREMEN1 |
1.857e-02 | -3.99 | CPSASE_2 | prosite domains | PS00867 | 6 | 1 | 12186 | 38 |
ACACB |
1.858e-02 | -3.99 | ENTREP1 (endosomal transmembrane epsin interactor 1) | protein interactions | 9413 | 83 | 2 | 19454 | 49 |
RHBDF2,SLC9A1 |
1.858e-02 | -3.99 | N4BP2 (NEDD4 binding protein 2) | protein interactions | 55728 | 83 | 2 | 19454 | 49 |
RBM47,DISC1 |
1.858e-02 | -3.99 | NEXN (nexilin F-actin binding protein) | protein interactions | 91624 | 83 | 2 | 19454 | 49 |
DISC1,VMP1 |
1.864e-02 | -3.98 | medulla | COSMIC cancer mutations | medulla | 14778 | 45 | 16828 | 46 |
SYK,STAB1,RBM47,PLXND1,PPP1R7,RAPGEF6,ENTPD1,DISC1,DIAPH2,BLVRA,TMTC1,ATP10D,GAB1,PTPN6,NACC2,DOCK8,FCHO2,PPFIBP2,SMOX,ASCC3,PTPRC,HCK,GALNT1,SEMA4B,SH2B3,SLC9A1,GRK6,ATG14,TMCC3,ACACB,KREMEN1,TFEB,DAB2,PREX2,SLC16A10,ACER2,MPP1,CADM4,DOCK2,VMP1,VAV3,PREX1,BMP2K,PTGIR,RHBDF2 |
1.869e-02 | -3.98 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 45 | 16828 | 46 |
ENTPD1,STAB1,SYK,RAPGEF6,PPP1R7,PLXND1,RBM47,SMOX,FCHO2,DOCK8,PPFIBP2,HCK,PTPRC,ASCC3,BLVRA,DIAPH2,DISC1,ATP10D,NACC2,GAB1,PTPN6,TMTC1,TMCC3,ACACB,SEMA4B,SH2B3,GALNT1,GRK6,SLC9A1,ATG14,VMP1,DOCK2,VAV3,PTGIR,BMP2K,RHBDF2,PREX1,PREX2,TFEB,KREMEN1,DAB2,MPP1,ACER2,CADM4,SLC16A10 |
1.871e-02 | -3.98 | Osteopontin-mediated events | Pathway Interaction DB | avb3_opn_pathway | 32 | 2 | 2226 | 15 |
VAV3,SYK |
1.871e-02 | -3.98 | Alpha-synuclein signaling | Pathway Interaction DB | alphasynuclein_pathway | 32 | 2 | 2226 | 15 |
SYK,HCK |
1.873e-02 | -3.98 | CPSase_L_D2 | pfam domains | PF02786 | 7 | 1 | 17795 | 48 |
ACACB |
1.873e-02 | -3.98 | ILEI | pfam domains | PF15711 | 7 | 1 | 17795 | 48 |
CEMIP |
1.880e-02 | -3.97 | Semaphorin interactions | REACTOME pathways | R-HSA-373755 | 68 | 2 | 10285 | 32 |
PLXND1,PTPRC |
1.881e-02 | -3.97 | clathrin-coated vesicle | cellular component | GO:0030136 | 220 | 3 | 19108 | 49 |
FCHO2,DAB2,CEMIP |
1.885e-02 | -3.97 | RAC3 (Rac family small GTPase 3) | protein interactions | 5881 | 615 | 5 | 19454 | 49 |
GAB1,OSBPL8,DIAPH2,SLC9A1,FCHO2 |
1.898e-02 | -3.96 | skin-upper_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-nodular | 7 | 1 | 16828 | 46 |
PREX2 |
1.898e-02 | -3.96 | skin-face-malignant_melanoma-nodular | COSMIC cancer mutations | skin-face-malignant_melanoma-nodular | 7 | 1 | 16828 | 46 |
PREX2 |
1.900e-02 | -3.96 | KRTAP3-1 (keratin associated protein 3-1) | protein interactions | 83896 | 84 | 2 | 19454 | 49 |
HCK,DOCK2 |
1.900e-02 | -3.96 | Tyr_kinase_cat_dom | interpro domains | IPR020635 | 80 | 2 | 18521 | 49 |
SYK,HCK |
1.921e-02 | -3.95 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 49 |
HCK,ENTPD1 |
1.939e-02 | -3.94 | LIMA1 (LIM domain and actin binding 1) | protein interactions | 51474 | 409 | 4 | 19454 | 49 |
DISC1,FCHO2,DAB2,BMP2K |
1.943e-02 | -3.94 | WSB2 (WD repeat and SOCS box containing 2) | protein interactions | 55884 | 85 | 2 | 19454 | 49 |
PREX1,ACACB |
1.943e-02 | -3.94 | ABRAXAS2 (abraxas 2, BRISC complex subunit) | protein interactions | 23172 | 85 | 2 | 19454 | 49 |
SH2B3,SYK |
1.948e-02 | -3.94 | PRKCD (protein kinase C delta) | protein interactions | 5580 | 227 | 3 | 19454 | 49 |
DAB2,BLVRA,PTPN6 |
1.948e-02 | -3.94 | MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4) | protein interactions | 9448 | 227 | 3 | 19454 | 49 |
SLC9A1,DISC1,ATG14 |
1.954e-02 | -3.94 | LDLR (low density lipoprotein receptor) | protein interactions | 3949 | 410 | 4 | 19454 | 49 |
SLC16A10,PREX2,FCHO2,DAB2 |
1.959e-02 | -3.93 | transport | biological process | GO:0006810 | 3615 | 16 | 18204 | 48 |
ATG14,FCHO2,STAB1,VAV3,ACACB,SYK,PTPRC,ATP10D,OSBPL8,SLC9A1,VMP1,SLC16A10,DOCK2,RHBDF2,DAB2,HCK |
1.973e-02 | -3.93 | regulation of metal ion transport | biological process | GO:0010959 | 393 | 4 | 18204 | 48 |
CEMIP,PTPN6,VMP1,SLC9A1 |
1.974e-02 | -3.93 | PROSTANOIDR | prints domains | PR01788 | 8 | 1 | 5227 | 13 |
PTGIR |
1.975e-02 | -3.92 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 45 | 16828 | 46 |
PREX1,BMP2K,PTGIR,RHBDF2,VMP1,DOCK2,VAV3,SLC16A10,MPP1,ACER2,TFEB,KREMEN1,DAB2,PREX2,ACACB,TMCC3,GRK6,SLC9A1,ATG14,GALNT1,SEMA4B,SH2B3,PTPRC,ASCC3,HCK,FCHO2,DOCK8,PPFIBP2,SMOX,TMTC1,ATP10D,NACC2,GAB1,PTPN6,DISC1,BLVRA,DIAPH2,ENTPD1,PPP1R7,RBM47,PLXND1,OSBPL8,RAPGEF6,SYK,STAB1 |
1.975e-02 | -3.92 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 45 | 16828 | 46 |
TMCC3,ACACB,GALNT1,SH2B3,SEMA4B,ATG14,SLC9A1,GRK6,VAV3,DOCK2,VMP1,PREX1,RHBDF2,BMP2K,PTGIR,DAB2,KREMEN1,TFEB,PREX2,SLC16A10,MPP1,ACER2,ENTPD1,SYK,STAB1,OSBPL8,RBM47,PLXND1,PPP1R7,RAPGEF6,PPFIBP2,DOCK8,FCHO2,SMOX,ASCC3,PTPRC,HCK,DISC1,DIAPH2,BLVRA,TMTC1,PTPN6,NACC2,GAB1,ATP10D |
1.985e-02 | -3.92 | UTP and CTP dephosphorylation II | BIOCYC pathways | META_PWY-7177 | 3 | 1 | 902 | 6 |
ENTPD1 |
1.985e-02 | -3.92 | UTP and CTP dephosphorylation I | BIOCYC pathways | META_PWY-7185 | 3 | 1 | 902 | 6 |
ENTPD1 |
1.985e-02 | -3.92 | biotin-carboxyl carrier protein assembly | BIOCYC pathways | HUMAN_PWY0-1264 | 3 | 1 | 902 | 6 |
ACACB |
1.998e-02 | -3.91 | LILRB1 (leukocyte immunoglobulin like receptor B1) | protein interactions | 10859 | 8 | 1 | 19454 | 49 |
PTPN6 |
1.998e-02 | -3.91 | KMO (kynurenine 3-monooxygenase) | protein interactions | 8564 | 8 | 1 | 19454 | 49 |
DISC1 |
1.998e-02 | -3.91 | TREML1 (triggering receptor expressed on myeloid cells like 1) | protein interactions | 340205 | 8 | 1 | 19454 | 49 |
PTPN6 |
1.998e-02 | -3.91 | CD1D (CD1d molecule) | protein interactions | 912 | 8 | 1 | 19454 | 49 |
PTPRC |
1.998e-02 | -3.91 | C14orf93 (chromosome 14 open reading frame 93) | protein interactions | 60686 | 8 | 1 | 19454 | 49 |
PPFIBP2 |
1.998e-02 | -3.91 | LRRC58 (leucine rich repeat containing 58) | protein interactions | 116064 | 8 | 1 | 19454 | 49 |
ATG14 |
1.998e-02 | -3.91 | BCDIN3D (BCDIN3 domain containing RNA methyltransferase) | protein interactions | 144233 | 8 | 1 | 19454 | 49 |
ACACB |
1.998e-02 | -3.91 | RNPEPL1 (arginyl aminopeptidase like 1) | protein interactions | 57140 | 8 | 1 | 19454 | 49 |
TMCC3 |
2.000e-02 | -3.91 | receptor tyrosine kinase binding | molecular function | GO:0030971 | 82 | 2 | 18094 | 48 |
SH2B3,CADM4 |
2.016e-02 | -3.90 | DST (dystonin) | protein interactions | 667 | 230 | 3 | 19454 | 49 |
DISC1,VMP1,RHBDF2 |
2.023e-02 | -3.90 | positive regulation of ion transmembrane transporter activity | biological process | GO:0032414 | 83 | 2 | 18204 | 48 |
VMP1,SLC9A1 |
2.023e-02 | -3.90 | nucleoside diphosphate metabolic process | biological process | GO:0009132 | 83 | 2 | 18204 | 48 |
MPP1,ENTPD1 |
2.034e-02 | -3.90 | presynaptic endocytic zone membrane | cellular component | GO:0098835 | 8 | 1 | 19108 | 49 |
FCHO2 |
2.034e-02 | -3.90 | phosphatidylinositol 3-kinase complex, class III | cellular component | GO:0035032 | 8 | 1 | 19108 | 49 |
ATG14 |
2.039e-02 | -3.89 | CALD1 (caldesmon 1) | protein interactions | 800 | 231 | 3 | 19454 | 49 |
DOCK8,DISC1,VMP1 |
2.049e-02 | -3.89 | SRP9 (signal recognition particle 9) | protein interactions | 6726 | 416 | 4 | 19454 | 49 |
ASCC3,OSBPL8,MPP1,VMP1 |
2.049e-02 | -3.89 | TMPRSS11B (transmembrane serine protease 11B) | protein interactions | 132724 | 416 | 4 | 19454 | 49 |
SLC9A1,GALNT1,SLC16A10,OSBPL8 |
2.065e-02 | -3.88 | forearm | COSMIC cancer mutations | forearm | 81 | 2 | 16828 | 46 |
PREX2,PTPRC |
2.069e-02 | -3.88 | autophagosome organization | biological process | GO:1905037 | 84 | 2 | 18204 | 48 |
ATG14,VMP1 |
2.069e-02 | -3.88 | stem cell development | biological process | GO:0048864 | 84 | 2 | 18204 | 48 |
SEMA4B,PTPRC |
2.069e-02 | -3.88 | membrane docking | biological process | GO:0022406 | 84 | 2 | 18204 | 48 |
VMP1,ATG14 |
2.069e-02 | -3.88 | regulation of release of sequestered calcium ion into cytosol | biological process | GO:0051279 | 84 | 2 | 18204 | 48 |
CEMIP,PTPN6 |
2.075e-02 | -3.88 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 13 | 18204 | 48 |
DISC1,SLC9A1,NACC2,DIAPH2,VMP1,DAB2,ATG14,RAPGEF6,FCHO2,VAV3,PREX1,ACACB,PLXND1 |
2.090e-02 | -3.87 | regulation of neutrophil degranulation | biological process | GO:0043313 | 8 | 1 | 18204 | 48 |
SYK |
2.090e-02 | -3.87 | regulation of aldosterone biosynthetic process | biological process | GO:0032347 | 8 | 1 | 18204 | 48 |
DAB2 |
2.090e-02 | -3.87 | lactate transport | biological process | GO:0015727 | 8 | 1 | 18204 | 48 |
ACACB |
2.090e-02 | -3.87 | regulation of aldosterone metabolic process | biological process | GO:0032344 | 8 | 1 | 18204 | 48 |
DAB2 |
2.090e-02 | -3.87 | positive regulation of killing of cells of another organism | biological process | GO:0051712 | 8 | 1 | 18204 | 48 |
SYK |
2.090e-02 | -3.87 | positive regulation of action potential | biological process | GO:0045760 | 8 | 1 | 18204 | 48 |
SLC9A1 |
2.090e-02 | -3.87 | lactate transmembrane transport | biological process | GO:0035873 | 8 | 1 | 18204 | 48 |
ACACB |
2.090e-02 | -3.87 | dichotomous subdivision of an epithelial terminal unit | biological process | GO:0060600 | 8 | 1 | 18204 | 48 |
PLXND1 |
2.092e-02 | -3.87 | phosphatidylinositol-4,5-bisphosphate binding | molecular function | GO:0005546 | 84 | 2 | 18094 | 48 |
SLC9A1,FCHO2 |
2.097e-02 | -3.86 | Pectin_lyase_fold/virulence | interpro domains | IPR011050 | 8 | 1 | 18521 | 49 |
CEMIP |
2.097e-02 | -3.86 | GDA1_CD39_NTPase | interpro domains | IPR000407 | 8 | 1 | 18521 | 49 |
ENTPD1 |
2.097e-02 | -3.86 | Prostanoid_rcpt | interpro domains | IPR008365 | 8 | 1 | 18521 | 49 |
PTGIR |
2.097e-02 | -3.86 | TIG1_plexin | interpro domains | IPR041019 | 8 | 1 | 18521 | 49 |
PLXND1 |
2.097e-02 | -3.86 | DAD_dom | interpro domains | IPR014767 | 8 | 1 | 18521 | 49 |
DIAPH2 |
2.101e-02 | -3.86 | cellular metabolic process | biological process | GO:0044237 | 5975 | 23 | 18204 | 48 |
MPP1,ACER2,PREX1,TFEB,TMTC1,ATG14,BMP2K,PHKB,GRK6,GALNT1,HCK,OSBPL8,VMP1,SMOX,ENTPD1,ASCC3,ACACB,CEMIP,RBM47,SLC16A10,SYK,PTPRC,PTPN6 |
2.103e-02 | -3.86 | dolichyl-phosphate-mannose-protein mannosyltransferase activity | molecular function | GO:0004169 | 8 | 1 | 18094 | 48 |
TMTC1 |
2.103e-02 | -3.86 | thyroid hormone transmembrane transporter activity | molecular function | GO:0015349 | 8 | 1 | 18094 | 48 |
SLC16A10 |
2.103e-02 | -3.86 | phosphorylation-dependent protein binding | molecular function | GO:0140031 | 8 | 1 | 18094 | 48 |
PTPN6 |
2.103e-02 | -3.86 | hyalurononglucosaminidase activity | molecular function | GO:0004415 | 8 | 1 | 18094 | 48 |
CEMIP |
2.109e-02 | -3.86 | PRKCB (protein kinase C beta) | protein interactions | 5579 | 234 | 3 | 19454 | 49 |
BLVRA,DAB2,OSBPL8 |
2.110e-02 | -3.86 | TYR_PHOSPHATASE_1 | prosite domains | PS00383 | 72 | 2 | 12186 | 38 |
PTPN6,PTPRC |
2.117e-02 | -3.85 | INSRR (insulin receptor related receptor) | protein interactions | 3645 | 89 | 2 | 19454 | 49 |
RHBDF2,OSBPL8 |
2.124e-02 | -3.85 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 16 | 16828 | 46 |
ASCC3,PTPRC,ACACB,VAV3,DOCK8,DOCK2,TMCC3,TMTC1,OSBPL8,SLC9A1,PLXND1,SLC16A10,RAPGEF6,DAB2,DIAPH2,PREX2 |
2.133e-02 | -3.85 | LAMP1 (lysosomal associated membrane protein 1) | protein interactions | 3916 | 635 | 5 | 19454 | 49 |
SLC16A10,OSBPL8,PPFIBP2,FCHO2,DISC1 |
2.135e-02 | -3.85 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 16 | 16828 | 46 |
DOCK8,DOCK2,VAV3,TMCC3,PTPRC,ASCC3,ACACB,DAB2,PREX2,DIAPH2,PLXND1,SLC16A10,SLC9A1,OSBPL8,TMTC1,RAPGEF6 |
2.138e-02 | -3.85 | GDA1_CD39 | pfam domains | PF01150 | 8 | 1 | 17795 | 48 |
ENTPD1 |
2.138e-02 | -3.85 | TIG_plexin | pfam domains | PF17960 | 8 | 1 | 17795 | 48 |
PLXND1 |
2.143e-02 | -3.84 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 46 |
PREX2,PLXND1,GRK6,PREX1,PTPRC |
2.158e-02 | -3.84 | Reversal of alkylation damage by DNA dioxygenases | REACTOME pathways | R-HSA-73943 | 7 | 1 | 10285 | 32 |
ASCC3 |
2.162e-02 | -3.83 | malignant | COSMIC cancer mutations | malignant | 83 | 2 | 16828 | 46 |
GALNT1,ASCC3 |
2.163e-02 | -3.83 | GG_LECTIN | prosite domains | PS52031 | 7 | 1 | 12186 | 38 |
CEMIP |
2.163e-02 | -3.83 | STX4 (syntaxin 4) | protein interactions | 6810 | 423 | 4 | 19454 | 49 |
SLC9A1,TMCC3,GAB1,OSBPL8 |
2.166e-02 | -3.83 | skin-chest-malignant_melanoma-nodular | COSMIC cancer mutations | skin-chest-malignant_melanoma-nodular | 8 | 1 | 16828 | 46 |
PREX2 |
2.166e-02 | -3.83 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 46 |
NACC2 |
2.168e-02 | -3.83 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 10 | 16828 | 46 |
TMTC1,ATG14,SLC9A1,PTPN6,RAPGEF6,ATP10D,DOCK2,DOCK8,STAB1,ENTPD1 |
2.168e-02 | -3.83 | functioning | COSMIC cancer mutations | functioning | 1803 | 10 | 16828 | 46 |
SLC9A1,ATG14,TMTC1,ATP10D,RAPGEF6,PTPN6,DOCK2,DOCK8,ENTPD1,STAB1 |
2.176e-02 | -3.83 | Tyr_Pase_dom | interpro domains | IPR000387 | 86 | 2 | 18521 | 49 |
PTPN6,PTPRC |
2.204e-02 | -3.81 | SNAP29 (synaptosome associated protein 29) | protein interactions | 9342 | 238 | 3 | 19454 | 49 |
ATG14,RHBDF2,PPFIBP2 |
2.206e-02 | -3.81 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 11 | 16828 | 46 |
BMP2K,HCK,GRK6,PLXND1,PTPRC,PREX2,STAB1,SYK,TFEB,GALNT1,DAB2 |
2.207e-02 | -3.81 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 2 | 19454 | 49 |
DISC1,DAB2 |
2.218e-02 | -3.81 | NAHEXCHNGR | prints domains | PR01084 | 9 | 1 | 5227 | 13 |
SLC9A1 |
2.222e-02 | -3.81 | regulation of cell development | biological process | GO:0060284 | 839 | 6 | 18204 | 48 |
PTPN6,PTPRC,DISC1,SYK,TMEM131L,PLXND1 |
2.227e-02 | -3.80 | T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection | WikiPathways | WP3863 | 62 | 2 | 5310 | 20 |
PTPN6,PTPRC |
2.227e-02 | -3.80 | human chr12p11.22 | chromosome location | human chr12p11.22 | 12 | 1 | 26134 | 49 |
TMTC1 |
2.230e-02 | -3.80 | ORF8 (ORF8 protein) | protein interactions | 43740577 | 427 | 4 | 19454 | 49 |
OSBPL8,GALNT1,CEMIP,ACACB |
2.232e-02 | -3.80 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 36 | 16828 | 46 |
SH2B3,STAB1,SEMA4B,GALNT1,RAPGEF6,ATG14,OSBPL8,PPP1R7,PLXND1,SLC9A1,TMCC3,ACACB,PREX2,BLVRA,DIAPH2,DAB2,KREMEN1,GAB1,CADM4,NACC2,MPP1,ACER2,ATP10D,TMTC1,SLC16A10,PPFIBP2,VAV3,VMP1,DOCK2,DOCK8,HCK,RHBDF2,PTGIR,PTPRC,ASCC3,PREX1 |
2.243e-02 | -3.80 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 5 | 16828 | 46 |
DAB2,ASCC3,PREX2,DIAPH2,ACACB |
2.245e-02 | -3.80 | NPAP1 (nuclear pore associated protein 1) | protein interactions | 23742 | 9 | 1 | 19454 | 49 |
ACACB |
2.245e-02 | -3.80 | AIFM3 (apoptosis inducing factor mitochondria associated 3) | protein interactions | 150209 | 9 | 1 | 19454 | 49 |
GRK6 |
2.245e-02 | -3.80 | RBM46 (RNA binding motif protein 46) | protein interactions | 166863 | 9 | 1 | 19454 | 49 |
RBM47 |
2.245e-02 | -3.80 | LILRB2 (leukocyte immunoglobulin like receptor B2) | protein interactions | 10288 | 9 | 1 | 19454 | 49 |
PTPN6 |
2.245e-02 | -3.80 | SEMA3A (semaphorin 3A) | protein interactions | 10371 | 9 | 1 | 19454 | 49 |
DISC1 |
2.245e-02 | -3.80 | CALCB (calcitonin related polypeptide beta) | protein interactions | 797 | 9 | 1 | 19454 | 49 |
ATG14 |
2.245e-02 | -3.80 | TSSK4 (testis specific serine kinase 4) | protein interactions | 283629 | 9 | 1 | 19454 | 49 |
ACACB |
2.245e-02 | -3.80 | PPFIA4 (PTPRF interacting protein alpha 4) | protein interactions | 8497 | 9 | 1 | 19454 | 49 |
DISC1 |
2.245e-02 | -3.80 | Ppp1r3b (protein phosphatase 1, regulatory subunit 3B) | protein interactions | 244416 | 9 | 1 | 19454 | 49 |
PHKB |
2.245e-02 | -3.80 | PCNX4 (pecanex 4) | protein interactions | 64430 | 9 | 1 | 19454 | 49 |
DISC1 |
2.245e-02 | -3.80 | PEAR1 (platelet endothelial aggregation receptor 1) | protein interactions | 375033 | 9 | 1 | 19454 | 49 |
SYK |
2.245e-02 | -3.80 | SLN (sarcolipin) | protein interactions | 6588 | 9 | 1 | 19454 | 49 |
VMP1 |
2.251e-02 | -3.79 | trunk | COSMIC cancer mutations | trunk | 3554 | 16 | 16828 | 46 |
ACACB,HCK,ASCC3,PTPRC,DOCK2,DOCK8,CADM4,ATP10D,SLC9A1,RBM47,STAB1,PREX2,DAB2,DISC1,SYK,TFEB |
2.262e-02 | -3.79 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 23 | 16828 | 46 |
TMTC1,PLXND1,GRK6,SLC16A10,NACC2,PTPN6,GAB1,ATP10D,DAB2,KREMEN1,SH2B3,PREX2,DIAPH2,SEMA4B,PTPRC,ASCC3,ACACB,PPFIBP2,VAV3,VMP1,DOCK8,DOCK2,ENTPD1 |
2.268e-02 | -3.79 | regulation of defense response | biological process | GO:0031347 | 843 | 6 | 18204 | 48 |
HCK,RBM47,RHBDF2,SYK,PTPRC,PTPN6 |
2.285e-02 | -3.78 | bleb | cellular component | GO:0032059 | 9 | 1 | 19108 | 49 |
PTPRC |
2.285e-02 | -3.78 | presynaptic endocytic zone | cellular component | GO:0098833 | 9 | 1 | 19108 | 49 |
FCHO2 |
2.299e-02 | -3.77 | positive regulation of phosphorylation | biological process | GO:0042327 | 619 | 5 | 18204 | 48 |
DAB2,ATG14,CEMIP,PTPRC,SYK |
2.299e-02 | -3.77 | - | gene3d domains | 3.90.660.10 | 8 | 1 | 14470 | 42 |
SMOX |
2.299e-02 | -3.77 | Exopolyphosphatase. Domain 2 | gene3d domains | 3.30.420.150 | 8 | 1 | 14470 | 42 |
ENTPD1 |
2.302e-02 | -3.77 | ATG16L1 (autophagy related 16 like 1) | protein interactions | 55054 | 1138 | 7 | 19454 | 49 |
OSBPL8,TFEB,DOCK2,ASCC3,SYK,PTPRC,ACACB |
2.305e-02 | -3.77 | negative regulation of lymphocyte proliferation | biological process | GO:0050672 | 89 | 2 | 18204 | 48 |
PTPN6,TMEM131L |
2.316e-02 | -3.77 | Cell death signalling via NRAGE, NRIF and NADE | REACTOME pathways | R-HSA-204998 | 76 | 2 | 10285 | 32 |
VAV3,PREX1 |
2.331e-02 | -3.76 | SHMT2 (serine hydroxymethyltransferase 2) | protein interactions | 6472 | 650 | 5 | 19454 | 49 |
GRK6,RAPGEF6,DOCK8,CADM4,PREX1 |
2.342e-02 | -3.75 | WH-like_DNA-bd_sf | interpro domains | IPR036388 | 232 | 3 | 18521 | 49 |
ASCC3,PREX1,PREX2 |
2.345e-02 | -3.75 | DIP2A (disco interacting protein 2 homolog A) | protein interactions | 23181 | 94 | 2 | 19454 | 49 |
DAB2,CADM4 |
2.349e-02 | -3.75 | negative regulation of chemokine-mediated signaling pathway | biological process | GO:0070100 | 9 | 1 | 18204 | 48 |
SH2B3 |
2.349e-02 | -3.75 | negative regulation of protein autophosphorylation | biological process | GO:0031953 | 9 | 1 | 18204 | 48 |
PTPRC |
2.349e-02 | -3.75 | intracellular amino acid homeostasis | biological process | GO:0080144 | 9 | 1 | 18204 | 48 |
ACACB |
2.349e-02 | -3.75 | positive regulation of hormone biosynthetic process | biological process | GO:0046886 | 9 | 1 | 18204 | 48 |
DAB2 |
2.349e-02 | -3.75 | negative regulation of inflammatory response to wounding | biological process | GO:0106015 | 9 | 1 | 18204 | 48 |
PTPN6 |
2.349e-02 | -3.75 | positive regulation of Wnt signaling pathway, planar cell polarity pathway | biological process | GO:2000096 | 9 | 1 | 18204 | 48 |
DAB2 |
2.349e-02 | -3.75 | positive regulation of early endosome to late endosome transport | biological process | GO:2000643 | 9 | 1 | 18204 | 48 |
DAB2 |
2.349e-02 | -3.75 | bone marrow development | biological process | GO:0048539 | 9 | 1 | 18204 | 48 |
PTPRC |
2.349e-02 | -3.75 | respiratory burst involved in defense response | biological process | GO:0002679 | 9 | 1 | 18204 | 48 |
HCK |
2.349e-02 | -3.75 | antibacterial innate immune response | biological process | GO:0140367 | 9 | 1 | 18204 | 48 |
TFEB |
2.349e-02 | -3.75 | regulation of killing of cells of another organism | biological process | GO:0051709 | 9 | 1 | 18204 | 48 |
SYK |
2.349e-02 | -3.75 | phosphatidylserine acyl-chain remodeling | biological process | GO:0036150 | 9 | 1 | 18204 | 48 |
OSBPL8 |
2.349e-02 | -3.75 | establishment of T cell polarity | biological process | GO:0001768 | 9 | 1 | 18204 | 48 |
DOCK2 |
2.354e-02 | -3.75 | LRRcap | smart domains | SM00446 | 7 | 1 | 9717 | 33 |
PPP1R7 |
2.357e-02 | -3.75 | Plexin_cytoplasmic_RasGAP_dom | interpro domains | IPR013548 | 9 | 1 | 18521 | 49 |
PLXND1 |
2.357e-02 | -3.75 | NaH_exchanger | interpro domains | IPR004709 | 9 | 1 | 18521 | 49 |
SLC9A1 |
2.357e-02 | -3.75 | GTPase-bd | interpro domains | IPR010473 | 9 | 1 | 18521 | 49 |
DIAPH2 |
2.357e-02 | -3.75 | Peptidase_S54_rhomboid_dom | interpro domains | IPR022764 | 9 | 1 | 18521 | 49 |
RHBDF2 |
2.357e-02 | -3.75 | FH3_dom | interpro domains | IPR010472 | 9 | 1 | 18521 | 49 |
DIAPH2 |
2.357e-02 | -3.75 | BEN_domain | interpro domains | IPR018379 | 9 | 1 | 18521 | 49 |
NACC2 |
2.357e-02 | -3.75 | Plexin_RBD | interpro domains | IPR046800 | 9 | 1 | 18521 | 49 |
PLXND1 |
2.363e-02 | -3.75 | vascular endothelial growth factor receptor 2 binding | molecular function | GO:0043184 | 9 | 1 | 18094 | 48 |
CADM4 |
2.363e-02 | -3.75 | UDP phosphatase activity | molecular function | GO:0045134 | 9 | 1 | 18094 | 48 |
ENTPD1 |
2.363e-02 | -3.75 | guanylate kinase activity | molecular function | GO:0004385 | 9 | 1 | 18094 | 48 |
MPP1 |
2.363e-02 | -3.75 | focal adhesion | cellular component | GO:0005925 | 427 | 4 | 19108 | 49 |
DAB2,PTPRC,HCK,SLC9A1 |
2.373e-02 | -3.74 | TYRKINASE | prints domains | PR00109 | 98 | 2 | 5227 | 13 |
SYK,HCK |
2.381e-02 | -3.74 | cell leading edge | cellular component | GO:0031252 | 428 | 4 | 19108 | 49 |
PLXND1,CADM4,SLC9A1,DOCK8 |
2.399e-02 | -3.73 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 5 | 18204 | 48 |
HCK,DAB2,SH2B3,GAB1,SYK |
2.402e-02 | -3.73 | Drf_FH3 | pfam domains | PF06367 | 9 | 1 | 17795 | 48 |
DIAPH2 |
2.402e-02 | -3.73 | Drf_GBD | pfam domains | PF06371 | 9 | 1 | 17795 | 48 |
DIAPH2 |
2.402e-02 | -3.73 | Plexin_cytopl | pfam domains | PF08337 | 9 | 1 | 17795 | 48 |
PLXND1 |
2.402e-02 | -3.73 | Rhomboid | pfam domains | PF01694 | 9 | 1 | 17795 | 48 |
RHBDF2 |
2.402e-02 | -3.73 | Biotin_lipoyl | pfam domains | PF00364 | 9 | 1 | 17795 | 48 |
ACACB |
2.402e-02 | -3.73 | BEN | pfam domains | PF10523 | 9 | 1 | 17795 | 48 |
NACC2 |
2.402e-02 | -3.73 | Plexin_RBD | pfam domains | PF20170 | 9 | 1 | 17795 | 48 |
PLXND1 |
2.402e-02 | -3.73 | negative regulation of mononuclear cell proliferation | biological process | GO:0032945 | 91 | 2 | 18204 | 48 |
TMEM131L,PTPN6 |
2.421e-02 | -3.72 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 46 |
PREX2,PTPRC,PREX1,GRK6,PLXND1 |
2.434e-02 | -3.72 | skin-upper_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 46 |
PREX2 |
2.434e-02 | -3.72 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 46 |
PREX2 |
2.439e-02 | -3.71 | GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1) | protein interactions | 8729 | 439 | 4 | 19454 | 49 |
DAB2,ASCC3,TMEM131L,PTPN6 |
2.451e-02 | -3.71 | response to chemokine | biological process | GO:1990868 | 92 | 2 | 18204 | 48 |
SH2B3,DOCK8 |
2.451e-02 | -3.71 | positive regulation of transporter activity | biological process | GO:0032411 | 92 | 2 | 18204 | 48 |
SLC9A1,VMP1 |
2.451e-02 | -3.71 | cellular response to chemokine | biological process | GO:1990869 | 92 | 2 | 18204 | 48 |
DOCK8,SH2B3 |
2.452e-02 | -3.71 | ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) | protein interactions | 25 | 248 | 3 | 19454 | 49 |
HCK,PTPN6,BMP2K |
2.463e-02 | -3.70 | Phosphate bond hydrolysis by NTPDase proteins | REACTOME pathways | R-HSA-8850843 | 8 | 1 | 10285 | 32 |
ENTPD1 |
2.463e-02 | -3.70 | DNA Damage Reversal | REACTOME pathways | R-HSA-73942 | 8 | 1 | 10285 | 32 |
ASCC3 |
2.466e-02 | -3.70 | negative regulation of protein modification process | biological process | GO:0031400 | 421 | 4 | 18204 | 48 |
PTPRC,CADM4,ATG14,PTPN6 |
2.468e-02 | -3.70 | GDA1_CD39_NTPASE | prosite domains | PS01238 | 8 | 1 | 12186 | 38 |
ENTPD1 |
2.468e-02 | -3.70 | DAD | prosite domains | PS51231 | 8 | 1 | 12186 | 38 |
DIAPH2 |
2.478e-02 | -3.70 | MYO19 (myosin XIX) | protein interactions | 80179 | 249 | 3 | 19454 | 49 |
BMP2K,DAB2,FCHO2 |
2.479e-02 | -3.70 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 48 |
FCHO2,RHBDF2,RAPGEF6 |
2.484e-02 | -3.70 | vesicle | cellular component | GO:0031982 | 4141 | 17 | 19108 | 49 |
DISC1,FCHO2,ATG14,SLC9A1,RAPGEF6,SYK,ENTPD1,HCK,CEMIP,DIAPH2,BLVRA,PTPRC,DOCK2,DAB2,PTPN6,STAB1,PPP1R7 |
2.486e-02 | -3.69 | Tpm1 (tropomyosin 1, alpha) | protein interactions | 22003 | 97 | 2 | 19454 | 49 |
BMP2K,DAB2 |
2.486e-02 | -3.69 | CBLB (Cbl proto-oncogene B) | protein interactions | 868 | 97 | 2 | 19454 | 49 |
VAV3,SYK |
2.491e-02 | -3.69 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 11 | 16828 | 46 |
DAB2,VAV3,PPFIBP2,DOCK2,DIAPH2,PREX2,TMTC1,PTPRC,SLC9A1,PPP1R7,GAB1 |
2.491e-02 | -3.69 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 11 | 16828 | 46 |
DAB2,DIAPH2,PREX2,TMTC1,SLC9A1,PPP1R7,GAB1,VAV3,PPFIBP2,DOCK2,PTPRC |
2.491e-02 | -3.69 | MACC1 (MET transcriptional regulator MACC1) | protein interactions | 346389 | 10 | 1 | 19454 | 49 |
FCHO2 |
2.491e-02 | -3.69 | SIGLEC7 (sialic acid binding Ig like lectin 7) | protein interactions | 27036 | 10 | 1 | 19454 | 49 |
PTPN6 |
2.491e-02 | -3.69 | SIGLEC10 (sialic acid binding Ig like lectin 10) | protein interactions | 89790 | 10 | 1 | 19454 | 49 |
PTPN6 |
2.491e-02 | -3.69 | N (nucleocapsid protein) | protein interactions | 14254601 | 10 | 1 | 19454 | 49 |
PPP1R7 |
2.491e-02 | -3.69 | ATRAID (all-trans retinoic acid induced differentiation factor) | protein interactions | 51374 | 10 | 1 | 19454 | 49 |
MPP1 |
2.491e-02 | -3.69 | PTPRT (protein tyrosine phosphatase receptor type T) | protein interactions | 11122 | 10 | 1 | 19454 | 49 |
PHKB |
2.491e-02 | -3.69 | PRTG (protogenin) | protein interactions | 283659 | 10 | 1 | 19454 | 49 |
DISC1 |
2.491e-02 | -3.69 | Gbf1 (golgi-specific brefeldin A-resistance factor 1) | protein interactions | 107338 | 10 | 1 | 19454 | 49 |
SLC9A1 |
2.491e-02 | -3.69 | HAS1 (hyaluronan synthase 1) | protein interactions | 3036 | 10 | 1 | 19454 | 49 |
CEMIP |
2.491e-02 | -3.69 | BECN2 (beclin 2) | protein interactions | 441925 | 10 | 1 | 19454 | 49 |
ATG14 |
2.491e-02 | -3.69 | METTL26 (methyltransferase like 26) | protein interactions | 84326 | 10 | 1 | 19454 | 49 |
DISC1 |
2.498e-02 | -3.69 | response to lipid | biological process | GO:0033993 | 862 | 6 | 18204 | 48 |
PTPRC,SYK,DAB2,ACER2,HCK,PTGIR |
2.501e-02 | -3.69 | regulation of receptor signaling pathway via STAT | biological process | GO:1904892 | 93 | 2 | 18204 | 48 |
SH2B3,PTPRC |
2.510e-02 | -3.68 | developmental process | biological process | GO:0032502 | 5716 | 22 | 18204 | 48 |
SH2B3,PREX1,TFEB,GAB1,HCK,DAB2,OSBPL8,VMP1,DIAPH2,PLXND1,RAPGEF6,KREMEN1,VAV3,SEMA4B,RBM47,DOCK2,PTPN6,DISC1,PTPRC,SYK,PREX2,SLC9A1 |
2.529e-02 | -3.68 | STX6 (syntaxin 6) | protein interactions | 10228 | 444 | 4 | 19454 | 49 |
BMP2K,DAB2,GAB1,OSBPL8 |
2.534e-02 | -3.68 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 2 | 19454 | 49 |
PTPN6,SYK |
2.534e-02 | -3.68 | VAV2 (vav guanine nucleotide exchange factor 2) | protein interactions | 7410 | 98 | 2 | 19454 | 49 |
GAB1,SYK |
2.534e-02 | -3.68 | GPRC5B (G protein-coupled receptor class C group 5 member B) | protein interactions | 51704 | 98 | 2 | 19454 | 49 |
ACACB,RHBDF2 |
2.536e-02 | -3.67 | immunoglobulin complex | cellular component | GO:0019814 | 10 | 1 | 19108 | 49 |
SYK |
2.542e-02 | -3.67 | regulation of hemopoiesis | biological process | GO:1903706 | 425 | 4 | 18204 | 48 |
PTPN6,PTPRC,TMEM131L,SYK |
2.542e-02 | -3.67 | leukocyte differentiation | biological process | GO:0002521 | 425 | 4 | 18204 | 48 |
DOCK2,SYK,PTPRC,PREX1 |
2.546e-02 | -3.67 | cell-substrate junction | cellular component | GO:0030055 | 437 | 4 | 19108 | 49 |
SLC9A1,PTPRC,HCK,DAB2 |
2.551e-02 | -3.67 | regulation of calcium-mediated signaling | biological process | GO:0050848 | 94 | 2 | 18204 | 48 |
SLC9A1,SYK |
2.551e-02 | -3.67 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 48 |
RAPGEF6,PREX1,OSBPL8,FCHO2,HCK,SLC9A1 |
2.555e-02 | -3.67 | ORF7b (ORF7b protein) | protein interactions | 1489675 | 252 | 3 | 19454 | 49 |
RHBDF2,SEMA4B,GALNT1 |
2.582e-02 | -3.66 | ARPC5 (actin related protein 2/3 complex subunit 5) | protein interactions | 10092 | 99 | 2 | 19454 | 49 |
ASCC3,VMP1 |
2.582e-02 | -3.66 | LMTK2 (lemur tyrosine kinase 2) | protein interactions | 22853 | 99 | 2 | 19454 | 49 |
PPP1R7,PTPN6 |
2.594e-02 | -3.65 | human chr9q22.2 | chromosome location | human chr9q22.2 | 14 | 1 | 26134 | 49 |
SYK |
2.595e-02 | -3.65 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | 413 | 4 | 16828 | 46 |
PTPRC,SLC9A1,SH2B3,DIAPH2 |
2.595e-02 | -3.65 | myelofibrosis | COSMIC cancer mutations | myelofibrosis | 413 | 4 | 16828 | 46 |
SH2B3,DIAPH2,PTPRC,SLC9A1 |
2.595e-02 | -3.65 | response to organic substance | biological process | GO:0010033 | 2498 | 12 | 18204 | 48 |
DOCK8,PTPRC,SYK,PTPN6,SLC9A1,DAB2,HCK,GAB1,SH2B3,PTGIR,ACER2,ACACB |
2.600e-02 | -3.65 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 48 |
GAB1,SYK,SH2B3,HCK |
2.606e-02 | -3.65 | regulation of Fc receptor mediated stimulatory signaling pathway | biological process | GO:0060368 | 10 | 1 | 18204 | 48 |
PTPRC |
2.606e-02 | -3.65 | establishment of lymphocyte polarity | biological process | GO:0001767 | 10 | 1 | 18204 | 48 |
DOCK2 |
2.606e-02 | -3.65 | protein O-linked glycosylation via threonine | biological process | GO:0018243 | 10 | 1 | 18204 | 48 |
GALNT1 |
2.606e-02 | -3.65 | endothelial cell chemotaxis | biological process | GO:0035767 | 10 | 1 | 18204 | 48 |
GAB1 |
2.606e-02 | -3.65 | negative regulation of T cell mediated cytotoxicity | biological process | GO:0001915 | 10 | 1 | 18204 | 48 |
PTPRC |
2.606e-02 | -3.65 | negative regulation of mast cell activation | biological process | GO:0033004 | 10 | 1 | 18204 | 48 |
PTPN6 |
2.606e-02 | -3.65 | protein O-linked glycosylation via serine | biological process | GO:0018242 | 10 | 1 | 18204 | 48 |
GALNT1 |
2.606e-02 | -3.65 | negative regulation of T cell differentiation in thymus | biological process | GO:0033085 | 10 | 1 | 18204 | 48 |
TMEM131L |
2.615e-02 | -3.64 | 6-hairpin_glycosidase_sf | interpro domains | IPR008928 | 10 | 1 | 18521 | 49 |
PHKB |
2.615e-02 | -3.64 | Amino_oxidase | interpro domains | IPR002937 | 10 | 1 | 18521 | 49 |
SMOX |
2.615e-02 | -3.64 | Biotin_lipoyl | interpro domains | IPR000089 | 10 | 1 | 18521 | 49 |
ACACB |
2.615e-02 | -3.64 | TPR_2 | interpro domains | IPR013105 | 10 | 1 | 18521 | 49 |
TMTC1 |
2.615e-02 | -3.64 | HAT | interpro domains | IPR003107 | 10 | 1 | 18521 | 49 |
TMTC1 |
2.615e-02 | -3.64 | Plexin | interpro domains | IPR031148 | 10 | 1 | 18521 | 49 |
PLXND1 |
2.619e-02 | -3.64 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 2 | 18521 | 49 |
SYK,HCK |
2.619e-02 | -3.64 | response to xenobiotic stimulus | biological process | GO:0009410 | 429 | 4 | 18204 | 48 |
VAV3,SMOX,ACACB,ACER2 |
2.622e-02 | -3.64 | GDP phosphatase activity | molecular function | GO:0004382 | 10 | 1 | 18094 | 48 |
ENTPD1 |
2.622e-02 | -3.64 | prostaglandin receptor activity | molecular function | GO:0004955 | 10 | 1 | 18094 | 48 |
PTGIR |
2.622e-02 | -3.64 | aromatic amino acid transmembrane transporter activity | molecular function | GO:0015173 | 10 | 1 | 18094 | 48 |
SLC16A10 |
2.622e-02 | -3.64 | AP-2 adaptor complex binding | molecular function | GO:0035612 | 10 | 1 | 18094 | 48 |
BMP2K |
2.630e-02 | -3.64 | stomach | COSMIC cancer mutations | stomach | 15550 | 46 | 16828 | 46 |
ENTPD1,RAPGEF6,PPP1R7,RBM47,PLXND1,OSBPL8,STAB1,SYK,HCK,ASCC3,PTPRC,SMOX,DOCK8,FCHO2,PPFIBP2,ATP10D,NACC2,GAB1,PTPN6,TMTC1,DIAPH2,BLVRA,DISC1,ACACB,TMCC3,GRK6,SLC9A1,ATG14,SEMA4B,SH2B3,GALNT1,PTGIR,BMP2K,RHBDF2,PREX1,DOCK2,VMP1,VAV3,ACER2,MPP1,CADM4,SLC16A10,PREX2,KREMEN1,TFEB,DAB2 |
2.630e-02 | -3.64 | REPS1 (RALBP1 associated Eps domain containing 1) | protein interactions | 85021 | 100 | 2 | 19454 | 49 |
BMP2K,DAB2 |
2.630e-02 | -3.64 | AP2S1 (adaptor related protein complex 2 subunit sigma 1) | protein interactions | 1175 | 100 | 2 | 19454 | 49 |
BMP2K,FCHO2 |
2.639e-02 | -3.63 | UTP and CTP dephosphorylation II | BIOCYC pathways | HUMAN_PWY-7177 | 4 | 1 | 902 | 6 |
ENTPD1 |
2.639e-02 | -3.63 | heme degradation | BIOCYC pathways | HUMAN_PWY-5874 | 4 | 1 | 902 | 6 |
BLVRA |
2.653e-02 | -3.63 | regulation of muscle adaptation | biological process | GO:0043502 | 96 | 2 | 18204 | 48 |
SLC9A1,ACACB |
2.656e-02 | -3.63 | glycosaminoglycan binding | molecular function | GO:0005539 | 243 | 3 | 18094 | 48 |
STAB1,CEMIP,PTPRC |
2.659e-02 | -3.63 | response to wounding | biological process | GO:0009611 | 431 | 4 | 18204 | 48 |
VAV3,ENTPD1,PTPN6,SYK |
2.666e-02 | -3.62 | Amino_oxidase | pfam domains | PF01593 | 10 | 1 | 17795 | 48 |
SMOX |
2.666e-02 | -3.62 | TPR_2 | pfam domains | PF07719 | 10 | 1 | 17795 | 48 |
TMTC1 |
2.671e-02 | -3.62 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 7 | 18204 | 48 |
DOCK2,PLXND1,DAB2,HCK,DISC1,PTPRC,SYK |
2.678e-02 | -3.62 | GJD3 (gap junction protein delta 3) | protein interactions | 125111 | 452 | 4 | 19454 | 49 |
GAB1,OSBPL8,VMP1,SLC9A1 |
2.679e-02 | -3.62 | DPP9 (dipeptidyl peptidase 9) | protein interactions | 91039 | 101 | 2 | 19454 | 49 |
SYK,CADM4 |
2.679e-02 | -3.62 | DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1) | protein interactions | 1780 | 101 | 2 | 19454 | 49 |
DISC1,CADM4 |
2.690e-02 | -3.62 | Protein tyrosine phosphatase superfamily | gene3d domains | 3.90.190.10 | 88 | 2 | 14470 | 42 |
PTPRC,PTPN6 |
2.694e-02 | -3.61 | regulation of catabolic process | biological process | GO:0009894 | 1124 | 7 | 18204 | 48 |
ATG14,DISC1,TFEB,ACACB,ACER2,DAB2,RBM47 |
2.701e-02 | -3.61 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 46 |
PREX2 |
2.701e-02 | -3.61 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 46 |
NACC2 |
2.705e-02 | -3.61 | SM22CALPONIN | prints domains | PR00888 | 11 | 1 | 5227 | 13 |
VAV3 |
2.727e-02 | -3.60 | regulation of leukocyte mediated immunity | biological process | GO:0002703 | 247 | 3 | 18204 | 48 |
PTPN6,SYK,PTPRC |
2.728e-02 | -3.60 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 2 | 19454 | 49 |
GAB1,SYK |
2.735e-02 | -3.60 | hydrolase activity, hydrolyzing O-glycosyl compounds | molecular function | GO:0004553 | 97 | 2 | 18094 | 48 |
CEMIP,ACER2 |
2.737e-02 | -3.60 | Fcho2 (FCH domain only 2) | protein interactions | 218503 | 11 | 1 | 19454 | 49 |
DAB2 |
2.737e-02 | -3.60 | CCDC141 (coiled-coil domain containing 141) | protein interactions | 285025 | 11 | 1 | 19454 | 49 |
DISC1 |
2.737e-02 | -3.60 | RUBCNL (rubicon like autophagy enhancer) | protein interactions | 80183 | 11 | 1 | 19454 | 49 |
GRK6 |
2.737e-02 | -3.60 | TESC (tescalcin) | protein interactions | 54997 | 11 | 1 | 19454 | 49 |
SLC9A1 |
2.737e-02 | -3.60 | EEIG2 (EEIG family member 2) | protein interactions | 284611 | 11 | 1 | 19454 | 49 |
MPP1 |
2.737e-02 | -3.60 | LAT2 (linker for activation of T cells family member 2) | protein interactions | 7462 | 11 | 1 | 19454 | 49 |
GAB1 |
2.737e-02 | -3.60 | RGS1 (regulator of G protein signaling 1) | protein interactions | 5996 | 11 | 1 | 19454 | 49 |
ACACB |
2.737e-02 | -3.60 | LAX1 (lymphocyte transmembrane adaptor 1) | protein interactions | 54900 | 11 | 1 | 19454 | 49 |
SYK |
2.737e-02 | -3.60 | catabolic process | biological process | GO:0009056 | 1936 | 10 | 18204 | 48 |
TFEB,BLVRA,DISC1,ATG14,CEMIP,VMP1,SMOX,ENTPD1,ASCC3,ACER2 |
2.738e-02 | -3.60 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 4 | 18204 | 48 |
SYK,GAB1,VAV3,PLXND1 |
2.753e-02 | -3.59 | large_intestine-colon-adenoma | COSMIC cancer mutations | large_intestine-colon-adenoma | 627 | 5 | 16828 | 46 |
PREX1,TMTC1,SYK,STAB1,HCK |
2.767e-02 | -3.59 | Sodium/Proton exchangers | REACTOME pathways | R-HSA-425986 | 9 | 1 | 10285 | 32 |
SLC9A1 |
2.767e-02 | -3.59 | Formation of annular gap junctions | REACTOME pathways | R-HSA-196025 | 9 | 1 | 10285 | 32 |
DAB2 |
2.767e-02 | -3.59 | ChREBP activates metabolic gene expression | REACTOME pathways | R-HSA-163765 | 9 | 1 | 10285 | 32 |
ACACB |
2.767e-02 | -3.59 | Prostanoid ligand receptors | REACTOME pathways | R-HSA-391908 | 9 | 1 | 10285 | 32 |
PTGIR |
2.773e-02 | -3.59 | BEN | prosite domains | PS51457 | 9 | 1 | 12186 | 38 |
NACC2 |
2.774e-02 | -3.58 | NUP155 (nucleoporin 155) | protein interactions | 9631 | 457 | 4 | 19454 | 49 |
OSBPL8,VMP1,DAB2,TMCC3 |
2.777e-02 | -3.58 | human chr9p24.3 | chromosome location | human chr9p24.3 | 15 | 1 | 26134 | 49 |
DOCK8 |
2.777e-02 | -3.58 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 49 |
OSBPL8 |
2.777e-02 | -3.58 | human chr17q23.1 | chromosome location | human chr17q23.1 | 15 | 1 | 26134 | 49 |
VMP1 |
2.788e-02 | -3.58 | Fc epsilon RI signaling pathway | KEGG pathways | hsa04664 | 67 | 2 | 7161 | 28 |
SYK,VAV3 |
2.788e-02 | -3.58 | Fc epsilon RI signaling pathway | KEGG pathways | ko04664 | 67 | 2 | 7161 | 28 |
VAV3,SYK |
2.797e-02 | -3.58 | negative regulation of signal transduction | biological process | GO:0009968 | 1393 | 8 | 18204 | 48 |
PTGIR,DAB2,CADM4,SH2B3,KREMEN1,TMEM131L,PTPRC,PTPN6 |
2.808e-02 | -3.57 | negative regulation of leukocyte proliferation | biological process | GO:0070664 | 99 | 2 | 18204 | 48 |
PTPN6,TMEM131L |
2.808e-02 | -3.57 | negative regulation of cytokine-mediated signaling pathway | biological process | GO:0001960 | 99 | 2 | 18204 | 48 |
PTPRC,SH2B3 |
2.812e-02 | -3.57 | TYR_PHOSPHATASE_2 | prosite domains | PS50056 | 84 | 2 | 12186 | 38 |
PTPRC,PTPN6 |
2.828e-02 | -3.57 | ARHGAP18 (Rho GTPase activating protein 18) | protein interactions | 93663 | 104 | 2 | 19454 | 49 |
PREX2,BMP2K |
2.863e-02 | -3.55 | positive regulation of steroid hormone secretion | biological process | GO:2000833 | 11 | 1 | 18204 | 48 |
DAB2 |
2.863e-02 | -3.55 | pigment catabolic process | biological process | GO:0046149 | 11 | 1 | 18204 | 48 |
BLVRA |
2.863e-02 | -3.55 | cellular response to epinephrine stimulus | biological process | GO:0071872 | 11 | 1 | 18204 | 48 |
SLC9A1 |
2.863e-02 | -3.55 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 48 |
SH2B3 |
2.863e-02 | -3.55 | positive regulation of isotype switching to IgG isotypes | biological process | GO:0048304 | 11 | 1 | 18204 | 48 |
PTPRC |
2.863e-02 | -3.55 | heme catabolic process | biological process | GO:0042167 | 11 | 1 | 18204 | 48 |
BLVRA |
2.863e-02 | -3.55 | GDP metabolic process | biological process | GO:0046710 | 11 | 1 | 18204 | 48 |
MPP1 |
2.863e-02 | -3.55 | collagen-activated tyrosine kinase receptor signaling pathway | biological process | GO:0038063 | 11 | 1 | 18204 | 48 |
SYK |
2.863e-02 | -3.55 | pinocytosis | biological process | GO:0006907 | 11 | 1 | 18204 | 48 |
DOCK2 |
2.863e-02 | -3.55 | negative regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002924 | 11 | 1 | 18204 | 48 |
PTPN6 |
2.863e-02 | -3.55 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 48 |
DISC1 |
2.866e-02 | -3.55 | - | gene3d domains | 6.10.140.1330 | 10 | 1 | 14470 | 42 |
SLC9A1 |
2.866e-02 | -3.55 | - | gene3d domains | 3.30.70.3490 | 10 | 1 | 14470 | 42 |
OSBPL8 |
2.866e-02 | -3.55 | Rhomboid-like | gene3d domains | 1.20.1540.10 | 10 | 1 | 14470 | 42 |
RHBDF2 |
2.873e-02 | -3.55 | SM22_calponin | interpro domains | IPR003096 | 11 | 1 | 18521 | 49 |
VAV3 |
2.873e-02 | -3.55 | Single_hybrid_motif | interpro domains | IPR011053 | 11 | 1 | 18521 | 49 |
ACACB |
2.873e-02 | -3.55 | GBD/FH3_dom | interpro domains | IPR014768 | 11 | 1 | 18521 | 49 |
DIAPH2 |
2.873e-02 | -3.55 | Cation/H_exchanger_CPA1 | interpro domains | IPR018422 | 11 | 1 | 18521 | 49 |
SLC9A1 |
2.879e-02 | -3.55 | PFKP (phosphofructokinase, platelet) | protein interactions | 5214 | 264 | 3 | 19454 | 49 |
PTPN6,GAB1,GRK6 |
2.880e-02 | -3.55 | T cell receptor binding | molecular function | GO:0042608 | 11 | 1 | 18094 | 48 |
DOCK2 |
2.880e-02 | -3.55 | clathrin heavy chain binding | molecular function | GO:0032050 | 11 | 1 | 18094 | 48 |
CEMIP |
2.880e-02 | -3.55 | prostanoid receptor activity | molecular function | GO:0004954 | 11 | 1 | 18094 | 48 |
PTGIR |
2.892e-02 | -3.54 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 5 |
PTGIR |
2.893e-02 | -3.54 | protein tyrosine phosphatase activity | molecular function | GO:0004725 | 100 | 2 | 18094 | 48 |
PTPN6,PTPRC |
2.907e-02 | -3.54 | OSBPL8 (oxysterol binding protein like 8) | protein interactions | 114882 | 265 | 3 | 19454 | 49 |
PTGIR,SYK,DISC1 |
2.910e-02 | -3.54 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 9 | 16828 | 46 |
GAB1,PTPN6,PTPRC,STAB1,SMOX,PREX2,SEMA4B,PPFIBP2,VAV3 |
2.910e-02 | -3.54 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 9 | 16828 | 46 |
PTPRC,PTPN6,GAB1,VAV3,PPFIBP2,SEMA4B,SMOX,PREX2,STAB1 |
2.911e-02 | -3.54 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 4 | 19454 | 49 |
MPP1,DAB2,SLC9A1,GAB1 |
2.914e-02 | -3.54 | protein O-linked glycosylation | biological process | GO:0006493 | 101 | 2 | 18204 | 48 |
TMTC1,GALNT1 |
2.933e-02 | -3.53 | Prot-tyrosine_phosphatase-like | interpro domains | IPR029021 | 101 | 2 | 18521 | 49 |
PTPRC,PTPN6 |
2.941e-02 | -3.53 | molecular adaptor activity | molecular function | GO:0060090 | 1138 | 7 | 18094 | 48 |
SLC9A1,SH2B3,DISC1,RBM47,DAB2,ATG14,GAB1 |
2.943e-02 | -3.53 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 2 | 16828 | 46 |
DIAPH2,VAV3 |
2.951e-02 | -3.52 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 46 |
HCK,BMP2K,SYK,GRK6 |
2.951e-02 | -3.52 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 46 |
BMP2K,HCK,SYK,GRK6 |
2.951e-02 | -3.52 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 49 |
DIAPH2,FCHO2,RAPGEF6,DOCK8 |
2.952e-02 | -3.52 | Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain | gene3d domains | 1.10.10.10 | 232 | 3 | 14470 | 42 |
ASCC3,PREX2,PREX1 |
2.967e-02 | -3.52 | skin-hand-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-hand-malignant_melanoma-acral_lentiginous | 11 | 1 | 16828 | 46 |
PREX2 |
2.967e-02 | -3.52 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 46 |
PREX2 |
2.967e-02 | -3.52 | regulation of interleukin-8 production | biological process | GO:0032677 | 102 | 2 | 18204 | 48 |
SYK,PTPRC |
2.980e-02 | -3.51 | APLP2 (amyloid beta precursor like protein 2) | protein interactions | 334 | 107 | 2 | 19454 | 49 |
DAB2,DISC1 |
2.982e-02 | -3.51 | TENM4 (teneurin transmembrane protein 4) | protein interactions | 26011 | 12 | 1 | 19454 | 49 |
DOCK2 |
2.982e-02 | -3.51 | ANO5 (anoctamin 5) | protein interactions | 203859 | 12 | 1 | 19454 | 49 |
PTGIR |
2.982e-02 | -3.51 | RTL6 (retrotransposon Gag like 6) | protein interactions | 84247 | 12 | 1 | 19454 | 49 |
PPFIBP2 |
2.982e-02 | -3.51 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 49 |
PTPN6 |
2.982e-02 | -3.51 | NUDT4 (nudix hydrolase 4) | protein interactions | 11163 | 12 | 1 | 19454 | 49 |
DISC1 |
2.982e-02 | -3.51 | IGKV1-5 (immunoglobulin kappa variable 1-5) | protein interactions | 28299 | 12 | 1 | 19454 | 49 |
CEMIP |
2.982e-02 | -3.51 | ZNF584 (zinc finger protein 584) | protein interactions | 201514 | 12 | 1 | 19454 | 49 |
MPP1 |
2.982e-02 | -3.51 | CIART (circadian associated repressor of transcription) | protein interactions | 148523 | 12 | 1 | 19454 | 49 |
BLVRA |
2.982e-02 | -3.51 | SIRPB1 (signal regulatory protein beta 1) | protein interactions | 10326 | 12 | 1 | 19454 | 49 |
SYK |
2.982e-02 | -3.51 | LTB4R (leukotriene B4 receptor) | protein interactions | 1241 | 12 | 1 | 19454 | 49 |
GRK6 |
2.982e-02 | -3.51 | TM7SF2 (transmembrane 7 superfamily member 2) | protein interactions | 7108 | 12 | 1 | 19454 | 49 |
DISC1 |
2.982e-02 | -3.51 | SSTR2 (somatostatin receptor 2) | protein interactions | 6752 | 12 | 1 | 19454 | 49 |
PTPN6 |
2.982e-02 | -3.51 | C8orf76 (chromosome 8 open reading frame 76) | protein interactions | 84933 | 12 | 1 | 19454 | 49 |
DISC1 |
2.982e-02 | -3.51 | PNMT (phenylethanolamine N-methyltransferase) | protein interactions | 5409 | 12 | 1 | 19454 | 49 |
HCK |
2.987e-02 | -3.51 | Class I PI3K signaling events | Pathway Interaction DB | pi3kcipathway | 41 | 2 | 2226 | 15 |
PREX1,HCK |
2.988e-02 | -3.51 | positive regulation of growth | biological process | GO:0045927 | 256 | 3 | 18204 | 48 |
ACACB,SLC9A1,DISC1 |
2.988e-02 | -3.51 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 48 |
SLC9A1,NACC2,ACACB |
2.997e-02 | -3.51 | TyrKc | smart domains | SM00219 | 80 | 2 | 9717 | 33 |
HCK,SYK |
3.000e-02 | -3.51 | modified amino acid binding | molecular function | GO:0072341 | 102 | 2 | 18094 | 48 |
OSBPL8,FCHO2 |
3.017e-02 | -3.50 | Drf_FH3 | smart domains | SM01139 | 9 | 1 | 9717 | 33 |
DIAPH2 |
3.017e-02 | -3.50 | Drf_GBD | smart domains | SM01140 | 9 | 1 | 9717 | 33 |
DIAPH2 |
3.017e-02 | -3.50 | BEN | smart domains | SM01025 | 9 | 1 | 9717 | 33 |
NACC2 |
3.024e-02 | -3.50 | XPO1 (exportin 1) | protein interactions | 7514 | 1479 | 8 | 19454 | 49 |
FCHO2,GRK6,BMP2K,RAPGEF6,ASCC3,DAB2,DOCK8,TFEB |
3.028e-02 | -3.50 | regulation of innate immune response | biological process | GO:0045088 | 449 | 4 | 18204 | 48 |
HCK,PTPN6,SYK,RBM47 |
3.028e-02 | -3.50 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 48 |
PREX1,PLXND1,KREMEN1,DAB2,DISC1 |
3.040e-02 | -3.49 | Ig_E-set | interpro domains | IPR014756 | 103 | 2 | 18521 | 49 |
ASCC3,PLXND1 |
3.041e-02 | -3.49 | G alpha (12/13) signalling events | REACTOME pathways | R-HSA-416482 | 88 | 2 | 10285 | 32 |
VAV3,PREX1 |
3.069e-02 | -3.48 | MET receptor recycling | REACTOME pathways | R-HSA-8875656 | 10 | 1 | 10285 | 32 |
GAB1 |
3.069e-02 | -3.48 | Gap junction degradation | REACTOME pathways | R-HSA-190873 | 10 | 1 | 10285 | 32 |
DAB2 |
3.069e-02 | -3.48 | Signaling by FGFR3 fusions in cancer | REACTOME pathways | R-HSA-8853334 | 10 | 1 | 10285 | 32 |
GAB1 |
3.070e-02 | -3.48 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 45 | 16828 | 46 |
SMOX,FCHO2,DOCK8,PPFIBP2,HCK,PTPRC,ASCC3,BLVRA,DIAPH2,DISC1,ATP10D,NACC2,PTPN6,GAB1,TMTC1,ENTPD1,STAB1,SYK,RAPGEF6,PPP1R7,RBM47,PLXND1,OSBPL8,VMP1,DOCK2,VAV3,PTGIR,RHBDF2,PREX1,PREX2,TFEB,KREMEN1,DAB2,MPP1,ACER2,CADM4,SLC16A10,TMCC3,ACACB,SEMA4B,SH2B3,GALNT1,SLC9A1,GRK6,ATG14 |
3.071e-02 | -3.48 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 35 | 16828 | 46 |
PTPRC,PREX1,ASCC3,RHBDF2,BMP2K,PPFIBP2,VAV3,VMP1,DOCK8,DOCK2,SMOX,TMTC1,SLC16A10,GAB1,CADM4,PTPN6,NACC2,ACER2,ATP10D,DAB2,KREMEN1,PREX2,DIAPH2,BLVRA,ACACB,TMCC3,ENTPD1,OSBPL8,ATG14,GRK6,PLXND1,SYK,SH2B3,STAB1,SEMA4B |
3.071e-02 | -3.48 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 35 | 16828 | 46 |
ACACB,ENTPD1,TMCC3,PLXND1,GRK6,ATG14,OSBPL8,SEMA4B,SH2B3,STAB1,SYK,BMP2K,RHBDF2,PREX1,ASCC3,PTPRC,SMOX,DOCK2,DOCK8,VMP1,VAV3,PPFIBP2,ATP10D,ACER2,NACC2,GAB1,PTPN6,CADM4,SLC16A10,TMTC1,DIAPH2,BLVRA,PREX2,KREMEN1,DAB2 |
3.075e-02 | -3.48 | epithelial cell migration | biological process | GO:0010631 | 104 | 2 | 18204 | 48 |
GAB1,PLXND1 |
3.075e-02 | -3.48 | regulation of dephosphorylation | biological process | GO:0035303 | 104 | 2 | 18204 | 48 |
PPP1R7,PTPRC |
3.075e-02 | -3.48 | protein polymerization | biological process | GO:0051258 | 104 | 2 | 18204 | 48 |
PREX1,DIAPH2 |
3.075e-02 | -3.48 | negative regulation of response to cytokine stimulus | biological process | GO:0060761 | 104 | 2 | 18204 | 48 |
PTPRC,SH2B3 |
3.075e-02 | -3.48 | positive regulation of ubiquitin-dependent protein catabolic process | biological process | GO:2000060 | 104 | 2 | 18204 | 48 |
DAB2,DISC1 |
3.076e-02 | -3.48 | BIOTINYL_LIPOYL | prosite domains | PS50968 | 10 | 1 | 12186 | 38 |
ACACB |
3.079e-02 | -3.48 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 5 | 18204 | 48 |
DAB2,PTPN6,SH2B3,SYK,PTPRC |
3.083e-02 | -3.48 | RPL10L (ribosomal protein L10 like) | protein interactions | 140801 | 109 | 2 | 19454 | 49 |
PTPN6,CEMIP |
3.083e-02 | -3.48 | TMEM9B (TMEM9 domain family member B) | protein interactions | 56674 | 109 | 2 | 19454 | 49 |
OSBPL8,RHBDF2 |
3.091e-02 | -3.48 | carbohydrate derivative binding | molecular function | GO:0097367 | 2251 | 11 | 18094 | 48 |
ASCC3,BMP2K,GRK6,ENTPD1,SYK,ATP10D,ACACB,CEMIP,PTPRC,HCK,STAB1 |
3.100e-02 | -3.47 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 7 | 19454 | 49 |
PPFIBP2,TMCC3,DISC1,RAPGEF6,GAB1,TFEB,OSBPL8 |
3.120e-02 | -3.47 | negative regulation of vascular endothelial growth factor receptor signaling pathway | biological process | GO:0030948 | 12 | 1 | 18204 | 48 |
CADM4 |
3.120e-02 | -3.47 | regulation of immature T cell proliferation in thymus | biological process | GO:0033084 | 12 | 1 | 18204 | 48 |
TMEM131L |
3.120e-02 | -3.47 | regulation of immature T cell proliferation | biological process | GO:0033083 | 12 | 1 | 18204 | 48 |
TMEM131L |
3.120e-02 | -3.47 | cytidine to uridine editing | biological process | GO:0016554 | 12 | 1 | 18204 | 48 |
RBM47 |
3.120e-02 | -3.47 | thyroid hormone transport | biological process | GO:0070327 | 12 | 1 | 18204 | 48 |
SLC16A10 |
3.120e-02 | -3.47 | cellular response to antibiotic | biological process | GO:0071236 | 12 | 1 | 18204 | 48 |
SLC9A1 |
3.120e-02 | -3.47 | regulation of protein glycosylation | biological process | GO:0060049 | 12 | 1 | 18204 | 48 |
ACER2 |
3.120e-02 | -3.47 | aromatic amino acid transport | biological process | GO:0015801 | 12 | 1 | 18204 | 48 |
SLC16A10 |
3.120e-02 | -3.47 | DNA alkylation repair | biological process | GO:0006307 | 12 | 1 | 18204 | 48 |
ASCC3 |
3.120e-02 | -3.47 | serotonin transport | biological process | GO:0006837 | 12 | 1 | 18204 | 48 |
SYK |
3.120e-02 | -3.47 | regulation of chemokine-mediated signaling pathway | biological process | GO:0070099 | 12 | 1 | 18204 | 48 |
SH2B3 |
3.120e-02 | -3.47 | regulation of inflammatory response to wounding | biological process | GO:0106014 | 12 | 1 | 18204 | 48 |
PTPN6 |
3.120e-02 | -3.47 | negative regulation of cell adhesion mediated by integrin | biological process | GO:0033629 | 12 | 1 | 18204 | 48 |
ACER2 |
3.120e-02 | -3.47 | cellular response to electrical stimulus | biological process | GO:0071257 | 12 | 1 | 18204 | 48 |
SLC9A1 |
3.130e-02 | -3.46 | OSBP_sf | interpro domains | IPR037239 | 12 | 1 | 18521 | 49 |
OSBPL8 |
3.130e-02 | -3.46 | Oxysterol-bd_CS | interpro domains | IPR018494 | 12 | 1 | 18521 | 49 |
OSBPL8 |
3.130e-02 | -3.46 | PreATP-grasp_dom_sf | interpro domains | IPR016185 | 12 | 1 | 18521 | 49 |
ACACB |
3.130e-02 | -3.46 | Oxysterol-bd | interpro domains | IPR000648 | 12 | 1 | 18521 | 49 |
OSBPL8 |
3.138e-02 | -3.46 | semaphorin receptor activity | molecular function | GO:0017154 | 12 | 1 | 18094 | 48 |
PLXND1 |
3.138e-02 | -3.46 | non-membrane spanning protein tyrosine phosphatase activity | molecular function | GO:0004726 | 12 | 1 | 18094 | 48 |
PTPN6 |
3.138e-02 | -3.46 | phosphatidylinositol 3-kinase regulator activity | molecular function | GO:0035014 | 12 | 1 | 18094 | 48 |
ATG14 |
3.139e-02 | -3.46 | positive regulation of immune effector process | biological process | GO:0002699 | 261 | 3 | 18204 | 48 |
SYK,PTPRC,PTPN6 |
3.150e-02 | -3.46 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 4 | 16828 | 46 |
BMP2K,HCK,SYK,GRK6 |
3.157e-02 | -3.46 | regulation of cellular catabolic process | biological process | GO:0031329 | 455 | 4 | 18204 | 48 |
TFEB,ATG14,ACER2,ACACB |
3.160e-02 | -3.45 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 11 | 16828 | 46 |
HCK,BMP2K,PTPRC,STAB1,PREX2,DAB2,SYK,TFEB,GALNT1,GRK6,PLXND1 |
3.164e-02 | -3.45 | phosphatase regulator activity | molecular function | GO:0019208 | 105 | 2 | 18094 | 48 |
PPP1R7,BMP2K |
3.165e-02 | -3.45 | ACTBL2 (actin beta like 2) | protein interactions | 345651 | 274 | 3 | 19454 | 49 |
OSBPL8,DISC1,VMP1 |
3.165e-02 | -3.45 | PANX1 (pannexin 1) | protein interactions | 24145 | 274 | 3 | 19454 | 49 |
SLC9A1,VMP1,OSBPL8 |
3.190e-02 | -3.45 | Oxysterol_BP | pfam domains | PF01237 | 12 | 1 | 17795 | 48 |
OSBPL8 |
3.223e-02 | -3.43 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 48 |
PLXND1,DISC1,SYK,PTPRC |
3.224e-02 | -3.43 | RBBP5 (RB binding protein 5, histone lysine methyltransferase complex subunit) | protein interactions | 5929 | 276 | 3 | 19454 | 49 |
ACACB,DISC1,PHKB |
3.226e-02 | -3.43 | CHP2 (calcineurin like EF-hand protein 2) | protein interactions | 63928 | 13 | 1 | 19454 | 49 |
SLC9A1 |
3.226e-02 | -3.43 | RPC11 (DNA-directed RNA polymerase III core subunit RPC11) | protein interactions | 851615 | 13 | 1 | 19454 | 49 |
PPFIBP2 |
3.226e-02 | -3.43 | OTOA (otoancorin) | protein interactions | 146183 | 13 | 1 | 19454 | 49 |
GALNT1 |
3.226e-02 | -3.43 | NFAM1 (NFAT activating protein with ITAM motif 1) | protein interactions | 150372 | 13 | 1 | 19454 | 49 |
SYK |
3.226e-02 | -3.43 | CEACAM16 (CEA cell adhesion molecule 16, tectorial membrane component) | protein interactions | 388551 | 13 | 1 | 19454 | 49 |
MPP1 |
3.226e-02 | -3.43 | C1orf74 (chromosome 1 open reading frame 74) | protein interactions | 148304 | 13 | 1 | 19454 | 49 |
HCK |
3.226e-02 | -3.43 | Kif20b (kinesin family member 20B) | protein interactions | 240641 | 13 | 1 | 19454 | 49 |
DIAPH2 |
3.226e-02 | -3.43 | CRYGC (crystallin gamma C) | protein interactions | 1420 | 13 | 1 | 19454 | 49 |
DISC1 |
3.226e-02 | -3.43 | PPP1R2B (PPP1R2 family member B) | protein interactions | 153743 | 13 | 1 | 19454 | 49 |
BMP2K |
3.232e-02 | -3.43 | bone-sacrum-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-sacrum-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 12 | 1 | 16828 | 46 |
STAB1 |
3.232e-02 | -3.43 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 46 |
PREX2 |
3.232e-02 | -3.43 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 46 |
NACC2 |
3.234e-02 | -3.43 | Platelet homeostasis | REACTOME pathways | R-HSA-418346 | 91 | 2 | 10285 | 32 |
PTGIR,PTPN6 |
3.240e-02 | -3.43 | T cell receptor signaling pathway | biological process | GO:0050852 | 107 | 2 | 18204 | 48 |
PTPN6,PTPRC |
3.240e-02 | -3.43 | epithelium migration | biological process | GO:0090132 | 107 | 2 | 18204 | 48 |
PLXND1,GAB1 |
3.241e-02 | -3.43 | GLG1 (golgi glycoprotein 1) | protein interactions | 2734 | 112 | 2 | 19454 | 49 |
SYK,OSBPL8 |
3.241e-02 | -3.43 | C10orf88 (chromosome 10 open reading frame 88) | protein interactions | 80007 | 112 | 2 | 19454 | 49 |
RBM47,BMP2K |
3.241e-02 | -3.43 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 2 | 19454 | 49 |
OSBPL8,PTGIR |
3.246e-02 | -3.43 | immune system process | biological process | GO:0002376 | 1991 | 10 | 18204 | 48 |
HCK,PREX1,DOCK2,SH2B3,VAV3,DOCK8,TFEB,SYK,PTPRC,PTPN6 |
3.262e-02 | -3.42 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 48 |
DAB2,KREMEN1,TMEM131L |
3.281e-02 | -3.42 | endoplasmic reticulum membrane | cellular component | GO:0005789 | 1204 | 7 | 19108 | 49 |
ATG14,OSBPL8,RHBDF2,GALNT1,ATP10D,TMCC3,VMP1 |
3.284e-02 | -3.42 | early phagosome | cellular component | GO:0032009 | 13 | 1 | 19108 | 49 |
SYK |
3.284e-02 | -3.42 | semaphorin receptor complex | cellular component | GO:0002116 | 13 | 1 | 19108 | 49 |
PLXND1 |
3.289e-02 | -3.41 | response to bacterium | biological process | GO:0009617 | 681 | 5 | 18204 | 48 |
STAB1,SYK,TFEB,HCK,PTGIR |
3.289e-02 | -3.41 | fatty acid biosynthesis initiation | BIOCYC pathways | HUMAN_PWY-5966-1 | 5 | 1 | 902 | 6 |
ACACB |
3.289e-02 | -3.41 | mucin core 1 and core 2 O-glycosylation | BIOCYC pathways | META_PWY-7433 | 5 | 1 | 902 | 6 |
GALNT1 |
3.294e-02 | -3.41 | LAT (linker for activation of T cells) | protein interactions | 27040 | 113 | 2 | 19454 | 49 |
PTPN6,SYK |
3.319e-02 | -3.41 | SH3_1 | pfam domains | PF00018 | 106 | 2 | 17795 | 48 |
HCK,MPP1 |
3.323e-02 | -3.40 | human chr4p12 | chromosome location | human chr4p12 | 18 | 1 | 26134 | 49 |
ATP10D |
3.323e-02 | -3.40 | human chr4q21.21 | chromosome location | human chr4q21.21 | 18 | 1 | 26134 | 49 |
BMP2K |
3.325e-02 | -3.40 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 48 |
PLXND1,PREX1,KREMEN1,DAB2,DISC1 |
3.325e-02 | -3.40 | MTDH (metadherin) | protein interactions | 92140 | 484 | 4 | 19454 | 49 |
RHBDF2,SYK,DOCK2,DISC1 |
3.332e-02 | -3.40 | phosphatidylinositol bisphosphate binding | molecular function | GO:1902936 | 108 | 2 | 18094 | 48 |
FCHO2,SLC9A1 |
3.346e-02 | -3.40 | endoplasmic reticulum subcompartment | cellular component | GO:0098827 | 1209 | 7 | 19108 | 49 |
GALNT1,RHBDF2,OSBPL8,ATG14,VMP1,TMCC3,ATP10D |
3.346e-02 | -3.40 | HAT | smart domains | SM00386 | 10 | 1 | 9717 | 33 |
TMTC1 |
3.350e-02 | -3.40 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 14 | 16828 | 46 |
DOCK2,VAV3,PPFIBP2,PREX1,ASCC3,KREMEN1,GALNT1,DIAPH2,PREX2,RBM47,TMTC1,GAB1,PTPN6,NACC2 |
3.351e-02 | -3.40 | positive regulation of tumor necrosis factor production | biological process | GO:0032760 | 109 | 2 | 18204 | 48 |
PTPRC,SYK |
3.353e-02 | -3.40 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 27 | 16828 | 46 |
PPFIBP2,VAV3,DOCK8,DOCK2,SMOX,PTPRC,ASCC3,PREX1,HCK,RHBDF2,DAB2,KREMEN1,PREX2,TMTC1,GAB1,PTPN6,NACC2,MPP1,ATP10D,TMCC3,ENTPD1,ACACB,STAB1,SEMA4B,PLXND1,GRK6,RAPGEF6 |
3.362e-02 | -3.39 | Signaling by the B Cell Receptor (BCR) | REACTOME pathways | R-HSA-983705 | 229 | 3 | 10285 | 32 |
GAB1,SYK,PTPN6 |
3.371e-02 | -3.39 | Signaling by FGFR4 in disease | REACTOME pathways | R-HSA-5655291 | 11 | 1 | 10285 | 32 |
GAB1 |
3.371e-02 | -3.39 | MET activates RAP1 and RAC1 | REACTOME pathways | R-HSA-8875555 | 11 | 1 | 10285 | 32 |
GAB1 |
3.371e-02 | -3.39 | Biotin transport and metabolism | REACTOME pathways | R-HSA-196780 | 11 | 1 | 10285 | 32 |
ACACB |
3.375e-02 | -3.39 | porphyrin-containing compound catabolic process | biological process | GO:0006787 | 13 | 1 | 18204 | 48 |
BLVRA |
3.375e-02 | -3.39 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 48 |
SH2B3 |
3.375e-02 | -3.39 | protein localization to nuclear envelope | biological process | GO:0090435 | 13 | 1 | 18204 | 48 |
OSBPL8 |
3.375e-02 | -3.39 | type II interferon-mediated signaling pathway | biological process | GO:0060333 | 13 | 1 | 18204 | 48 |
HCK |
3.375e-02 | -3.39 | tetrapyrrole catabolic process | biological process | GO:0033015 | 13 | 1 | 18204 | 48 |
BLVRA |
3.375e-02 | -3.39 | negative regulation of platelet-derived growth factor receptor signaling pathway | biological process | GO:0010642 | 13 | 1 | 18204 | 48 |
PTGIR |
3.375e-02 | -3.39 | modulation of process of another organism | biological process | GO:0035821 | 13 | 1 | 18204 | 48 |
SYK |
3.375e-02 | -3.39 | cellular response to cold | biological process | GO:0070417 | 13 | 1 | 18204 | 48 |
SLC9A1 |
3.379e-02 | -3.39 | GBD_FH3 | prosite domains | PS51232 | 11 | 1 | 12186 | 38 |
DIAPH2 |
3.386e-02 | -3.39 | ATP-grasp | interpro domains | IPR011761 | 13 | 1 | 18521 | 49 |
ACACB |
3.388e-02 | -3.38 | regulation of actin filament organization | biological process | GO:0110053 | 269 | 3 | 18204 | 48 |
SLC9A1,HCK,PREX1 |
3.395e-02 | -3.38 | vascular endothelial growth factor receptor binding | molecular function | GO:0005172 | 13 | 1 | 18094 | 48 |
CADM4 |
3.401e-02 | -3.38 | PPARD (peroxisome proliferator activated receptor delta) | protein interactions | 5467 | 115 | 2 | 19454 | 49 |
NACC2,ACACB |
3.403e-02 | -3.38 | regulation of monoatomic ion transport | biological process | GO:0043269 | 466 | 4 | 18204 | 48 |
CEMIP,PTPN6,VMP1,SLC9A1 |
3.404e-02 | -3.38 | PGK1 (phosphoglycerate kinase 1) | protein interactions | 5230 | 282 | 3 | 19454 | 49 |
DISC1,ATG14,DOCK8 |
3.411e-02 | -3.38 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 22 | 16828 | 46 |
GAB1,ATP10D,MPP1,ACER2,TMTC1,PLXND1,DIAPH2,BLVRA,SEMA4B,DAB2,DISC1,SYK,TFEB,GALNT1,ACACB,PREX1,PTPRC,TMCC3,SMOX,VAV3,DOCK2,FCHO2 |
3.411e-02 | -3.38 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 22 | 16828 | 46 |
PTPRC,PREX1,ACACB,VAV3,FCHO2,DOCK2,TMCC3,SMOX,TMTC1,PLXND1,GAB1,MPP1,ACER2,ATP10D,DISC1,DAB2,GALNT1,TFEB,SYK,BLVRA,SEMA4B,DIAPH2 |
3.429e-02 | -3.37 | - | gene3d domains | 2.40.160.120 | 12 | 1 | 14470 | 42 |
OSBPL8 |
3.429e-02 | -3.37 | - | gene3d domains | 3.40.50.20 | 12 | 1 | 14470 | 42 |
ACACB |
3.430e-02 | -3.37 | KRINGLE | prints domains | PR00018 | 14 | 1 | 5227 | 13 |
KREMEN1 |
3.434e-02 | -3.37 | PSPC1 (paraspeckle component 1) | protein interactions | 55269 | 489 | 4 | 19454 | 49 |
DISC1,VAV3,ASCC3,OSBPL8 |
3.452e-02 | -3.37 | TPR_19 | pfam domains | PF14559 | 13 | 1 | 17795 | 48 |
TMTC1 |
3.455e-02 | -3.37 | ARL5A (ADP ribosylation factor like GTPase 5A) | protein interactions | 26225 | 116 | 2 | 19454 | 49 |
CADM4,ACACB |
3.455e-02 | -3.37 | CD4 (CD4 molecule) | protein interactions | 920 | 116 | 2 | 19454 | 49 |
SYK,PTPRC |
3.458e-02 | -3.36 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 2 | 12186 | 38 |
HCK,SYK |
3.459e-02 | -3.36 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 49 |
ENTPD1,HCK |
3.465e-02 | -3.36 | negative regulation of binding | biological process | GO:0051100 | 111 | 2 | 18204 | 48 |
DAB2,DISC1 |
3.465e-02 | -3.36 | positive regulation of lipid localization | biological process | GO:1905954 | 111 | 2 | 18204 | 48 |
DAB2,ACACB |
3.470e-02 | -3.36 | ZNF287 (zinc finger protein 287) | protein interactions | 57336 | 14 | 1 | 19454 | 49 |
MPP1 |
3.470e-02 | -3.36 | PHF13 (PHD finger protein 13) | protein interactions | 148479 | 14 | 1 | 19454 | 49 |
BLVRA |
3.470e-02 | -3.36 | TFEC (transcription factor EC) | protein interactions | 22797 | 14 | 1 | 19454 | 49 |
TFEB |
3.470e-02 | -3.36 | PNLIPRP2 (pancreatic lipase related protein 2 (gene/pseudogene)) | protein interactions | 5408 | 14 | 1 | 19454 | 49 |
GRK6 |
3.470e-02 | -3.36 | ITGAL (integrin subunit alpha L) | protein interactions | 3683 | 14 | 1 | 19454 | 49 |
PTPRC |
3.470e-02 | -3.36 | SPMIP4 (sperm microtubule inner protein 4) | protein interactions | 136895 | 14 | 1 | 19454 | 49 |
GRK6 |
3.470e-02 | -3.36 | GRK1 (G protein-coupled receptor kinase 1) | protein interactions | 6011 | 14 | 1 | 19454 | 49 |
GRK6 |
3.497e-02 | -3.35 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 46 |
PREX2 |
3.497e-02 | -3.35 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 46 |
PREX2 |
3.497e-02 | -3.35 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 46 |
NACC2 |
3.504e-02 | -3.35 | human chr14q22.3 | chromosome location | human chr14q22.3 | 19 | 1 | 26134 | 49 |
ATG14 |
3.514e-02 | -3.35 | autophagosome | cellular component | GO:0005776 | 115 | 2 | 19108 | 49 |
ATG14,VMP1 |
3.523e-02 | -3.35 | MAPK1 (mitogen-activated protein kinase 1) | protein interactions | 5594 | 493 | 4 | 19454 | 49 |
GAB1,PTPRC,BLVRA,SLC9A1 |
3.523e-02 | -3.35 | SEC62 (SEC62 homolog, preprotein translocation factor) | protein interactions | 7095 | 493 | 4 | 19454 | 49 |
OSBPL8,TMEM131L,SLC9A1,VMP1 |
3.527e-02 | -3.34 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 13 | 16828 | 46 |
ASCC3,BMP2K,HCK,ACACB,VMP1,DOCK2,SLC9A1,PLXND1,TMTC1,PTPN6,GALNT1,PREX2,DIAPH2 |
3.527e-02 | -3.34 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 13 | 16828 | 46 |
BMP2K,HCK,ACACB,ASCC3,VMP1,DOCK2,PTPN6,PLXND1,SLC9A1,TMTC1,PREX2,DIAPH2,GALNT1 |
3.532e-02 | -3.34 | phospholipid-translocating ATPase complex | cellular component | GO:1990531 | 14 | 1 | 19108 | 49 |
ATP10D |
3.533e-02 | -3.34 | rib | COSMIC cancer mutations | rib | 264 | 3 | 16828 | 46 |
ACACB,RHBDF2,ASCC3 |
3.549e-02 | -3.34 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 46 |
GRK6,SYK,HCK,BMP2K |
3.565e-02 | -3.33 | SLC22A9 (solute carrier family 22 member 9) | protein interactions | 114571 | 118 | 2 | 19454 | 49 |
TMEM131L,SLC16A10 |
3.565e-02 | -3.33 | B4GALT2 (beta-1,4-galactosyltransferase 2) | protein interactions | 8704 | 118 | 2 | 19454 | 49 |
NACC2,ASCC3 |
3.565e-02 | -3.33 | DNASE1L1 (deoxyribonuclease 1 like 1) | protein interactions | 1774 | 118 | 2 | 19454 | 49 |
PLXND1,CEMIP |
3.565e-02 | -3.33 | DNAAF10 (dynein axonemal assembly factor 10) | protein interactions | 116143 | 118 | 2 | 19454 | 49 |
PPP1R7,GRK6 |
3.567e-02 | -3.33 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 265 | 3 | 16828 | 46 |
SYK,HCK,SH2B3 |
3.567e-02 | -3.33 | OCLN (occludin) | protein interactions | 100506658 | 495 | 4 | 19454 | 49 |
GAB1,RHBDF2,RAPGEF6,FCHO2 |
3.570e-02 | -3.33 | cytokine receptor binding | molecular function | GO:0005126 | 273 | 3 | 18094 | 48 |
SH2B3,SYK,CADM4 |
3.578e-02 | -3.33 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 45 | 16828 | 46 |
ENTPD1,RAPGEF6,PPP1R7,PLXND1,RBM47,OSBPL8,STAB1,SYK,HCK,ASCC3,PTPRC,SMOX,DOCK8,FCHO2,PPFIBP2,ATP10D,GAB1,PTPN6,TMTC1,BLVRA,DIAPH2,DISC1,ACACB,TMCC3,GRK6,SLC9A1,ATG14,SEMA4B,SH2B3,GALNT1,BMP2K,PTGIR,RHBDF2,PREX1,DOCK2,VMP1,VAV3,MPP1,ACER2,CADM4,SLC16A10,PREX2,KREMEN1,TFEB,DAB2 |
3.579e-02 | -3.33 | positive regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903557 | 113 | 2 | 18204 | 48 |
PTPRC,SYK |
3.579e-02 | -3.33 | tissue migration | biological process | GO:0090130 | 113 | 2 | 18204 | 48 |
GAB1,PLXND1 |
3.584e-02 | -3.33 | nuclear outer membrane-endoplasmic reticulum membrane network | cellular component | GO:0042175 | 1227 | 7 | 19108 | 49 |
OSBPL8,ATG14,GALNT1,RHBDF2,TMCC3,ATP10D,VMP1 |
3.598e-02 | -3.32 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 46 |
BMP2K,HCK,SYK,GRK6 |
3.619e-02 | -3.32 | signaling adaptor activity | molecular function | GO:0035591 | 113 | 2 | 18094 | 48 |
SH2B3,GAB1 |
3.620e-02 | -3.32 | UXT (ubiquitously expressed prefoldin like chaperone) | protein interactions | 8409 | 119 | 2 | 19454 | 49 |
PPP1R7,MPP1 |
3.620e-02 | -3.32 | MCM10 (minichromosome maintenance 10 replication initiation factor) | protein interactions | 55388 | 119 | 2 | 19454 | 49 |
ATG14,DISC1 |
3.630e-02 | -3.32 | negative regulation of fatty acid oxidation | biological process | GO:0046322 | 14 | 1 | 18204 | 48 |
ACACB |
3.630e-02 | -3.32 | pentose-phosphate shunt | biological process | GO:0006098 | 14 | 1 | 18204 | 48 |
ACACB |
3.630e-02 | -3.32 | regulation of protein complex stability | biological process | GO:0061635 | 14 | 1 | 18204 | 48 |
ATG14 |
3.630e-02 | -3.32 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 1 | 18204 | 48 |
SLC9A1 |
3.630e-02 | -3.32 | regulation of podosome assembly | biological process | GO:0071801 | 14 | 1 | 18204 | 48 |
HCK |
3.630e-02 | -3.32 | polyamine biosynthetic process | biological process | GO:0006596 | 14 | 1 | 18204 | 48 |
SMOX |
3.630e-02 | -3.32 | sphingosine biosynthetic process | biological process | GO:0046512 | 14 | 1 | 18204 | 48 |
ACER2 |
3.630e-02 | -3.32 | positive regulation of sodium ion transmembrane transporter activity | biological process | GO:2000651 | 14 | 1 | 18204 | 48 |
SLC9A1 |
3.630e-02 | -3.32 | response to epinephrine | biological process | GO:0071871 | 14 | 1 | 18204 | 48 |
SLC9A1 |
3.630e-02 | -3.32 | sphingoid biosynthetic process | biological process | GO:0046520 | 14 | 1 | 18204 | 48 |
ACER2 |
3.635e-02 | -3.31 | p75 NTR receptor-mediated signalling | REACTOME pathways | R-HSA-193704 | 97 | 2 | 10285 | 32 |
VAV3,PREX1 |
3.637e-02 | -3.31 | regulation of cell killing | biological process | GO:0031341 | 114 | 2 | 18204 | 48 |
PTPRC,SYK |
3.642e-02 | -3.31 | MHD | interpro domains | IPR028565 | 14 | 1 | 18521 | 49 |
FCHO2 |
3.642e-02 | -3.31 | Rhomboid-like_sf | interpro domains | IPR035952 | 14 | 1 | 18521 | 49 |
RHBDF2 |
3.642e-02 | -3.31 | P_typ_ATPase_c | interpro domains | IPR032630 | 14 | 1 | 18521 | 49 |
ATP10D |
3.642e-02 | -3.31 | Cation/H_exchanger | interpro domains | IPR006153 | 14 | 1 | 18521 | 49 |
SLC9A1 |
3.642e-02 | -3.31 | P-type_ATPase_IV | interpro domains | IPR006539 | 14 | 1 | 18521 | 49 |
ATP10D |
3.642e-02 | -3.31 | ATP_grasp_subdomain_1 | interpro domains | IPR013815 | 14 | 1 | 18521 | 49 |
ACACB |
3.642e-02 | -3.31 | Neurexin-like | interpro domains | IPR003585 | 14 | 1 | 18521 | 49 |
CADM4 |
3.642e-02 | -3.31 | P-type_ATPase_N | interpro domains | IPR032631 | 14 | 1 | 18521 | 49 |
ATP10D |
3.642e-02 | -3.31 | Link_dom | interpro domains | IPR000538 | 14 | 1 | 18521 | 49 |
STAB1 |
3.652e-02 | -3.31 | RRBP1 (ribosome binding protein 1) | protein interactions | 6238 | 290 | 3 | 19454 | 49 |
CEMIP,DISC1,RHBDF2 |
3.652e-02 | -3.31 | Toll-like receptor binding | molecular function | GO:0035325 | 14 | 1 | 18094 | 48 |
SYK |
3.652e-02 | -3.31 | potassium:proton antiporter activity | molecular function | GO:0015386 | 14 | 1 | 18094 | 48 |
SLC9A1 |
3.655e-02 | -3.31 | vacuolar membrane | cellular component | GO:0005774 | 490 | 4 | 19108 | 49 |
ATG14,DAB2,TFEB,VMP1 |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
SLC9A1,FCHO2,OSBPL8 |
3.672e-02 | -3.30 | PECAM1 interactions | REACTOME pathways | R-HSA-210990 | 12 | 1 | 10285 | 32 |
PTPN6 |
3.672e-02 | -3.30 | Hyaluronan uptake and degradation | REACTOME pathways | R-HSA-2160916 | 12 | 1 | 10285 | 32 |
SLC9A1 |
3.680e-02 | -3.30 | LINK_1 | prosite domains | PS01241 | 12 | 1 | 12186 | 38 |
STAB1 |
3.680e-02 | -3.30 | OSBP | prosite domains | PS01013 | 12 | 1 | 12186 | 38 |
OSBPL8 |
3.680e-02 | -3.30 | establishment of localization | biological process | GO:0051234 | 3887 | 16 | 18204 | 48 |
SLC9A1,VMP1,SYK,PTPRC,ATP10D,OSBPL8,HCK,DAB2,DOCK2,SLC16A10,RHBDF2,VAV3,FCHO2,STAB1,ATG14,ACACB |
3.685e-02 | -3.30 | human chr18q12.2 | chromosome location | human chr18q12.2 | 20 | 1 | 26134 | 49 |
GALNT1 |
3.703e-02 | -3.30 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 3 | 16828 | 46 |
SYK,SH2B3,HCK |
3.712e-02 | -3.29 | PhoLip_ATPase_N | pfam domains | PF16209 | 14 | 1 | 17795 | 48 |
ATP10D |
3.712e-02 | -3.29 | PhoLip_ATPase_C | pfam domains | PF16212 | 14 | 1 | 17795 | 48 |
ATP10D |
3.712e-02 | -3.29 | Na_H_Exchanger | pfam domains | PF00999 | 14 | 1 | 17795 | 48 |
SLC9A1 |
3.712e-02 | -3.29 | Xlink | pfam domains | PF00193 | 14 | 1 | 17795 | 48 |
STAB1 |
3.714e-02 | -3.29 | GALNT4 (polypeptide N-acetylgalactosaminyltransferase 4) | protein interactions | 8693 | 15 | 1 | 19454 | 49 |
GALNT1 |
3.714e-02 | -3.29 | ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) | protein interactions | 953 | 15 | 1 | 19454 | 49 |
ASCC3 |
3.714e-02 | -3.29 | FAM187B (family with sequence similarity 187 member B) | protein interactions | 148109 | 15 | 1 | 19454 | 49 |
OSBPL8 |
3.714e-02 | -3.29 | AANAT (aralkylamine N-acetyltransferase) | protein interactions | 15 | 15 | 1 | 19454 | 49 |
NACC2 |
3.714e-02 | -3.29 | PRSS22 (serine protease 22) | protein interactions | 64063 | 15 | 1 | 19454 | 49 |
GALNT1 |
3.714e-02 | -3.29 | UCP3 (uncoupling protein 3) | protein interactions | 7352 | 15 | 1 | 19454 | 49 |
RBM47 |
3.714e-02 | -3.29 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 1 | 19454 | 49 |
DISC1 |
3.714e-02 | -3.29 | SAMD3 (sterile alpha motif domain containing 3) | protein interactions | 154075 | 15 | 1 | 19454 | 49 |
ACACB |
3.715e-02 | -3.29 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 24 | 16828 | 46 |
ACACB,ENTPD1,RBM47,GRK6,PLXND1,SEMA4B,STAB1,SYK,PTGIR,RHBDF2,HCK,PREX1,ASCC3,PTPRC,DOCK2,DOCK8,FCHO2,PPFIBP2,CADM4,PTPN6,NACC2,DIAPH2,PREX2,KREMEN1 |
3.740e-02 | -3.29 | protein kinase binding | molecular function | GO:0019901 | 701 | 5 | 18094 | 48 |
PTPRC,CADM4,SYK,PTPN6,SH2B3 |
3.747e-02 | -3.28 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 46 |
BMP2K,HCK,SYK,GRK6 |
3.754e-02 | -3.28 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 46 |
ACACB,RAPGEF6,PTPRC,PREX2,SH2B3,STAB1,DOCK2,PPFIBP2 |
3.754e-02 | -3.28 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 46 |
PREX2,STAB1,SH2B3,DOCK2,PPFIBP2,RAPGEF6,ACACB,PTPRC |
3.754e-02 | -3.28 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | GO:0043280 | 116 | 2 | 18204 | 48 |
SYK,ACER2 |
3.754e-02 | -3.28 | regulation of alpha-beta T cell activation | biological process | GO:0046634 | 116 | 2 | 18204 | 48 |
SYK,PTPRC |
3.761e-02 | -3.28 | soft_tissue-fibrous_tissue_and_uncertain_origin-solitary_fibrous_tumour-malignant | COSMIC cancer mutations | soft_tissue-fibrous_tissue_and_uncertain_origin-solitary_fibrous_tumour-malignant | 14 | 1 | 16828 | 46 |
ASCC3 |
3.768e-02 | -3.28 | ATP binding | molecular function | GO:0005524 | 1467 | 8 | 18094 | 48 |
ACACB,HCK,ASCC3,SYK,ATP10D,BMP2K,GRK6,ENTPD1 |
3.773e-02 | -3.28 | Cargo recognition for clathrin-mediated endocytosis | REACTOME pathways | R-HSA-8856825 | 99 | 2 | 10285 | 32 |
FCHO2,DAB2 |
3.776e-02 | -3.28 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 4 | 18521 | 49 |
GRK6,SYK,BMP2K,HCK |
3.779e-02 | -3.28 | IGF2R (insulin like growth factor 2 receptor) | protein interactions | 3482 | 294 | 3 | 19454 | 49 |
SLC9A1,DISC1,RHBDF2 |
3.787e-02 | -3.27 | biological regulation | biological process | GO:0065007 | 12501 | 39 | 18204 | 48 |
DAB2,HCK,GRK6,RHBDF2,VMP1,OSBPL8,PPP1R7,TMEM131L,PREX1,ACER2,MPP1,SH2B3,BMP2K,ATG14,STAB1,GAB1,TFEB,SEMA4B,DOCK2,SLC16A10,RBM47,PREX2,SLC9A1,NACC2,PTPN6,PTPRC,SYK,DISC1,ATP10D,DOCK8,ACACB,PLXND1,PTGIR,ENTPD1,CADM4,VAV3,KREMEN1,CEMIP,RAPGEF6 |
3.788e-02 | -3.27 | HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) | protein interactions | 3123 | 122 | 2 | 19454 | 49 |
CADM4,TMEM131L |
3.797e-02 | -3.27 | actin filament | cellular component | GO:0005884 | 120 | 2 | 19108 | 49 |
DIAPH2,HCK |
3.811e-02 | -3.27 | ACTR2 (actin related protein 2) | protein interactions | 10097 | 295 | 3 | 19454 | 49 |
VMP1,DAB2,BLVRA |
3.825e-02 | -3.26 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 10 | 16828 | 46 |
ENTPD1,SMOX,DOCK2,NACC2,RHBDF2,HCK,PLXND1,PPP1R7,TMTC1,ASCC3 |
3.825e-02 | -3.26 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 10 | 16828 | 46 |
NACC2,RHBDF2,HCK,TMTC1,ASCC3,PPP1R7,PLXND1,ENTPD1,SMOX,DOCK2 |
3.844e-02 | -3.26 | PTK2 (protein tyrosine kinase 2) | protein interactions | 5747 | 296 | 3 | 19454 | 49 |
PTPN6,HCK,SYK |
3.854e-02 | -3.26 | export from cell | biological process | GO:0140352 | 485 | 4 | 18204 | 48 |
SLC16A10,SYK,HCK,SLC9A1 |
3.859e-02 | -3.25 | endometrium-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-endometrioid_carcinoma | 15680 | 46 | 16828 | 46 |
STAB1,SYK,RAPGEF6,PPP1R7,PLXND1,RBM47,OSBPL8,ENTPD1,BLVRA,DIAPH2,DISC1,ATP10D,GAB1,NACC2,PTPN6,TMTC1,SMOX,FCHO2,DOCK8,PPFIBP2,HCK,PTPRC,ASCC3,SEMA4B,SH2B3,GALNT1,GRK6,SLC9A1,ATG14,TMCC3,ACACB,PREX2,TFEB,KREMEN1,DAB2,MPP1,ACER2,CADM4,SLC16A10,VMP1,DOCK2,VAV3,BMP2K,PTGIR,RHBDF2,PREX1 |
3.862e-02 | -3.25 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 9 | 16828 | 46 |
ASCC3,GRK6,HCK,SYK,KREMEN1,DOCK2,VMP1,GALNT1,SEMA4B |
3.880e-02 | -3.25 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 2 | 16828 | 46 |
PREX2,RBM47 |
3.880e-02 | -3.25 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 46 |
PTPRC,PREX2 |
3.884e-02 | -3.25 | cellular response to acidic pH | biological process | GO:0071468 | 15 | 1 | 18204 | 48 |
SLC9A1 |
3.884e-02 | -3.25 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 48 |
DISC1 |
3.884e-02 | -3.25 | negative regulation of androgen receptor signaling pathway | biological process | GO:0060766 | 15 | 1 | 18204 | 48 |
DAB2 |
3.884e-02 | -3.25 | positive regulation of granulocyte macrophage colony-stimulating factor production | biological process | GO:0032725 | 15 | 1 | 18204 | 48 |
SYK |
3.884e-02 | -3.25 | regulation of sequestering of triglyceride | biological process | GO:0010889 | 15 | 1 | 18204 | 48 |
OSBPL8 |
3.884e-02 | -3.25 | negative regulation of axon regeneration | biological process | GO:0048681 | 15 | 1 | 18204 | 48 |
KREMEN1 |
3.884e-02 | -3.25 | negative regulation of B cell mediated immunity | biological process | GO:0002713 | 15 | 1 | 18204 | 48 |
PTPN6 |
3.884e-02 | -3.25 | negative regulation of immunoglobulin mediated immune response | biological process | GO:0002890 | 15 | 1 | 18204 | 48 |
PTPN6 |
3.884e-02 | -3.25 | neutrophil activation involved in immune response | biological process | GO:0002283 | 15 | 1 | 18204 | 48 |
SYK |
3.884e-02 | -3.25 | positive regulation of non-canonical Wnt signaling pathway | biological process | GO:2000052 | 15 | 1 | 18204 | 48 |
DAB2 |
3.884e-02 | -3.25 | positive regulation of monocyte chemotactic protein-1 production | biological process | GO:0071639 | 15 | 1 | 18204 | 48 |
SYK |
3.884e-02 | -3.25 | regulation of steroid hormone biosynthetic process | biological process | GO:0090030 | 15 | 1 | 18204 | 48 |
DAB2 |
3.884e-02 | -3.25 | positive regulation of hormone metabolic process | biological process | GO:0032352 | 15 | 1 | 18204 | 48 |
DAB2 |
3.884e-02 | -3.25 | collagen-activated signaling pathway | biological process | GO:0038065 | 15 | 1 | 18204 | 48 |
SYK |
3.884e-02 | -3.25 | regulation of isotype switching to IgG isotypes | biological process | GO:0048302 | 15 | 1 | 18204 | 48 |
PTPRC |
3.884e-02 | -3.25 | establishment of endothelial intestinal barrier | biological process | GO:0090557 | 15 | 1 | 18204 | 48 |
RAPGEF6 |
3.887e-02 | -3.25 | negative regulation of signaling | biological process | GO:0023057 | 1485 | 8 | 18204 | 48 |
PTPRC,TMEM131L,PTPN6,KREMEN1,CADM4,SH2B3,PTGIR,DAB2 |
3.887e-02 | -3.25 | negative regulation of cell communication | biological process | GO:0010648 | 1485 | 8 | 18204 | 48 |
DAB2,PTGIR,SH2B3,CADM4,KREMEN1,PTPN6,PTPRC,TMEM131L |
3.890e-02 | -3.25 | RHOH (ras homolog family member H) | protein interactions | 399 | 509 | 4 | 19454 | 49 |
OSBPL8,PREX1,DAB2,SLC9A1 |
3.897e-02 | -3.24 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 49 |
DIAPH2 |
3.897e-02 | -3.24 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 49 |
DIAPH2 |
3.901e-02 | -3.24 | DAB2 (DAB adaptor protein 2) | protein interactions | 1601 | 124 | 2 | 19454 | 49 |
BMP2K,FCHO2 |
3.907e-02 | -3.24 | small GTPase binding | molecular function | GO:0031267 | 283 | 3 | 18094 | 48 |
RAPGEF6,DOCK2,DIAPH2 |
3.908e-02 | -3.24 | phospholipid scramblase activity | molecular function | GO:0017128 | 15 | 1 | 18094 | 48 |
VMP1 |
3.908e-02 | -3.24 | 3'-5' DNA helicase activity | molecular function | GO:0043138 | 15 | 1 | 18094 | 48 |
ASCC3 |
3.908e-02 | -3.24 | hexosaminidase activity | molecular function | GO:0015929 | 15 | 1 | 18094 | 48 |
CEMIP |
3.908e-02 | -3.24 | icosanoid receptor activity | molecular function | GO:0004953 | 15 | 1 | 18094 | 48 |
PTGIR |
3.908e-02 | -3.24 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 48 |
STAB1 |
3.935e-02 | -3.24 | perinuclear region of cytoplasm | cellular component | GO:0048471 | 735 | 5 | 19108 | 49 |
PREX1,SLC9A1,DAB2,DISC1,GALNT1 |
3.956e-02 | -3.23 | TNFRSF25 (TNF receptor superfamily member 25) | protein interactions | 8718 | 16 | 1 | 19454 | 49 |
PTPN6 |
3.956e-02 | -3.23 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 49 |
NACC2 |
3.956e-02 | -3.23 | KEL (Kell metallo-endopeptidase (Kell blood group)) | protein interactions | 3792 | 16 | 1 | 19454 | 49 |
SLC16A10 |
3.956e-02 | -3.23 | SLCO6A1 (solute carrier organic anion transporter family member 6A1) | protein interactions | 133482 | 16 | 1 | 19454 | 49 |
SLC9A1 |
3.956e-02 | -3.23 | AKAP6 (A-kinase anchoring protein 6) | protein interactions | 9472 | 16 | 1 | 19454 | 49 |
DISC1 |
3.956e-02 | -3.23 | RHO (rhodopsin) | protein interactions | 6010 | 16 | 1 | 19454 | 49 |
GRK6 |
3.956e-02 | -3.23 | GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13) | protein interactions | 114805 | 16 | 1 | 19454 | 49 |
GALNT1 |
3.956e-02 | -3.23 | TAMALIN (trafficking regulator and scaffold protein tamalin) | protein interactions | 160622 | 16 | 1 | 19454 | 49 |
SYK |
3.956e-02 | -3.23 | SELPLG (selectin P ligand) | protein interactions | 6404 | 16 | 1 | 19454 | 49 |
SYK |
3.956e-02 | -3.23 | GPNMB (glycoprotein nmb) | protein interactions | 10457 | 16 | 1 | 19454 | 49 |
TFEB |
3.956e-02 | -3.23 | ZSCAN4 (zinc finger and SCAN domain containing 4) | protein interactions | 201516 | 16 | 1 | 19454 | 49 |
HCK |
3.958e-02 | -3.23 | SLC4A2 (solute carrier family 4 member 2) | protein interactions | 6522 | 125 | 2 | 19454 | 49 |
CEMIP,PTGIR |
3.958e-02 | -3.23 | CFC1 (cryptic, EGF-CFC family member 1) | protein interactions | 55997 | 125 | 2 | 19454 | 49 |
SEMA4B,CEMIP |
3.961e-02 | -3.23 | HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) | protein interactions | 9146 | 512 | 4 | 19454 | 49 |
RHBDF2,SYK,VMP1,PPP1R7 |
3.972e-02 | -3.23 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 48 |
DIAPH2 |
3.972e-02 | -3.23 | Signal regulatory protein (SIRP) family interactions | REACTOME pathways | R-HSA-391160 | 13 | 1 | 10285 | 32 |
PTPN6 |
3.974e-02 | -3.23 | endometrioid_carcinoma | COSMIC cancer mutations | endometrioid_carcinoma | 15690 | 46 | 16828 | 46 |
TMCC3,ACACB,SH2B3,SEMA4B,GALNT1,ATG14,SLC9A1,GRK6,VAV3,VMP1,DOCK2,RHBDF2,PTGIR,BMP2K,PREX1,PREX2,DAB2,TFEB,KREMEN1,CADM4,MPP1,ACER2,SLC16A10,ENTPD1,STAB1,SYK,RAPGEF6,OSBPL8,PLXND1,RBM47,PPP1R7,SMOX,PPFIBP2,FCHO2,DOCK8,HCK,PTPRC,ASCC3,BLVRA,DIAPH2,DISC1,GAB1,PTPN6,NACC2,ATP10D,TMTC1 |
3.981e-02 | -3.22 | ATP_GRASP | prosite domains | PS50975 | 13 | 1 | 12186 | 38 |
ACACB |
3.986e-02 | -3.22 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 8 | 16828 | 46 |
ASCC3,PTGIR,HCK,RAPGEF6,ACACB,DOCK8,ENTPD1,STAB1 |
3.990e-02 | -3.22 | ATP-grasp fold, A domain | gene3d domains | 3.30.1490.20 | 14 | 1 | 14470 | 42 |
ACACB |
3.997e-02 | -3.22 | endometrium | COSMIC cancer mutations | endometrium | 15692 | 46 | 16828 | 46 |
TMTC1,NACC2,PTPN6,GAB1,ATP10D,DISC1,BLVRA,DIAPH2,PTPRC,ASCC3,HCK,PPFIBP2,FCHO2,DOCK8,SMOX,OSBPL8,PPP1R7,PLXND1,RBM47,RAPGEF6,SYK,STAB1,ENTPD1,SLC16A10,CADM4,ACER2,MPP1,DAB2,TFEB,KREMEN1,PREX2,PREX1,RHBDF2,BMP2K,PTGIR,VAV3,VMP1,DOCK2,ATG14,SLC9A1,GRK6,GALNT1,SH2B3,SEMA4B,ACACB,TMCC3 |
3.998e-02 | -3.22 | cellular localization | biological process | GO:0051641 | 2660 | 12 | 18204 | 48 |
RAPGEF6,ATG14,FCHO2,VMP1,OSBPL8,DISC1,SYK,PTPRC,DAB2,HCK,RHBDF2,DOCK2 |
3.999e-02 | -3.22 | TCR signaling in naive CD8+ T cells | Pathway Interaction DB | cd8tcrpathway | 48 | 2 | 2226 | 15 |
PTPRC,PTPN6 |
4.004e-02 | -3.22 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 6 | 18204 | 48 |
VAV3,GAB1,SYK,PTPN6,PLXND1,DOCK2 |
4.016e-02 | -3.21 | ANP32A (acidic nuclear phosphoprotein 32 family member A) | protein interactions | 8125 | 126 | 2 | 19454 | 49 |
DOCK8,PTPRC |
4.020e-02 | -3.21 | positive regulation of innate immune response | biological process | GO:0045089 | 288 | 3 | 18204 | 48 |
SYK,RBM47,HCK |
4.024e-02 | -3.21 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 46 |
NACC2 |
4.038e-02 | -3.21 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 6 | 16828 | 46 |
SYK,GRK6,PREX2,BMP2K,ACACB,HCK |
4.052e-02 | -3.21 | negative regulation of immune effector process | biological process | GO:0002698 | 121 | 2 | 18204 | 48 |
PTPRC,PTPN6 |
4.052e-02 | -3.21 | positive regulation of T cell differentiation | biological process | GO:0045582 | 121 | 2 | 18204 | 48 |
PTPRC,SYK |
4.064e-02 | -3.20 | SEC61B (SEC61 translocon subunit beta) | protein interactions | 10952 | 755 | 5 | 19454 | 49 |
VMP1,TMCC3,SLC9A1,TMEM131L,OSBPL8 |
4.108e-02 | -3.19 | C3orf52 (chromosome 3 open reading frame 52) | protein interactions | 79669 | 304 | 3 | 19454 | 49 |
SLC9A1,OSBPL8,RHBDF2 |
4.138e-02 | -3.18 | positive regulation of B cell differentiation | biological process | GO:0045579 | 16 | 1 | 18204 | 48 |
SYK |
4.138e-02 | -3.18 | hyaluronan catabolic process | biological process | GO:0030214 | 16 | 1 | 18204 | 48 |
CEMIP |
4.138e-02 | -3.18 | tricarboxylic acid metabolic process | biological process | GO:0072350 | 16 | 1 | 18204 | 48 |
ACACB |
4.138e-02 | -3.18 | neutrophil homeostasis | biological process | GO:0001780 | 16 | 1 | 18204 | 48 |
SH2B3 |
4.138e-02 | -3.18 | regulation of Wnt signaling pathway, planar cell polarity pathway | biological process | GO:2000095 | 16 | 1 | 18204 | 48 |
DAB2 |
4.138e-02 | -3.18 | regulation of corticosteroid hormone secretion | biological process | GO:2000846 | 16 | 1 | 18204 | 48 |
DAB2 |
4.138e-02 | -3.18 | branching involved in salivary gland morphogenesis | biological process | GO:0060445 | 16 | 1 | 18204 | 48 |
PLXND1 |
4.138e-02 | -3.18 | thyroid hormone generation | biological process | GO:0006590 | 16 | 1 | 18204 | 48 |
SLC16A10 |
4.138e-02 | -3.18 | negative regulation of neuron projection regeneration | biological process | GO:0070571 | 16 | 1 | 18204 | 48 |
KREMEN1 |
4.138e-02 | -3.18 | natural killer cell differentiation | biological process | GO:0001779 | 16 | 1 | 18204 | 48 |
PTPRC |
4.152e-02 | -3.18 | Guanylate_kinase_CS | interpro domains | IPR020590 | 16 | 1 | 18521 | 49 |
MPP1 |
4.152e-02 | -3.18 | Kringle_sf | interpro domains | IPR038178 | 16 | 1 | 18521 | 49 |
KREMEN1 |
4.152e-02 | -3.18 | Kringle | interpro domains | IPR000001 | 16 | 1 | 18521 | 49 |
KREMEN1 |
4.152e-02 | -3.18 | Kringle_CS | interpro domains | IPR018056 | 16 | 1 | 18521 | 49 |
KREMEN1 |
4.163e-02 | -3.18 | flippase activity | molecular function | GO:0140327 | 16 | 1 | 18094 | 48 |
ATP10D |
4.163e-02 | -3.18 | sodium:proton antiporter activity | molecular function | GO:0015385 | 16 | 1 | 18094 | 48 |
SLC9A1 |
4.182e-02 | -3.17 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 4 | 18204 | 48 |
DISC1,HCK,VAV3,PREX1 |
4.190e-02 | -3.17 | Lima1 (LIM domain and actin binding 1) | protein interactions | 65970 | 129 | 2 | 19454 | 49 |
DAB2,FCHO2 |
4.190e-02 | -3.17 | COL8A1 (collagen type VIII alpha 1 chain) | protein interactions | 1295 | 129 | 2 | 19454 | 49 |
DISC1,BMP2K |
4.198e-02 | -3.17 | OLFM1 (olfactomedin 1) | protein interactions | 10439 | 17 | 1 | 19454 | 49 |
DISC1 |
4.198e-02 | -3.17 | SLAMF6 (SLAM family member 6) | protein interactions | 114836 | 17 | 1 | 19454 | 49 |
PTPN6 |
4.198e-02 | -3.17 | NYX (nyctalopin) | protein interactions | 60506 | 17 | 1 | 19454 | 49 |
GALNT1 |
4.198e-02 | -3.17 | MRAS (muscle RAS oncogene homolog) | protein interactions | 22808 | 17 | 1 | 19454 | 49 |
RAPGEF6 |
4.198e-02 | -3.17 | DUXB (double homeobox B) | protein interactions | 100033411 | 17 | 1 | 19454 | 49 |
ACACB |
4.198e-02 | -3.17 | GYPC (glycophorin C (Gerbich blood group)) | protein interactions | 2995 | 17 | 1 | 19454 | 49 |
MPP1 |
4.198e-02 | -3.17 | SLC25A21 (solute carrier family 25 member 21) | protein interactions | 89874 | 17 | 1 | 19454 | 49 |
BLVRA |
4.198e-02 | -3.17 | FAM131C (family with sequence similarity 131 member C) | protein interactions | 348487 | 17 | 1 | 19454 | 49 |
RHBDF2 |
4.198e-02 | -3.17 | STRA6 (signaling receptor and transporter of retinol STRA6) | protein interactions | 64220 | 17 | 1 | 19454 | 49 |
SLC9A1 |
4.210e-02 | -3.17 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 15 | 16828 | 46 |
TMTC1,SLC9A1,GRK6,SLC16A10,RAPGEF6,ATP10D,GALNT1,KREMEN1,STAB1,PREX2,SEMA4B,PTPRC,ASCC3,DOCK2,SMOX |
4.216e-02 | -3.17 | phosphorylation | biological process | GO:0016310 | 729 | 5 | 18204 | 48 |
SYK,PTPN6,BMP2K,GRK6,HCK |
4.231e-02 | -3.16 | Kringle | pfam domains | PF00051 | 16 | 1 | 17795 | 48 |
KREMEN1 |
4.236e-02 | -3.16 | regulation of ossification | biological process | GO:0030278 | 124 | 2 | 18204 | 48 |
KREMEN1,BMP2K |
4.247e-02 | -3.16 | TGOLN2 (trans-golgi network protein 2) | protein interactions | 10618 | 1581 | 8 | 19454 | 49 |
PLXND1,SEMA4B,FCHO2,BMP2K,TMEM131L,DAB2,GALNT1,VMP1 |
4.248e-02 | -3.16 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 15 | 16828 | 46 |
VAV3,DOCK8,PTPRC,HCK,ACACB,DAB2,TFEB,PREX2,DIAPH2,BLVRA,OSBPL8,TMTC1,RBM47,ACER2,ATP10D |
4.248e-02 | -3.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 15 | 16828 | 46 |
TFEB,DAB2,PREX2,DIAPH2,BLVRA,RBM47,OSBPL8,TMTC1,ACER2,ATP10D,DOCK8,VAV3,PTPRC,HCK,ACACB |
4.269e-02 | -3.15 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 42 |
DIAPH2 |
4.271e-02 | -3.15 | Regulation of IFNG signaling | REACTOME pathways | R-HSA-877312 | 14 | 1 | 10285 | 32 |
PTPN6 |
4.281e-02 | -3.15 | MHD | prosite domains | PS51072 | 14 | 1 | 12186 | 38 |
FCHO2 |
4.281e-02 | -3.15 | LINK_2 | prosite domains | PS50963 | 14 | 1 | 12186 | 38 |
STAB1 |
4.304e-02 | -3.15 | EZR (ezrin) | protein interactions | 7430 | 526 | 4 | 19454 | 49 |
GAB1,SYK,PTPRC,FCHO2 |
4.308e-02 | -3.14 | LGALS7 (galectin 7) | protein interactions | 3963 | 131 | 2 | 19454 | 49 |
DOCK8,GAB1 |
4.312e-02 | -3.14 | protein phosphorylation | biological process | GO:0006468 | 503 | 4 | 18204 | 48 |
HCK,GRK6,PTPN6,SYK |
4.312e-02 | -3.14 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 3 | 19454 | 49 |
FCHO2,GAB1,OSBPL8 |
4.321e-02 | -3.14 | cellular response to cytokine stimulus | biological process | GO:0071345 | 734 | 5 | 18204 | 48 |
HCK,PTPN6,SH2B3,SYK,DOCK8 |
4.344e-02 | -3.14 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 32 |
SLC9A1,SLC16A10 |
4.345e-02 | -3.14 | protein tyrosine kinase binding | molecular function | GO:1990782 | 125 | 2 | 18094 | 48 |
SH2B3,CADM4 |
4.349e-02 | -3.14 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 4 | 16828 | 46 |
GRK6,SYK,BMP2K,HCK |
4.367e-02 | -3.13 | DDR2 (discoidin domain receptor tyrosine kinase 2) | protein interactions | 4921 | 132 | 2 | 19454 | 49 |
VMP1,OSBPL8 |
4.367e-02 | -3.13 | TRIM52 (tripartite motif containing 52) | protein interactions | 84851 | 132 | 2 | 19454 | 49 |
DISC1,ASCC3 |
4.367e-02 | -3.13 | TXNDC12 (thioredoxin domain containing 12) | protein interactions | 51060 | 132 | 2 | 19454 | 49 |
DIAPH2,HCK |
4.371e-02 | -3.13 | Proteoglycans in cancer | KEGG pathways | hsa05205 | 203 | 3 | 7161 | 28 |
SLC9A1,PTPN6,GAB1 |
4.371e-02 | -3.13 | Proteoglycans in cancer | KEGG pathways | ko05205 | 203 | 3 | 7161 | 28 |
GAB1,SLC9A1,PTPN6 |
4.379e-02 | -3.13 | ENO1 (enolase 1) | protein interactions | 2023 | 529 | 4 | 19454 | 49 |
SLC9A1,TMCC3,RAPGEF6,ASCC3 |
4.382e-02 | -3.13 | organelle membrane | cellular component | GO:0031090 | 3742 | 15 | 19108 | 49 |
SMOX,ATG14,OSBPL8,ACER2,CEMIP,GALNT1,VMP1,RHBDF2,ACACB,PTPRC,TFEB,DAB2,ATP10D,STAB1,TMCC3 |
4.391e-02 | -3.13 | negative regulation of vascular endothelial growth factor signaling pathway | biological process | GO:1900747 | 17 | 1 | 18204 | 48 |
CADM4 |
4.391e-02 | -3.13 | response to hepatocyte growth factor | biological process | GO:0035728 | 17 | 1 | 18204 | 48 |
GAB1 |
4.391e-02 | -3.13 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 48 |
RAPGEF6 |
4.391e-02 | -3.13 | negative regulation of neuroinflammatory response | biological process | GO:0150079 | 17 | 1 | 18204 | 48 |
PTPRC |
4.391e-02 | -3.13 | NADPH regeneration | biological process | GO:0006740 | 17 | 1 | 18204 | 48 |
ACACB |
4.391e-02 | -3.13 | negative regulation of humoral immune response | biological process | GO:0002921 | 17 | 1 | 18204 | 48 |
PTPN6 |
4.391e-02 | -3.13 | negative regulation of macrophage activation | biological process | GO:0043031 | 17 | 1 | 18204 | 48 |
PTPRC |
4.417e-02 | -3.12 | nucleoside diphosphate phosphatase activity | molecular function | GO:0017110 | 17 | 1 | 18094 | 48 |
ENTPD1 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine kinase adaptor activity | molecular function | GO:0005068 | 17 | 1 | 18094 | 48 |
SH2B3 |
4.417e-02 | -3.12 | low-density lipoprotein particle binding | molecular function | GO:0030169 | 17 | 1 | 18094 | 48 |
STAB1 |
4.422e-02 | -3.12 | negative regulation of neuron projection development | biological process | GO:0010977 | 127 | 2 | 18204 | 48 |
DAB2,KREMEN1 |
4.427e-02 | -3.12 | HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) | protein interactions | 3117 | 133 | 2 | 19454 | 49 |
TMEM131L,SEMA4B |
4.433e-02 | -3.12 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 12 | 16828 | 46 |
DOCK2,VAV3,SMOX,ACACB,SYK,DAB2,PREX2,SLC9A1,PLXND1,SLC16A10,OSBPL8,GAB1 |
4.440e-02 | -3.11 | ADO (2-aminoethanethiol dioxygenase) | protein interactions | 84890 | 18 | 1 | 19454 | 49 |
DISC1 |
4.440e-02 | -3.11 | SPARCL1 (SPARC like 1) | protein interactions | 8404 | 18 | 1 | 19454 | 49 |
DISC1 |
4.440e-02 | -3.11 | ZNF365 (zinc finger protein 365) | protein interactions | 22891 | 18 | 1 | 19454 | 49 |
DISC1 |
4.440e-02 | -3.11 | Tgfbr1 (transforming growth factor, beta receptor I) | protein interactions | 21812 | 18 | 1 | 19454 | 49 |
GALNT1 |
4.440e-02 | -3.11 | ARHGDIG (Rho GDP dissociation inhibitor gamma) | protein interactions | 398 | 18 | 1 | 19454 | 49 |
CEMIP |
4.440e-02 | -3.11 | Numb (NUMB endocytic adaptor protein) | protein interactions | 18222 | 18 | 1 | 19454 | 49 |
BMP2K |
4.440e-02 | -3.11 | Chmp6 (charged multivesicular body protein 6) | protein interactions | 208092 | 18 | 1 | 19454 | 49 |
PTPN6 |
4.440e-02 | -3.11 | PROSER3 (proline and serine rich 3) | protein interactions | 148137 | 18 | 1 | 19454 | 49 |
CEMIP |
4.440e-02 | -3.11 | DNAAF11 (dynein axonemal assembly factor 11) | protein interactions | 23639 | 18 | 1 | 19454 | 49 |
PPP1R7 |
4.440e-02 | -3.11 | CNDP1 (carnosine dipeptidase 1) | protein interactions | 84735 | 18 | 1 | 19454 | 49 |
SLC16A10 |
4.440e-02 | -3.11 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 49 |
PREX1 |
4.440e-02 | -3.11 | SRR (serine racemase) | protein interactions | 63826 | 18 | 1 | 19454 | 49 |
DISC1 |
4.451e-02 | -3.11 | ATP5PO (ATP synthase peripheral stalk subunit OSCP) | protein interactions | 539 | 314 | 3 | 19454 | 49 |
GRK6,PREX1,DOCK8 |
4.485e-02 | -3.10 | regulation of protein binding | biological process | GO:0043393 | 128 | 2 | 18204 | 48 |
DISC1,DAB2 |
4.487e-02 | -3.10 | ARL4C (ADP ribosylation factor like GTPase 4C) | protein interactions | 10123 | 134 | 2 | 19454 | 49 |
CADM4,GAB1 |
4.487e-02 | -3.10 | SLU7 (SLU7 homolog, splicing factor) | protein interactions | 10569 | 134 | 2 | 19454 | 49 |
ACACB,PHKB |
4.487e-02 | -3.10 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 4 | 16828 | 46 |
HCK,BMP2K,SYK,GRK6 |
4.502e-02 | -3.10 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 6 | 18204 | 48 |
ACER2,HCK,PTPN6,PTPRC,DISC1,VAV3 |
4.515e-02 | -3.10 | skin-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma | 493 | 4 | 16828 | 46 |
SYK,SH2B3,PREX2,BMP2K |
4.519e-02 | -3.10 | T-Cell antigen Receptor (TCR) Signaling Pathway | WikiPathways | WP69 | 91 | 2 | 5310 | 20 |
VAV3,SH2B3 |
4.525e-02 | -3.10 | kinase activity | molecular function | GO:0016301 | 739 | 5 | 18094 | 48 |
HCK,GRK6,BMP2K,SYK,MPP1 |
4.547e-02 | -3.09 | Plasminogen Kringle 4 | gene3d domains | 2.40.20.10 | 16 | 1 | 14470 | 42 |
KREMEN1 |
4.547e-02 | -3.09 | JAK3 (Janus kinase 3) | protein interactions | 3718 | 135 | 2 | 19454 | 49 |
PTPRC,PTPN6 |
4.547e-02 | -3.09 | URI1 (URI1 prefoldin like chaperone) | protein interactions | 8725 | 135 | 2 | 19454 | 49 |
GRK6,PPP1R7 |
4.549e-02 | -3.09 | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.549e-02 | -3.09 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 46 |
NACC2 |
4.549e-02 | -3.09 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.549e-02 | -3.09 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 46 |
NACC2 |
4.557e-02 | -3.09 | protein-macromolecule adaptor activity | molecular function | GO:0030674 | 989 | 6 | 18094 | 48 |
DAB2,RBM47,SH2B3,GAB1,SLC9A1,ATG14 |
4.558e-02 | -3.09 | IQGAP1 (IQ motif containing GTPase activating protein 1) | protein interactions | 8826 | 536 | 4 | 19454 | 49 |
ASCC3,BMP2K,VMP1,DAB2 |
4.570e-02 | -3.09 | Negative regulation of TCF-dependent signaling by WNT ligand antagonists | REACTOME pathways | R-HSA-3772470 | 15 | 1 | 10285 | 32 |
KREMEN1 |
4.570e-02 | -3.09 | Eicosanoid ligand-binding receptors | REACTOME pathways | R-HSA-391903 | 15 | 1 | 10285 | 32 |
PTGIR |
4.579e-02 | -3.08 | FH2 | prosite domains | PS51444 | 15 | 1 | 12186 | 38 |
DIAPH2 |
4.597e-02 | -3.08 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 11 | 18204 | 48 |
SH2B3,PREX1,ACER2,GAB1,VAV3,HCK,SYK,DOCK8,PTPN6,SLC9A1,SMOX |
4.608e-02 | -3.08 | NAF1 (nuclear assembly factor 1 ribonucleoprotein) | protein interactions | 92345 | 136 | 2 | 19454 | 49 |
SYK,MPP1 |
4.611e-02 | -3.08 | negative regulation of T cell activation | biological process | GO:0050868 | 130 | 2 | 18204 | 48 |
TMEM131L,PTPN6 |
4.611e-02 | -3.08 | B cell differentiation | biological process | GO:0030183 | 130 | 2 | 18204 | 48 |
SYK,PTPRC |
4.615e-02 | -3.08 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 46 | 16828 | 46 |
SMOX,PPFIBP2,FCHO2,DOCK8,HCK,PTPRC,ASCC3,DIAPH2,BLVRA,DISC1,PTPN6,NACC2,GAB1,ATP10D,TMTC1,ENTPD1,STAB1,SYK,RAPGEF6,OSBPL8,RBM47,PLXND1,PPP1R7,VAV3,VMP1,DOCK2,RHBDF2,BMP2K,PTGIR,PREX1,PREX2,DAB2,TFEB,KREMEN1,CADM4,ACER2,MPP1,SLC16A10,TMCC3,ACACB,SH2B3,SEMA4B,GALNT1,ATG14,SLC9A1,GRK6 |
4.621e-02 | -3.07 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 8 | 18094 | 48 |
ATP10D,ASCC3,SYK,BMP2K,ENTPD1,GRK6,ACACB,HCK |
4.634e-02 | -3.07 | endoplasmic reticulum-Golgi intermediate compartment | cellular component | GO:0005793 | 134 | 2 | 19108 | 49 |
GALNT1,VMP1 |
4.643e-02 | -3.07 | positive regulation of sodium ion transmembrane transport | biological process | GO:1902307 | 18 | 1 | 18204 | 48 |
SLC9A1 |
4.643e-02 | -3.07 | regulation of cardiac muscle adaptation | biological process | GO:0010612 | 18 | 1 | 18204 | 48 |
ACACB |
4.643e-02 | -3.07 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 1 | 18204 | 48 |
SH2B3 |
4.643e-02 | -3.07 | regulation of granulocyte macrophage colony-stimulating factor production | biological process | GO:0032645 | 18 | 1 | 18204 | 48 |
SYK |
4.643e-02 | -3.07 | positive regulation of superoxide anion generation | biological process | GO:0032930 | 18 | 1 | 18204 | 48 |
SYK |
4.643e-02 | -3.07 | regulation of cardiac muscle hypertrophy in response to stress | biological process | GO:1903242 | 18 | 1 | 18204 | 48 |
ACACB |
4.643e-02 | -3.07 | maintenance of cell polarity | biological process | GO:0030011 | 18 | 1 | 18204 | 48 |
SLC9A1 |
4.651e-02 | -3.07 | nuclear membrane | cellular component | GO:0031965 | 314 | 3 | 19108 | 49 |
OSBPL8,CEMIP,SMOX |
4.654e-02 | -3.07 | LINK | smart domains | SM00445 | 14 | 1 | 9717 | 33 |
STAB1 |
4.654e-02 | -3.07 | 4.1m | smart domains | SM00294 | 14 | 1 | 9717 | 33 |
CADM4 |
4.659e-02 | -3.07 | EGF_dom | interpro domains | IPR024731 | 18 | 1 | 18521 | 49 |
STAB1 |
4.659e-02 | -3.07 | Leu-rich_rpt_4 | interpro domains | IPR025875 | 18 | 1 | 18521 | 49 |
PPP1R7 |
4.671e-02 | -3.06 | defense response to bacterium | biological process | GO:0042742 | 306 | 3 | 18204 | 48 |
STAB1,SYK,TFEB |
4.671e-02 | -3.06 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 48 |
PTPRC |
4.671e-02 | -3.06 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 48 |
STAB1 |
4.671e-02 | -3.06 | clathrin adaptor activity | molecular function | GO:0035615 | 18 | 1 | 18094 | 48 |
DAB2 |
4.675e-02 | -3.06 | positive regulation of cysteine-type endopeptidase activity | biological process | GO:2001056 | 131 | 2 | 18204 | 48 |
ACER2,SYK |
4.681e-02 | -3.06 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 1 | 19454 | 49 |
SEMA4B |
4.681e-02 | -3.06 | ICOSLG (inducible T cell costimulator ligand) | protein interactions | 23308 | 19 | 1 | 19454 | 49 |
TMEM131L |
4.681e-02 | -3.06 | NHERF4 (NHERF family PDZ scaffold protein 4) | protein interactions | 79849 | 19 | 1 | 19454 | 49 |
PTGIR |
4.681e-02 | -3.06 | RCVRN (recoverin) | protein interactions | 5957 | 19 | 1 | 19454 | 49 |
GRK6 |
4.681e-02 | -3.06 | HTR3B (5-hydroxytryptamine receptor 3B) | protein interactions | 9177 | 19 | 1 | 19454 | 49 |
SLC9A1 |
4.681e-02 | -3.06 | TBX20 (T-box transcription factor 20) | protein interactions | 57057 | 19 | 1 | 19454 | 49 |
BLVRA |
4.681e-02 | -3.06 | SIT1 (signaling threshold regulating transmembrane adaptor 1) | protein interactions | 27240 | 19 | 1 | 19454 | 49 |
SYK |
4.681e-02 | -3.06 | PEX2 (peroxisomal biogenesis factor 2) | protein interactions | 5828 | 19 | 1 | 19454 | 49 |
PTPN6 |
4.681e-02 | -3.06 | SLITRK3 (SLIT and NTRK like family member 3) | protein interactions | 22865 | 19 | 1 | 19454 | 49 |
RHBDF2 |
4.681e-02 | -3.06 | CRYBB1 (crystallin beta B1) | protein interactions | 1414 | 19 | 1 | 19454 | 49 |
DISC1 |
4.681e-02 | -3.06 | HMGCLL1 (3-hydroxy-3-methylglutaryl-CoA lyase like 1) | protein interactions | 54511 | 19 | 1 | 19454 | 49 |
CEMIP |
4.681e-02 | -3.06 | ZNF197 (zinc finger protein 197) | protein interactions | 10168 | 19 | 1 | 19454 | 49 |
DISC1 |
4.699e-02 | -3.06 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 3 | 19454 | 49 |
PPP1R7,CADM4,SLC16A10 |
4.715e-02 | -3.05 | intracellular anatomical structure | cellular component | GO:0005622 | 15205 | 44 | 19108 | 49 |
ASCC3,SLC9A1,HCK,DOCK8,FCHO2,PHKB,VAV3,NACC2,ATP10D,TMTC1,PTGIR,GAB1,BLVRA,PTPRC,CEMIP,GALNT1,SMOX,PREX1,SH2B3,OSBPL8,DISC1,RBM47,TMCC3,BMP2K,DIAPH2,TFEB,GRK6,ACER2,SLC16A10,ATG14,PTPN6,PPP1R7,DAB2,RHBDF2,ACACB,MPP1,SYK,RAPGEF6,PPFIBP2,STAB1,PREX2,VMP1,DOCK2,TMEM131L |
4.716e-02 | -3.05 | peptidyl-amino acid modification | biological process | GO:0018193 | 518 | 4 | 18204 | 48 |
SYK,PTPN6,GALNT1,HCK |
4.730e-02 | -3.05 | EXOC1 (exocyst complex component 1) | protein interactions | 55763 | 138 | 2 | 19454 | 49 |
ATG14,DISC1 |
4.730e-02 | -3.05 | AKAP12 (A-kinase anchoring protein 12) | protein interactions | 9590 | 138 | 2 | 19454 | 49 |
RHBDF2,HCK |
4.739e-02 | -3.05 | positive regulation of proteolysis involved in protein catabolic process | biological process | GO:1903052 | 132 | 2 | 18204 | 48 |
DISC1,DAB2 |
4.748e-02 | -3.05 | EGF_3 | pfam domains | PF12947 | 18 | 1 | 17795 | 48 |
STAB1 |
4.748e-02 | -3.05 | LRR_4 | pfam domains | PF12799 | 18 | 1 | 17795 | 48 |
PPP1R7 |
4.764e-02 | -3.04 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 49 |
SLC9A1 |
4.765e-02 | -3.04 | defense response to other organism | biological process | GO:0098542 | 1006 | 6 | 18204 | 48 |
PTPN6,STAB1,PTPRC,SYK,TFEB,HCK |
4.771e-02 | -3.04 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 4 | 16828 | 46 |
GRK6,SYK,HCK,BMP2K |
4.785e-02 | -3.04 | anion binding | molecular function | GO:0043168 | 2412 | 11 | 18094 | 48 |
RAPGEF6,ASCC3,BMP2K,GRK6,ENTPD1,SYK,ATP10D,ACACB,FCHO2,HCK,SLC9A1 |
4.792e-02 | -3.04 | DPPA4 (developmental pluripotency associated 4) | protein interactions | 55211 | 139 | 2 | 19454 | 49 |
ACACB,TMTC1 |
4.792e-02 | -3.04 | ARMC6 (armadillo repeat containing 6) | protein interactions | 93436 | 139 | 2 | 19454 | 49 |
GALNT1,SLC16A10 |
4.792e-02 | -3.04 | DUSP22 (dual specificity phosphatase 22) | protein interactions | 56940 | 139 | 2 | 19454 | 49 |
ACACB,PTPN6 |
4.802e-02 | -3.04 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 2 | 17795 | 48 |
SYK,HCK |
4.810e-02 | -3.03 | Regulation of actin cytoskeleton | KEGG pathways | ko04810 | 211 | 3 | 7161 | 28 |
DIAPH2,SLC9A1,VAV3 |
4.810e-02 | -3.03 | Regulation of actin cytoskeleton | KEGG pathways | hsa04810 | 211 | 3 | 7161 | 28 |
SLC9A1,DIAPH2,VAV3 |
4.824e-02 | -3.03 | - | gene3d domains | 2.40.50.100 | 17 | 1 | 14470 | 42 |
ACACB |
4.834e-02 | -3.03 | Ser-Thr/Tyr_kinase_cat_dom | interpro domains | IPR001245 | 133 | 2 | 18521 | 49 |
HCK,SYK |
4.835e-02 | -3.03 | coated vesicle | cellular component | GO:0030135 | 319 | 3 | 19108 | 49 |
CEMIP,DAB2,FCHO2 |
4.853e-02 | -3.03 | PTPRO (protein tyrosine phosphatase receptor type O) | protein interactions | 5800 | 140 | 2 | 19454 | 49 |
SYK,TMEM131L |
4.853e-02 | -3.03 | PCDHB3 (protocadherin beta 3) | protein interactions | 56132 | 140 | 2 | 19454 | 49 |
TMEM131L,RHBDF2 |
4.867e-02 | -3.02 | Signaling by EGFRvIII in Cancer | REACTOME pathways | R-HSA-5637812 | 16 | 1 | 10285 | 32 |
GAB1 |
4.867e-02 | -3.02 | Constitutive Signaling by EGFRvIII | REACTOME pathways | R-HSA-5637810 | 16 | 1 | 10285 | 32 |
GAB1 |
4.867e-02 | -3.02 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 32 |
GAB1 |
4.869e-02 | -3.02 | organelle disassembly | biological process | GO:1903008 | 134 | 2 | 18204 | 48 |
ASCC3,ATG14 |
4.869e-02 | -3.02 | regulation of actin filament polymerization | biological process | GO:0030833 | 134 | 2 | 18204 | 48 |
HCK,PREX1 |
4.877e-02 | -3.02 | GUANYLATE_KINASE_1 | prosite domains | PS00856 | 16 | 1 | 12186 | 38 |
MPP1 |
4.877e-02 | -3.02 | KRINGLE_2 | prosite domains | PS50070 | 16 | 1 | 12186 | 38 |
KREMEN1 |
4.877e-02 | -3.02 | KRINGLE_1 | prosite domains | PS00021 | 16 | 1 | 12186 | 38 |
KREMEN1 |
4.880e-02 | -3.02 | DTX2 (deltex E3 ubiquitin ligase 2) | protein interactions | 113878 | 326 | 3 | 19454 | 49 |
ACACB,RBM47,DAB2 |
4.884e-02 | -3.02 | clathrin-coated vesicle membrane | cellular component | GO:0030665 | 138 | 2 | 19108 | 49 |
DAB2,CEMIP |
4.895e-02 | -3.02 | negative regulation of cellular response to vascular endothelial growth factor stimulus | biological process | GO:1902548 | 19 | 1 | 18204 | 48 |
CADM4 |
4.895e-02 | -3.02 | positive regulation of bone resorption | biological process | GO:0045780 | 19 | 1 | 18204 | 48 |
SYK |
4.895e-02 | -3.02 | response to mitochondrial depolarisation | biological process | GO:0098780 | 19 | 1 | 18204 | 48 |
ATG14 |
4.895e-02 | -3.02 | regulation of microglial cell activation | biological process | GO:1903978 | 19 | 1 | 18204 | 48 |
PTPRC |
4.895e-02 | -3.02 | leukotriene biosynthetic process | biological process | GO:0019370 | 19 | 1 | 18204 | 48 |
SYK |
4.895e-02 | -3.02 | amine catabolic process | biological process | GO:0009310 | 19 | 1 | 18204 | 48 |
SMOX |
4.895e-02 | -3.02 | cellular biogenic amine catabolic process | biological process | GO:0042402 | 19 | 1 | 18204 | 48 |
SMOX |
4.895e-02 | -3.02 | base conversion or substitution editing | biological process | GO:0016553 | 19 | 1 | 18204 | 48 |
RBM47 |
4.895e-02 | -3.02 | detection of temperature stimulus involved in sensory perception of pain | biological process | GO:0050965 | 19 | 1 | 18204 | 48 |
DISC1 |
4.895e-02 | -3.02 | regulation of early endosome to late endosome transport | biological process | GO:2000641 | 19 | 1 | 18204 | 48 |
DAB2 |
4.895e-02 | -3.02 | positive regulation of phosphoprotein phosphatase activity | biological process | GO:0032516 | 19 | 1 | 18204 | 48 |
PTPRC |
4.895e-02 | -3.02 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 48 |
RAPGEF6 |
4.895e-02 | -3.02 | protein O-linked mannosylation | biological process | GO:0035269 | 19 | 1 | 18204 | 48 |
TMTC1 |
4.895e-02 | -3.02 | response to aldosterone | biological process | GO:1904044 | 19 | 1 | 18204 | 48 |
PTPRC |
4.895e-02 | -3.02 | polyamine metabolic process | biological process | GO:0006595 | 19 | 1 | 18204 | 48 |
SMOX |
4.895e-02 | -3.02 | lipoprotein transport | biological process | GO:0042953 | 19 | 1 | 18204 | 48 |
VMP1 |
4.895e-02 | -3.02 | macrophage activation involved in immune response | biological process | GO:0002281 | 19 | 1 | 18204 | 48 |
SYK |
4.895e-02 | -3.02 | regulation of mast cell activation | biological process | GO:0033003 | 19 | 1 | 18204 | 48 |
PTPN6 |
4.895e-02 | -3.02 | production of molecular mediator involved in inflammatory response | biological process | GO:0002532 | 19 | 1 | 18204 | 48 |
SYK |
4.895e-02 | -3.02 | negative regulation of peptidyl-threonine phosphorylation | biological process | GO:0010801 | 19 | 1 | 18204 | 48 |
CADM4 |
4.901e-02 | -3.02 | protein-containing complex assembly | biological process | GO:0065003 | 1279 | 7 | 18204 | 48 |
FCHO2,DIAPH2,NACC2,SLC9A1,DAB2,PREX1,ACACB |
4.910e-02 | -3.01 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 4 | 18521 | 49 |
GRK6,HCK,BMP2K,SYK |
4.916e-02 | -3.01 | UPK2 (uroplakin 2) | protein interactions | 7379 | 141 | 2 | 19454 | 49 |
TMEM131L,SLC16A10 |
4.921e-02 | -3.01 | RARRES1 (retinoic acid receptor responder 1) | protein interactions | 5918 | 20 | 1 | 19454 | 49 |
RAPGEF6 |
4.921e-02 | -3.01 | MYF6 (myogenic factor 6) | protein interactions | 4618 | 20 | 1 | 19454 | 49 |
DISC1 |
4.921e-02 | -3.01 | JPH2 (junctophilin 2) | protein interactions | 57158 | 20 | 1 | 19454 | 49 |
TMTC1 |
4.921e-02 | -3.01 | GGT1 (gamma-glutamyltransferase 1) | protein interactions | 2678 | 20 | 1 | 19454 | 49 |
CEMIP |
4.921e-02 | -3.01 | TSPAN16 (tetraspanin 16) | protein interactions | 26526 | 20 | 1 | 19454 | 49 |
CADM4 |
4.921e-02 | -3.01 | HSD17B7P2 (hydroxysteroid 17-beta dehydrogenase 7 pseudogene 2) | protein interactions | 158160 | 20 | 1 | 19454 | 49 |
ASCC3 |
4.921e-02 | -3.01 | CCDC197 (coiled-coil domain containing 197) | protein interactions | 256369 | 20 | 1 | 19454 | 49 |
DISC1 |
4.921e-02 | -3.01 | NUTM2F (NUT family member 2F) | protein interactions | 54754 | 20 | 1 | 19454 | 49 |
RBM47 |
4.921e-02 | -3.01 | SNCB (synuclein beta) | protein interactions | 6620 | 20 | 1 | 19454 | 49 |
GRK6 |
4.924e-02 | -3.01 | ankyrin binding | molecular function | GO:0030506 | 19 | 1 | 18094 | 48 |
PTPRC |
4.924e-02 | -3.01 | solute:potassium antiporter activity | molecular function | GO:0022821 | 19 | 1 | 18094 | 48 |
SLC9A1 |
4.924e-02 | -3.01 | cargo adaptor activity | molecular function | GO:0140312 | 19 | 1 | 18094 | 48 |
DAB2 |
4.924e-02 | -3.01 | polypeptide N-acetylgalactosaminyltransferase activity | molecular function | GO:0004653 | 19 | 1 | 18094 | 48 |
GALNT1 |
4.934e-02 | -3.01 | positive regulation of lymphocyte differentiation | biological process | GO:0045621 | 135 | 2 | 18204 | 48 |
SYK,PTPRC |
4.934e-02 | -3.01 | positive regulation of production of molecular mediator of immune response | biological process | GO:0002702 | 135 | 2 | 18204 | 48 |
PTPRC,SYK |
4.943e-02 | -3.01 | human chr5p13.1 | chromosome location | human chr5p13.1 | 27 | 1 | 26134 | 49 |
DAB2 |
4.945e-02 | -3.01 | lung-carcinoid-endocrine_tumour-atypical | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour-atypical | 508 | 4 | 16828 | 46 |
SYK,GRK6,BMP2K,HCK |
4.956e-02 | -3.00 | bounding membrane of organelle | cellular component | GO:0098588 | 2198 | 10 | 19108 | 49 |
GALNT1,CEMIP,ACER2,STAB1,ATG14,DAB2,TFEB,PTPRC,ACACB,VMP1 |
4.957e-02 | -3.00 | PDGFR-beta signaling pathway | Pathway Interaction DB | pdgfrbpathway | 54 | 2 | 2226 | 15 |
HCK,GAB1 |
4.970e-02 | -3.00 | Fatty acid biosynthesis | KEGG pathways | hsa00061 | 13 | 1 | 7161 | 28 |
ACACB |
4.970e-02 | -3.00 | Fatty acid biosynthesis | KEGG pathways | ko00061 | 13 | 1 | 7161 | 28 |
ACACB |
4.976e-02 | -3.00 | positive regulation of response to biotic stimulus | biological process | GO:0002833 | 314 | 3 | 18204 | 48 |
RBM47,SYK,HCK |
4.978e-02 | -3.00 | ERLIN1 (ER lipid raft associated 1) | protein interactions | 10613 | 142 | 2 | 19454 | 49 |
DISC1,OSBPL8 |
4.978e-02 | -3.00 | Myh10 (myosin, heavy polypeptide 10, non-muscle) | protein interactions | 77579 | 142 | 2 | 19454 | 49 |
DAB2,BMP2K |
4.978e-02 | -3.00 | FH2 | smart domains | SM00498 | 15 | 1 | 9717 | 33 |
DIAPH2 |
4.986e-02 | -3.00 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 12 | 16828 | 46 |
VAV3,DOCK8,VMP1,PTPRC,ACACB,DAB2,SH2B3,DIAPH2,PREX2,PLXND1,PTPN6,NACC2 |
4.986e-02 | -3.00 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 12 | 16828 | 46 |
PLXND1,PTPN6,NACC2,DAB2,PREX2,DIAPH2,SH2B3,PTPRC,ACACB,VMP1,DOCK8,VAV3 |
4.999e-02 | -3.00 | protein dephosphorylation | biological process | GO:0006470 | 136 | 2 | 18204 | 48 |
PTPN6,PTPRC |